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Abstract 
In our studies towards the synthesis of tetronothiodin, we completed the synthesis 
of 195, a precursor of the oxaspirobyciclic unit of tetronothiodin. 
The synthesis was achieved in an eight step strategy and afforded the a-hydroxy 
lactone 195 as a diasteroisomeric mixture with 194 in a 5.7% overall yield. 
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Chapter 1: provides a report of the biological effects of tetronothiodin and a survey 
of a selection of previous syntheses of oxaspirobyciclic units. 
Chapter 2: states the progress and the shortfalls encountered during my three years 
of research. 
Chapter 3: provides experimental data for our studies. 
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Chapter 1 
Introduction 
1. Introduction 
Cholecystokinin 1 is a 33-amino acid intestinal peptide hormone that was 
discovered in the 1920's, purified in the 1960's, and was isolated as a gastrin-like 
material from brain tissue in 197 S by Vanderhaegen et al.! 
Lys-Ala-Pro-Ser-Gly-Arg-V al-Ser-Met-ne-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg-lle-Ser-Asp-Arg-
Asp-Tyr(S03H)-Met-Gly-Trp-Met-Asp-Phe-NH, 
CCK-33 
1 
CCK-33 1 is a linear polypeptide hormone closely related to gastrin_2 Both CCK 
and gastrin have a common terminal peptide amide sequence, but exhibit different 
biological effects on their target tissues_ CCK is found in the mammalian intestinal 
tract, where it acts as a peripheral hormone, and in the central nervous system 
where it is the most abundant peptide, and plays the role of a central 
neurotransmitter or neuromodulator_ 
1.1. Various types of CCK pep tides 
The two predominant naturally occurring molecular forms of CCK peptides are 
CCK-58 and the sulphurated octapeptide (CCK-8S) 2 produced by the l1S-amino 
acid preprocholecystokinin_ 3 
-Asp -Tyr -Met -GIy -Trp -Met -Asp -Phe -NH2 
I 
S03H 
CCK-26-33 or CCK-8 
2 
1 
They are found in the periphery (throughout the digestive tract and in the small 
intestine, with high concentration in the duodenum) with, to a lesser extent, CCK-
33, the biosynthetic precursor, and CCK-4 which is identical to tetragastrin (G-4) 
3, the minimal peptide sequence exhibiting a high affinity for CCK receptor 
binding sites.4 
Trp-Met-Asp-Phe-NH2 
Tetragastrin or CCK-4 
3 
Most gastrin-like activity in the brain is due to CCK-S in sulphurated (CCK-SS) 
and desulphurated (CCK-SNS) forms. Other molecular forms of CCK, which have 
the -COOH terminal penta-peptide sequence of gastrin in common, have also been 
identified including CCK-5, CCK-21, and CCK-l2. A shorter peptide, caerulein 4, 
sharing seven of the eight amino acid residues of CCK-S has been isolated from 
the skin of the Australian Hylide frog, Hyla Caerulea, by Anatasi.4 
Pyr-Gln-Asp-Tyr(S03H)-Trp-Gly-Trp-Met-Asp-Phe-NH2 
Caerulein 
4 
CCK-39 and CCK-59 are also found. Like CCK-S and CCK-33, these correspond 
to peptides produced by cleavage of the arginine residue. 
1.2. CCK as a Peripheral Hormone 
CCK is an adrenohypophyseal hormone (Le. it is secreted by the endocrine cells of 
the anterior pituitary gland (AP) called "mucosal epithelial cells"), and is regulated 
by hypothalarnic hormones. CCK is released into the bloodstream, by which it is 
2 
transported to the duodenum, where it exerts its effects by selective binding to 
specific protein molecules known as CCK receptors.5 
1.2.1. Effect on pancreatic releasing enzymes 
Older literature refers to cholecystokinin as "pancreozymin". This name comes 
from the fact that CCK stimulates delivery of digestive enzymes from the pancreas 
into the duodenum. The pancreatic enzymes are large proteins containing around 
twenty amino acids. They can be divided into three major groups, critical to 
efficient digestion: 
The proteases, which cause the bulk of protein digestion, 
The pancreatic lipases, recently used as a target for management of obesity, 
The amylases, the major dietary carbohydrate for many species found in starch, a 
storage form of glucose in plants. 
The secretion of these enzymes, with the action of associated bicarbonate, 
contributes to the transformations of nutrients into energy. 
These enzymes together have the capacity to reduce virtually all digestible 
macromolecules (proteins, polysaccharides and triglycerides) into forms that are 
capable of being absorbed, for example, amino acids, monosaccharides and fatty 
acids. 
1.2.2. Effect on Bile Release 
Cholescystokinin also provokes the contraction of the gallbladder: in fact, the 
name cholecystokinin (from the ancient Greek "gallbladder movement") was 
given to describe this effect, leading to the delivery of bile into the small intestine. 
Bile contains bile acids (derivatives of cholesterol), which are critical for digestion 
3 
and absorption of fats and fat-soluble vitamins. Also, many waste products are 
eliminated from the body by secretion into bile and elimination in faeces. 
1.2.3. Interdependence of CCK and digestive secretions 
Full biological activity such as gallbladder contraction, gut motility and pancreas 
secretion is retained by the C-terminal sulphurated octapeptide (CCK-8S).4 Both 
pancreatic enzymes and bile flow lead to digestion and absorption of the molecules 
that stimulate cholecystokinin secretion. When absorption is completed, 
cholecystokinin secretion ceases, stopping the release of bile and pancreatic 
enzymes. 
1.3. CCK as a Central Neurotransmitter or Neuromodulator 
Like many substances used as peripheral hormones, cholecystokinin is also 
produced by neurons. It is released into the synapse by the synaptic vesicles 
located in the axon of a neuron, crossing this gap to the receptor located on the 
dendrite of the next neuron, and therefore acting as a neurotransmitter.6•7 CCK also 
appears to act as a neuromodulator, modulating the activity of other hormones, and 
neuropeptides such as dopamine, serotonin (5-HT),8 endogenous opioid, and y-
arninobutyric acid (GABA).9 
CCK appears to be the most abundant neuropeptide in the central nervous system 
(including cerebral cortex, hippocampus, basal ganglialO-12 and spinal cordJ3) 
where it is found predominantly in two forms: CCK-8 (around 80%) and CCK-
4.1,14-16 
4 
1.3.1. Agonists and Antagonists 
Specific protein molecules, known as receptors, are usually located within the cell 
membrane, and respond to endogenous chemicals or drugs. Chemicals that bind to 
receptors, and in turn activate them, are called agonists. These agonists initiate 
changes in cell function, producing a response, which can cause various effects. 
The potency of agonists depends upon two functions: the affinity for the receptor, 
which is the tendency to bind to a receptor and form an agonist-receptor complex; 
and the efficacy or the ability, once bound, to initiate changes in the receptor 
which leads to a response. 
However, some chemicals prevent or reverse the actions of neurotransmitters by 
keeping them from binding to receptors. These chemicals are known as 
antagonists. There are two types of antagonists: the indirect antagonists such as 
cocaine or amphetamine, which produce their effects by changing the flow of 
neurotransmitters, and the direct antagonists which combine with receptors, yet 
fail to activate them. Direct antagonists and agonists find their efficiency by their 
ability to bind to a specific receptor. 
Initially, agonists and direct antagonists are attracted to receptors by relatively 
long-range electrostatic forces. Once there, their affinity for the receptor will 
depend on the "closeness of fit" and the number of chemical bonds that can be 
formed between the two molecules. The bonds formed are usually non-covalent 
(for example, hydrogen bonds and Van der Waals attractions). But, irreversible 
antagonists bind to receptors with strong covalent bonds, in contrast to competitive 
antagonists that bind reversibly to receptors. 
5 
1.3.2. Heterogeneity of CCK receptors 
The existence of two distinct CCK receptor types in peripheral and central tissues 
has been suggested by a study on rats and guinea pigs, by Innis and 
Snyder, 17 showing that pancreatic and brain CCK receptors differed markedly by 
their affinity for CCK-8 and CCK-4. Peripherally circulating CCK does not cross 
the blood-brain barrier, suggesting that peripheral and central CCK represents two 
d" f . al I 18 Istmct unctIOn poo s. 
This hypothesis was demonstrated by determination of the molecular mass of both 
types of receptors, their differential affinities for various agonists and antagonists, 
and by radioligand binding studies. These latter techniques involve competitive 
binding experiments carried out in order to measure the binding of a single 
concentration of labelled drug (the radioligand) in the presence of a range of 
concentrations of unlabeled ligand.19 The concentration of unlabeled drugs that 
blocks 50% of the specific binding of the radioligand IC50 (Inhibition 
Concentration of 50% of the specific binding) represents the reference value used 
to show the affinity of a drug for a receptor. It can validate the expected potency of 
a drug, determine whether a drug binds to a receptor, or determine receptors 
number and affinity,zo 
Thus, two receptor subtypes, CCKA and CCKB, have been identified. This 
nomenclature was intended to reflect their localisation: A for Alimentary and B for 
BrainY 
This was an oversimplification. Instead, the techniques of receptor 
autoradiography I and homogenate binding allowed the localisation of the two 
subpopulations of CCK receptors to be more accurate.22.25 
Both of the receptor types are present in the brain and in gastric mucosa, even if 
one is in a minority. Consequently, the nomenclature had to be modified. CCKA 
became CCKI and CCKB was changed to CCK2. Little information is available on 
6 
the molecular structures of these receptors: so far limited only to their amino acid 
sequences?6 The elucidation of their secondary and tertiary structures by means of 
X-ray or NMR spectroscopy still awaits the availability of sufficient quantities of 
purified proteins and crystallised samples. 
1.3.3. CCK type 1 receptor 
The CCKl receptor is the predominant peripheral CCK receptor. It is present in 
gastric smooth muscle cells and gallbladder and regulates most of the 
gastrointestinal apparatus by mediating pancreatic enzyme secretion, gallbladder 
contraction, gastric emptying and intestinal motility, as described above.27 
The CCKl receptor is also found in the brain, but only in discrete regions which 
possess a relatively porous blood-brain barrier, and therefore represent brain sites 
opened to peripherally release circulating CCK. These regions mainly include the 
dorsomedial hypothalamus, the IPN (Interpendecular Nucleus),28 the AP (Anterior 
Pituitary), where a chemosensitive trigger zone is found29 and the NTS (Nucleus 
Tractus Solitarius) where afferents (vessels and nerves) enter the brain.3D This 
central reception of peripherically circulating CCK hormones by CCKl receptors 
could imply that they are involved in inhibitory actions on food intake. 
It is important to mention that these localisations are not only found for humans, 
but differences in the distribution of central CCK binding sites also occur in other 
species.3l 
CCKl receptor sUbtype binds only with the CCK forms presenting the intact 
terminal heptapeptide that is required for the full nanomolar affinity between the 
receptor and the agonist.32 Because of this specificity, the type 1 receptor can 
differentiate between circulating CCK, gastrin, and other CCK fragments, as it 
does in the pancreas for example.23 
7 
1.3.4. Type 2 CCK receptor 
In contrast with the CCK1 receptor, the CCK2 receptor is the CCK receptor 
prevalently present in the central nervous system with a high density. It is diffusely 
distributed in the brain including regions such as ventromedial hypothalamus, 
nucleus accumbens, cortex, hippocampus, and the area of the limbic system and 
basal ganglia where it plays different role associated with its location.2.33 In these 
non-porous regions, the type 2 receptor is protected from circulating CCK and 
gastrin by the blood-brain barrier and is responsive to central neurotransmitter 
CCKonly. 
In the periphery, CCK2 receptors are rare. They have similar structural and 
pharmacological receptor profiles than the gastrin receptors and in consequence, 
can regulate gastrin effects.34 
Contrary to the CCKl receptor subtype, the CCK2 receptor is relatively non-
specific.21 It binds with various forms of CCK: CCK-8 and also its desulphurated 
form (CCK-8NS), pentagastrin and CCK-4 the smallest active form of CCK 
whereas the type 1 CCK receptor will exhibit a high degree of selectivity for the 
sulphurated form of the octapepetideP,21 This aspect allowed differentiating the 
two types of receptors and their role in the pathologies discussed in the following 
section, 
1.4. Therapeutic applications 
The precise physiological function of cholecystokinin remains to be elucidated and 
is most intriguing. 
Diseases related to CCK can result from either its deficient or excessive secretion. 
CCK deficiency has been described in humans as a part of auto immune 
8 
polyglandular syndrome, and is manifested as a malabsorption syndrome clinically 
similar to pancreatic exocrine insufficiency.35 
Excessive production of CCK, or highly efficient assimilation by the receptors 
within the human brain, may play a part in several syndromes such as certain types 
of anxiety, panic attacks36 and schizophrenia37, nociception, and aberration in 
feeding behaviour.35 
1.4.1. Role of CCK in nociception (perception of the pain) 
CCK is found in CNS regions associated with pain modulation and opioid 
analgesia. In this regard, studies have established that CCK receptors are 
functional modulators of the opioidergic system with a tonic antiopioid effect in 
nociceptive pathways, and that CCK antagonists potentiate opioid analgesia and 
may also have intrinsic analgesic activity.38.39 This observation could lead to 
pharmacological applications in the treatment of pain. For instance, CCK 
antagonists may be useful as adjuvants to morphine induced analgesia in the 
treatment of pain and for preventing the development of opioid tolerance in 
patients receiving repeated injections of morphine for chronic pain. The action of 
endogenous CCK at CCK2 receptors opposes the action of endogenous opioids at 
opioid receptors. 
When morphine is administered, its opioid agonist action overcomes the effect of 
endogenous CCK, and analgesia results. This balance can be shifted by injecting 
an exogenous CCK antagonist, which opposes the action of morphine and 
decreases pain thresholds.4o 
1.4.2. Role of CCK in psychotic behaviours 
Patients with schizophrenia produce more dopamine than is normal. Clinical 
studies have also revealed that they show altered human cerebrospinal fluid (CSF) 
9 
levels of CCK. In addition, CCK and dopamine coexist in a subpopulation of 
meso-limbic neurons.41 Dopaminergic agents have been proven to alter the number 
of CCK brain binding sites, and CCK administration has been shown to increase 
dopamine binding sites in tbe brain.35 
These observations may reveal an interaction between dopamine and CCK. It is 
even thought that CCK2 receptors may potentiate dopamine-mediated motivational 
mechanisms which are driving exploratory behaviour.42 CCK might tberefore be 
used as a neuroleptic and antipsychotic agent. However, no clinically useful drugs 
have been yet reported, to our knowledge. 
1.4.3. Role of CCK in anxiety 
1.4.3.1. Action of CCK 
The known interaction of CCK with neurotransmitters implicated in anxiety states, 
such as GABA, 5-HT and norepinephrine, support the potential role of CCK in 
mediation of anxiety.9 In the same way, CCK-4 mainly, but also CCK-8 and 
pentagastrin, have panicogenic and anxiogenic effects similar to C02 effects.43.44 
On the basis of tbe accumulating evidence of abnormal CCK function in panic 
disorder, CSF and lymphocyte45 studies present a lower concentration of CCK-8S 
in panic disorder patients tban in normal comparison subjects. The decrease in 
CCK-8 concentration reflects a compensatory increased CCK-4 activity (in vitro 
studies in rodents have shown tbat pretreatment of cell preparations witb CCK-4 
prevent CCK-8 induced neuronal firing). 46 
This fact has been confirmed by tbe panic-like attack resulting from the 
intravenous administration of selective CCK2 receptor agonists CCK-4 and 
pentagastrin, which can cross the blood-brain barrier to act centrally through 
10 
excitation of deep cortical and hippocampal neurons, of the amygdala, and 
possibly other areas related to anxiety. 45,47 
1.4.3.2. Treatments with CCK antagonists 
Panic-inducing agents can be effectively prevented by pre-treatment with a CCK2 
receptor antagonist.48 The efficiency of CCK2 receptor antagonists in anxiolytic 
activity was revealed by several standard anxiety tests such as "the mouse 
light/dark compartment test" (the preference for the dark side of the box observed 
in the mice, is suppressed by the injection of the selective CCK2 antagonists), or 
"the rat elevated plus-maze test" (the time spent by the mice in the open arms of 
the elevated plus-maze is increased by the injection of the selective CCK2 
antagonists).2,49 In contrast, CCK-SS, an agonist of CCK] receptor, induced 
intestinal symptoms but did not induce apparent anxiety. These experiments 
suggest that CCK2 receptor is the only CCK receptor involved in the process of 
anxiety. 
However, the role of CCK] in anxiety is not so clear. Controversial results were 
obtained with L-365,031 5; a pattern for CCK] receptor antagonists, which was 
mostly found to be inactive in the rodent tests of anxiety but which showed 
anxiolytic profiles in some other cases where CCK2 antagonists were inefficient. 50 
L-365,031 
5 
11 
In addition, devazepide 6, another selective CCKI receptor, which was inactive in 
most of the studies, blocked brain CCKI receptors at excess doses.51 Other 
behavioural studies have reported devazepide to be active at very low doses in the 
rodent tests. However, its effect was not dose-related and it was only active at one 
of the doses tested.50 
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To conclude, interpretation is difficult but it seems that both CCK2 and CCKI 
receptors may be involved in the expression of distinct forms of anxiety or panic in 
humans. 
1.4.4. Role of CCK on feeding behaviour 
The possibility that bulimia might be associated with anxiety and not with core 
symptoms of eating disorder was exposed after CSF studies giving the same 
results with patients affected by bulimia nervosa as by anxiety.8.52 Researches on 
implications of CCK in the processes of eating disorders were subsequently 
carried out. CCK abnormalities were encountered in bulimia and anorexia 
nervosa.8.53,54 Injection of cholecystokinin into the ventricles of the brain induces 
satiety in laboratory animals. 55-57 CCK appeared to play a role, through both 
peripheral and central mechanisms, in stimulating cessation of feeding following 
food intake in a larger number of animal species and in obese humans,58,59 
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The idea of a link between eating disorder and anxiety was supported by the fact 
that patients with bulimia exhibit high anxiety, and the inhibitory action of CCK-8 
on food intake is dependent on intact function of central serotonin, a 
neurotransmitter also involved in satiety as well as anxiety. 
Consequently, experiments, involving starving rats were carried out. The 
anti satiety effects of both type 1 (devazepide 6 and proglumide 10) and type 2 (L-
365,260 17) receptor antagonists were demonstrated (see section 1.5.2.2 and 
section 1.5.2.3).60.61 
1.4.5. Limits ofthe therapy 
One major problem of this type of therapy remains in the drug addiction. 
Sometimes, cells adapt to previous drug exposure. For example, long-term 
treatment with CCK antagonists could increase the number of CCK receptors. This 
would happen as the nervous system tries to make up for less stimulation of the 
receptors by CCK itself. Likewise, the receptors themselves could become more 
sensitive to CCK. Both cases are examples of a process called "sensitisation". 
Tolerance, the opposite process, could also affect the therapy. Indeed, the nervous 
system will attempt to maintain homeostasis. By this process, it keeps a constant 
level of cell activity in spite of major changes in receptor stimulation due to the 
presence of foreign chemicals. In its attempt to keep the body in a state of 
equilibrium, the nervous system could defeat the strategy. 
1.5. CCK receptor antagonists 
The CCK field of research has been widened because of the diversity of structure 
types that are known to be antagonists. Comprehensive structure-affinity 
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relationship studies (SARS) between antagonists and receptors revealed regions of 
the antagonist molecules which induced modulation of physiochemical properties, 
and often resulted in improved CCK receptor affinity and selectivity. 
Antagonists range from peptides to cyclic nucleotides and benzodiazepines and 
have been classified into several main groups described below.49 
1.5.1. Pep tides and pseudopeptide analogues 
The major naturally occurring molecular forms of CCK are polypeptides. 
Therefore, peptides which can act as CCK antagonists have been developed. Their 
synthesis was based on the deletion or modification of phenylalanine at the 
carboxy-terminal of CCK, and three rules had to be respected: the sequences 
synthesised could not be smaller than a tetrapeptide, which represents the smallest 
required sequence for recognition by CCK2 receptors; the presence of a terminal 
amide, which is an important determinant of the inhibitory potency of the 
antagonist, was essential; and the presence of L-tryptophan 7 residue, important 
for binding to central and peripheral CCK receptors is also necessary. 
1.5.1.1. Peptides 
L-tryptophan 
7 
Deletion of the phenylalanine carboxy-terminal from CCK produces an antagonist: 
CBz-Tyr(S03H)-Met-Gly-Trp-Met-Asp-NH2 (CBz-CCK-27-32-NH2)' which is 
the most potent peptide CCK receptor antagonist described to date. It is 
approximately 30 times more potent than dibutyryl cyclic guanosine 
monophosphate (Bt2CGMP) (see section 1.5.2.1). But with an ICso of binding of 
14 
125r -CCK in guinea pig pancreatic acini of about 3/-tM, it does not compete with the 
potency of CCK-8 (IC50"'lnM).62 
Similarly, antagonists based on the modification of the partial C-terminal sequence 
of CCK have been investigated and Boc-Tyr(S03H)-Met-Gly-Trp-Met-X-Phe-
NH2 (where X is an amino acid) were found to be highly potent antagonists of the 
gastrin receptor.63 
Unfortunately, peptides and modified peptides show rapid in vivo degradation by 
proteases. Enzyme-resisting and potent pseudopeptide analogues of CCK are 
therefore interesting synthetic targets. 
1.5.1.2. Pseudopeptide analogues 
In vivo, degradative activity cleaves peptides at specific peptide bonds. Thus, it has 
been necessary to turn to the novel field of peptidomimetics to design 
pseudopeptide compounds which are used for their biological activity, but are 
resistant to degradation in vivo. 
Pseudopeptide analogues have been obtained by modifying the backbone of CCK 
or gastrin. Sequential replacement of each of the amide linkages in a CCK-4 
analogue (Boc-Trp-Leu-Asp-Phe-NH2) was investigated. 
Peptide bonds, between leucine and aspartic acid, and between aspartic acid and 
phenylalanine, were replaced by CHzNH bonds (schematised as 'II[CHz-NH]). The 
two resulting pseudopeptides, Boc-Trp-Leu'll[CH2-NHj-Asp-Phe-NH2 and Boc-
Trp-Leu-Asp'll[CH2-NHj-Phe-NH2, were found to act as antagonists of 
pentagastrin-stimulated acid secretion.64 
Similarly, antagonists from CCK-8 were synthesised by replacing the peptide bond 
between norleucine and glycine by a ketomethylene bond ('II[CO-CH2]). Thus, 
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Boc-Tyr(S03H)-Nle\jl[CO-CH21-Gly-Trp-Nle-Asp-Phe-NH2 was found to be a 
very potent inhibitor of the binding of radiolabeled CCK-8 to rat pancreas 
(lCso:::::SnM) and mouse brain (ICso"'O.7nM).64 
Unfortunately, very few peptidal and pseudopeptidal analogues were obtained, 
primarily due to the limitations inherent in the peptide structure itself. In addition, 
they show a poor oral bioavailability, partial agonist actions, and a lack of 
specificity. 
1.5.2. Non·peptidal analogues 
In contrast, non-peptidal analogues offer possible solutions, as they can be orally 
effective, metabolically stable, and can present a high affinity for CCK receptors. 
At least ten chemical classes of CCK non-peptide antagonists have been described. 
1.5.2.1. Derivatives of nucleotides 
Very limited studies have been focused on nucleotides; only on the pancreatic 
acini and ileum of the guinea pig. Guanyl nucleotides such as Bt2CGMP 8 have 
been shown to be the best CCK antagonists of this group.6S.66 This group is 
unfortunately not highly potent. 
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Nevertheless, cyclic nucleotides provide mechanistic insights. 
In the case of a nucleotide, one possibility has been suggested by MiIIer,67 that 
cyclic nucleotides are indirect antagonists, and combine with CCK to prevent or 
interfere with binding of the peptide to its receptor. This idea was confirmed by 
Gaudreau et al. The data obtained during their experiments suggest that the 
binding of the radioligands to CCK receptor sites is regulated by guanyl 
nucleotides.68 
1.5.2.2. Derivatives of amino acids 
Several amino acid derivatives were reported to act as CCK antagonists but with 
poor binding affinity for the receptors. Attention was, however, focused on two 
compounds: p-chlorobenzoyl-L-tryptophan (benzotript) 9, a glutaramic acid 
derivative and benzoyl-DL-glutamic acid dipropylamide (proglumide) 10, a 
derivative of tryptophan, the first gastrinlCCK antagonist used for the treatment of 
ulcers.69 
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However, they feature poor potency and selectivity compared to the antagonists 
examined previously (Table 1),62 
Table 1: Inhibition of e2SIjCCK-33 binding to CCK receptors in rat pancreas and 
brain 
Antagonist ICso (I!M) ICso (I!M) CCKdCCK2 
rat pancreas CCK] rat brain CCK2 
CBz-CCK-27-32-NH2 35±OA 6,8 ±0.8 0.51 
Bt2CGMP 87 ± 11 1600± 300 0.05 
Benzotript 102 ± 18 84 ± 13 1.21 
Proglumide 600±58 875 ± 125 0.69 
In consequence, studies towards the synthesis of new compounds such as 
glutamaric acid derivatives have been achieved. Surprisingly, the conclusions 
showed that neither tryptophan nor its various derivatives, in terms of their 
abilities to function as CCK receptor antagonists, depend on the stereospecificity 
of the tryptophan moiety?7 In contrast, it appears that potency was increased with 
increased hydrophobicity of the N-acyl moiety.7o N-carbobenzoxy-tryptophan was 
the most potent of the compounds tested. 
In the same way, glutaramic acid analogues such as lorglumide (CR 1409) 11 and 
loxiglumide 8 proved to have a potent antagonistic effect on gallbladder CCK] 
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receptors.71 For example, lorglumide 12 is 7000 times more potent than 
proglumide in displacing binding to CCK] receptors on pancreatic acini (Table 2).z 
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Table 2: Inhibition of eZSljCCK-33 binding to CCK receptors in rat pancreas and 
mouse cortex 72 
Antagonist ICso (nM) ICso (nM) CCKdCCKz 
rat pancreas CCK] mouse cortex CCKz 
Devazepide 0.19 ± 0.Q1 31.7 ± 5.0 0.006 
CR 1409 7.1 ± 0.5 >1000 <0.007 
Chemical manipulations of its structure, which found its CCK-antagonist activity, 
partially because of its R form, led to CR 2194 13.73 CR 2194 is the most potent 
CCKz antagonist among this class of chemicals. 
~Jyy ~y 
CR2194 
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However, the inhibitory potency of these classes of CCK receptors is relatively 
low, and this may limit their applications in in vivo systems. 
1.5.2.3. Benzodiazepines 
The selectivity of benzodiazepines has been confirmed for the cloned human 
CCK] and CCKz receptors. The benzodiazepines are chemicals used as active 
ingredients in mind-affecting drugs such as valium. They provide anxiolytic 
action, ataxia, and sedative effects exerted through specific recognition sites on the 
GABA receptor complex. 
In 1985, a fermentation product of Aspergillus alliaceus called asperlicin 14 was 
found to be the first effective nonpeptidal ligand CCK antagonist, possessing a 
better potency than the most widely used antagonists proglumide and benzotript 
(ICso"'lf!M, binding of e2sI]CCK-33 in rat pancreas). 
Asperlicin 
14 
Presenting poor water solubility, and a lack of oral bioavailability, asperlicin was 
not effective pharmacologically and could not be used as a potential therapeutic 
agent. Attempts have subsequently been made to improve its physical properties. 
Design of potent, orally effective benzodiazepines fusing the elements of 
diazepam 15 and D-tryptophan 16 was undertaken (Figure 1).74 
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First generation compounds, devazepide (also known as L-364,718 or MK-329) 
675 and L-365,260 1776 are respective selective antagonists of CCKl and CCK2, 
confirming and extending the original findings. 
L-365,260 
17 
Their high affinity permitted a much clearer differentiation between the two 
classes of CCK-receptors,77 Nevertheless, the low aqueous solubility of their 
crystalline form (0.002 mg.mL,1 at pH=7.4) required the benzodiazepine structures 
to be improved. The development of selective CCK1 receptor antagonists has not 
been significant, except for IQM-95,333 18 (from a series of I, 3-
dioxoperhydropyrido [I, 2-c] pyrimidine derivatives); devazepide 6, is the 
21 
commonly used pattern of CCK] receptor antagonists. In contrary, L-365,260 5 
has been replaced by more recently developed antagonists. YM-022 19 is an 
example of this evolution, exhibiting superior affinity and selectivity among 
benzodiazepine CCKz receptor antagonists (Table 3). 
IQM-95,333 
18 
YM-022 
19 
Table 3: Estimated binding affinities for the cloned human CCK] and CCK2 
receptors 78 
Antagonist ICso (nM) CCK] ICso (nM) CCK2 CCK]/CCK2 
L-365,260 589 12.6 47 
YM022 316 0.05 6000 
SARS revealed regions of the molecule which permitted improvement, CCKz 
receptor affinity and selectivity. 
A second-generation of benzodiazepines incorporating basic or acidic solubilising 
functionalities (sometimes 10 times more soluble than L-365,260 17) has thus 
been obtained. Compounds which incorporate an aminotetrazole unit attached to 
the phenylurea moiety of L-365,260 17 were designed and synthesised such as L-
738,425 20, most selective CCK2 reported so far (CCKdCCKz, 37000) and L-
736,380 21 showing an extremely high affinity due to the fact that it is very 
lipophilic (ICso=0.054nM, binding of eZSljCCK-8S in guinea pig cortical 
membranes).79 
22 
L-738,425 
20 
L-736,380 
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The real problem with these compounds is the tolerance developed to many of 
their behavioural effects following long-term administration.9 
1.5.2.4. Dipeptoids 
The synthesis of dipeptoids (derived from a non-contiguous dipeptide fragment of 
CCK) would be predicted to have a more improved side-effect profile in man than 
benzodiazepines. Indeed, CI-988 22 is an orally active compound which can be 
defined as anxioselective: it produces anxiolytic-like actions in several animal 
models of anxiety and does not appear to possess the adverse properties associated 
with benzodiazepines (like ataxia or myorelaxant effects).8o 
CI-988 
22 
23 
Table 4: Inhibition of e2SljBH CCK-8S binding to CCK receptors in guinea pig 
pancreas and cortex81 
Antagonist ICso (nM) ICso (nM) CCK1/CCK2 
g. pig pancreas CCK1 g. pig cortex CCK2 
L-365,260 86±29 8.1 ± 1.6 11 
CI-988 490± 170 0.65 ±0.03 754 
Here again, the stereochemistry of the compounds influences their behaviour. For 
instance, PO 135666 is a selective CCK2 receptor antagonist (ICso=O.lnM, binding 
of [12SljCCK_8S in mouse cerebral cortex), whereas its enantiomer PO 140548, 
shows a selectivity for the type 1 receptor (CCK1 ICso=2.8nM, binding of 
e2SljCCK-8S in rat pancreas; CCK2 ICso=260nM, binding of e2sI]CCK-8S in rat 
pancreas) (Table 5).82 
Table 5: Inhibition of e2SIjBH CCK-8S binding to CCK receptors in rat pancreas 
and mouse cortex82 
Antagonist ICso (nM) ICso (nM) CCK/CCK2 
rat pancreas CCKl Mouse cortex CCK2 
PO 135666 26± to 0.15 ± 0.06 170 
PO 140548 2.8 ± 2.3 260 ±50 0.01 
1.5.2.5. Other groups of CCK antagonists 
Likewise, but less significantly, quinazolinones 23 (based on the observation that 
asperlicin 14 contains a 3-phenyl-4-(3H)-quizanolinone nucleus), 
diphenylpyrazolidinones, ureidoacetamides, even hybrid CCK antagonists such as 
A-64,718 24, (prepared by coupling lorglumide 11 and devazepide 6) (Scheme 
1)83 may serve as potent non-peptidal chemical classes of CCK receptor 
antagonists. 
24 
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1.6. General remarks about tetronothiodin 
devazepide 
12 
Finally, looking forward to structurally unique and specific new receptor 
antagonists, tetronothiodin 26 was discovered through a screening process. The 
screening process involved microbial metabolites being screened through binding 
assays. In 1992, a binding assay method, involving rat cerebral cortex membranes 
as receptors and 125r-labelled Bolton Hunter CCK-8 as the radioligand, found a 
novel CCKz receptor antagonist called tetronothiodin. The screening process 
25 
discovered tetronothiodin from the culture broth of Streptomyces sp. NR0489, a 
bacterium which produces a quantity of various enzymes and metabolites.84•88 
Like other natural products produced by Streptomyces sp. including anthramycin 
25,89 tetronothiodin 26 was isolated through a procedure that first used 
fermentation of the strain NR0489. 
anthramycin 
25 
After a cultivation period of ten days, centrifugation is carried out to give the 
growth supematant, and its pH was adjusted to allow column chromatography. 
Concentrating under reduced pressure, further re-extraction of aqueous layers and 
column chromatography gave an active organic compound. Final purification was 
achieved using reverse-phase preparative HPLC to give 26 as pale brown 
powder.87 
HO 
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1.6.1. Biological activity of tetronothiodin 
The inhibitory activities of tetronothiodin against the binding of [125Ij_CCK_S to 
CCK1 and CCK2 receptors were tested. The test procedure involved incubation of 
test samples at 23°C with e25Ij-CCK-S of either pancreatic membranes 
(containing CCKl receptors) or cerebral cortex membranes (containing CCK2 
receptors), both of which are in a buffer and bovine serum albumin solution. After 
the samples reached eqUilibrium, they were filtered and the radioactivity was 
counted. 
Tetronothiodin 26 was shown to inhibit the binding of [125Ij_CCK_S to CCK2 
receptors on rat cerebral cortex membranes in a concentration dependent manner. 
The affinity of 26 to CCK2 receptors was shown to be three to four times greater 
than known potent and selective CCK2 receptor antagonists, and only three times 
less potent than the natural ligand CCK-S. Tetronothiodin did not, however, inhibit 
the binding of eZ5Ij-CCK-S to CCK1 receptors on rat pancreatic membranes. The 
ratio of affinity for CCK2 to CCKl receptors of tetronothiodin was more than 
27000; it is thus a highly selective binding inhibitor for CCK2 receptors, with 
selectivity much greater than most known antagonists (Table 6). 
Table 6: Inhibition of e25IjCCK-S binding to CCK receptors in rat pancreas and 
cortex90 
Antagonist 1C5o (IlM) IC50 (IlM) CCKdCCK2 
rat pancreas CCK1 rat cortex CCK2 
Tetronothiodin >100000 3.6 ± 0.33 >30000 
L-365,260 2700± 130 S.l ± 0.90 300 
Asperlicin llOO±200 >10000 <0.1 
Devazepide 0.51 ± 0.18 320±50 0.002 
Proglumide 50± 12 640 ± 150 O.OS 
Loxiglurnide 140 ± 33 4600±7S0 0.03 
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The results were further corroborated by tests on GH3 cells from rat anterior 
pituitary gland (cells considered as "pro-vitamins" that secrete the two pituitary 
polypeptide hormones, prolactin and growth hormone), which contain CCK2 
receptors. Tests with the same GH3 cells demonstrated that intracellular Ca2+ 
(known to control fundamental neuronal functions such as neurotransmitter 
release) was increased in a concentration-dependent manner and that 
tetronothiodin 26 inhibited this increase in the same dependent manner. 
1.6.2. Structural elucidation 
The isolation procedure of tetronothiodin 26, which involved extraction with ethyl 
acetate at pH=2 and back extraction with water at pH=7.5, indicated its acidic 
nature. Tetronothiodin 26 was found to be soluble in methanol, tetrahydrofuran, 
dimethylsulfoxyde and alkaline water but insoluble in ether, chloroform, hexane 
and water. The free form of tetronothiodin was unstable in solution; it gradually 
decomposed during NMR experiments over two weeks in DMSO-d6 or CD30D. 
Its alkaline metal salts were stable for at least five months under the same 
experimental conditions. The molecular formula of tetronothiodin was found to be 
C310sH3SS based on positive-ion FAB-MS (mJz 593 (M+».and negative-ion high 
resolution FAB-MS data (596.2237, calculated for M-H, C310sH37S - 569.2210). 
This molecular formula was further supported by qualitative analysis for sulphur 
and analyses of the IH NMR and the l3C NMR spectra, which shows 31 carbon 
signals.39 
Structural elucidation was mainly carried out based on the NMR data obtained 
with the potassium salt of tetronothiodin in D20 because all the carbon signals 
were observed in this solvent, compared to the use of DMSO-d6, which hides two 
carbon signals (Figure 2). 
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Interpretation of the IH_IH COSY spectra shows allylic coupling between H-8 and 
the methyl protons H-28 connecting the olefinic carbon C-8 and the quaternary 
carbon C-7. The fragments shown in Figure 2 and the remaining quaternary 
carbons, C-3, C-4, C-26 and C-30, were connected to form the partial structure 
based on the analysis of the 13C)H long-range couplings (shown by the arrows in 
Figure 3) obtained by HMBC experiments (Figure 3).84,87 
HO 
Figure 3 
E-stereochemistry was determined in all three double bonds in the macrocyc1e 
from the large coupling constant (J IS Hz) associated with these olefinic proton 
signals. A hydroxyl proton was located at C-16 through a spin-spin coupling 
experiment with H-16 in DMSO-d6• 
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Comparisons of the l3C NMR spectral data with a carolic acid derivative 279] 
shown in Figure 4, suggested the presence of an a-acetyl tetronic acid.92 The 
suggestion was confirmed by UV, and IR spectroscopy. IR indicated the presence 
of a y-lactone with a clearly separated band at 1760 cm'] as well as absorption 
bands at 3000-2300 and 1728, suggesting a carboxylic acid. The UV spectrum in 
methanol indicated absorption maxima at 233 and 273 nm, which were attributed 
to an a-acetyltetronic acid functionality. 
The carbon signals assigned at C-l, C-2, C-23 and C-26 all correspond to a 
tetronic acid moiety in tetronothiodin. This moiety was deemed to be attached to 
the cyclohexene ring at C-4 because of the 13C)H long-range coupling between H-
5a and C-3 (Figure 4). 
27 
Figure 4 
l3C)H long-range coupling was observed between H-23 and C-24, suggesting the 
linkage of C-23 and C-24 through a heteroatom or quaternary carbon even though 
protons H-23 and H-24 were not coupled. This suggested either a sulfur atom or 
keto function inserted between C-23 and C-24. The cyclopentanone was 
eliminated as the possible structure through l3C chemical shift and structural 
analysis of the reduced derivative. It was therefore reasonable to assume a sulfur 
atom between the two carbons, forming a tetrabydrothiophene ring. Comparisons 
with position 5 in dimethyl(2a,3~,4a)-2-(trimethylsilyl)tetrabydrothiophene-3,4-
dicarboxylate 28,93 by chemical shift data further corroborated this structure 
(Figure 5). 
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Confirmation of the tetrahydrothiophene unit left two possible structures A and B 
for tetronothiodin (Figure 6). 
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Allocation of the only remaining carboxylic function to either the C-26 or C-30 
position was achieved through reduction of tetronothiodin by sodium borohydride 
to give the epimeric alcohols 29a and 29b. The newly observed proton signal was 
assigned to H-30 by IH)H COSY experiments and shown to be spin-coupled only 
to H-23. This established the structure to be represented by A in Figure 6 and the 
gross structure to be established as 26 (Figure 7). 
HO 
26:RI =R2 =C=O 
29a,29b: RI = H, R2= OH 
Figure 7 
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1.6.3. Stereochemistry 
The relative stereochemistry for the six of the eight stereocentres has been 
determined through a series of nOe and long-range selective proton experiments 
(LSPD) carried out on the sodium salt of tetronothiodin in DMSO-d6 (Figure 8). 
A nOe between H-9 and H-5b indicated the cis relationship between these protons. 
A small coupling constant (J 2 Hz) between H-9 and H-8 was determined by 
homodecoupling, supporting the pseudo axial orientation of H -9. The cis 
relationship between C-27 and H-5a was determined by a strong nOe between H-
5a and H-27 and a weak nOe between H-5b and H-27. The coupling constant 
between C-3 and proton signals H-5b and H-9 was determined to be less than 4 Hz 
using a long-range coupling experiment with a double irradiation technique. The 
coupling constant between an axial proton and axial carbon would be large due to 
a trans relationship, thus these small coupling constants indicated a cis relationship 
between C-3 and H-5b or H_9.87 
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The cis relationship between H-23 and H-25 was established by the nOe between 
these protons for the tetrahydrothiophene ring (Figure 8). 
Treatment of the free acid of tetronothiodin in CD30H resulted in the complete 
disappearance of the active H-25. Treatment of this sample with methanol 
recovered tetronothiodin without epimerisation at C-25 as revealed by the IH NMR 
32 
spectrum. This then showed that only one stable configuration exists in solution, 
and thus the less hindered more thermodynamically stable trans relationship was 
assigned to the substituents C-22 and C-25, giving the partial structure shown 
(Figure 9).87 
Figure 9 
The stereochemistry for six of the eight stereocentres has thus been determined 
based on detailed spectroscopic analysis, although it is not supported by X-ray 
crystallography. 
The stereochemical arrangement of the hydroxyl and methyl group at positions 16 
and 21 respectively in the macrocyclic ring is currently unknown. Tetronothiodin 
26 is depicted as shown above, with two stereocentres unassigned. 
HO 
:7 :7 
.& HO 0 
H02C 
0 
26 
1.7. Synthesis 
Our synthetic approach is based around a flexible and convergent route, with the 
target molecule disconnected into three units; the oxaspirobicyclic unit 30, the 
33 
tetrahydrothiophene 31, and the unsaturated macrocyc1e framework 32 (Figure 
10). 
W E~~O 
30 
HO 
26 
31 
Figure 10 
32 
The synthetic plan involves a three stage construction of the oxaspirobicyc1e 
moiety, perhaps the most challenging feature of the molecule, and our aim in this 
thesis. This will be followed by preparation of the linking alkenol chain and 
macrocycIisation, and finally construction of the tetrahydrothiophene unit which is 
already under elahoration in our laboratories. 
There have been several different attempts to synthesise an oxaspirobycyc1e unit 
of structurally related antibiotics in terms of a macrocyclic molecule containing an 
a-acyltetronic acid. 
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1.7.1. Analogous spirocycles in other natural products 
The structure of tetronothiodin is related to a number of other natural products 
which contain analogous upper exo-spirotetronate fragments. In this section, we 
will be focusing specifically on investigations leading to the synthesis of these 
spirotetronate substructures. 
1.7.1.1. Aglycones of antitumor antibiotics 
Chlorothricolide 33, the aglycone of the chlorothricins, was one of the first 
compounds of the family isolated from Streptomyces antibiocus in 1969. These 
compounds inhibit pyruvate carboxylase (the enzyme that catalyse the irreversible 
carboxylation of pyruvate into oxaloacetate in the process of energy generation) 
and are active against Gram-positive bacteria.94 
H~C02:'Me 
~"", '''0 
HO ~ 
o 
o 
OH 
Chlorothricolide 
33 
Kijanolide 34 is the aglycone of kijanimicins, which are the major components of 
a complex of antibiotics produced by Antinomadura kijania SCC1256. It shows 
antitumor activity.95 
35 
Kijanolide 
34 
Tetronolide 35 is the aglycone of tetrocarcins (A, B, C, El, E2, F and F-l), which 
are isolated from the culture broth of Micromonospora chalcea KY 11091. These 
complex glycosides show activity against several types of tumours such as Ehrlich 
carcinoma,96 and show specific inhibitory activity towards Bcl-2 functions (genes 
that encode the protein that blocks the apoptotic death of some cells).97 
""Me 
OH 
Tetronolide 
35 
Finally, PA-46101 A 36 is an anti-bacterial agent isolated from the culture broth of 
a streptomycete.98 
36 
1.7.1.2. Quartromicins 
R = disaccharide 
PA-46JOl A 
36 
The quartromicins 37 are a family of antibiotics first isolated from Amycolatopsis 
orientalis Q247-8 in 1991. They possess antiviral activities against some types of 
herpes, influenza and human immunodeficiency virus. The quartromicins possess 
four spirotetronic acid units. Quartromicins A], A3, DJ and D3 are symmetrical, 
dimeric structures, in which the spirotetronic acid subunits at opposite corners of 
the structure are identical. Two of the subunits contain a-galactopyranosyl residues 
connected to C-26 and C-26'. The other type of spirotetronate is referred to 
agalacto fragments. The remaining A2 and D2 quartromicins differ from the C2 
symmetric members in that the two agalacto fragments have different oxidation 
states for C(8) and C(8') (Figure 11). 
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Since the structure elucidation of these two families in 1980, they have attracted 
considerable synthetic interest. In this section, some synthetic routes used for 
forming some of these fragments are discussed. 
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1.7.2. Strategy of synthesis for the exo-spirotetronate units 
1.7.2.1. The Bimolecular Diels-Alder approch 
1.7.2.1.1. Initial attempts 
The Diels-Alder reaction has been used from the very first synthesis of the upper 
fragment of kijanolide described by Y oshii et al. 99 This synthesis was also based 
on the treatment of ketone 43 with six equivalents of ethynylcerium dichloride 44. 
The bulkiness of cerium favoured equatorial attack to produce the acetylenic 
carbinol 45 (Scheme 2). 
HC=CCHO 9CHO ~ 39 I ~,,,,,, MOMO '" '" ~ ------ MOMO~"," a + PhMe, reflux, 20 h OHCy/"" MOMO~"",y" OIMS OIMS OTMS 
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By cycloaddition of the triene 38 with propargyl aldehyde 39 only a mixture of 
regioisomeric cycloadducts 40 and 41 was obtained. The yield was reasonable but 
the diastereoisomeric ratio was poor. This method was obviously unsatisfactory, 
and consequently, another route (described in the same publication) involving the 
cycioaddition of triene 46 and 5-methylenetetronate 47 was performed by the same 
group (Scheme 3).99 
J::(O 
I (OMOM 47 R-H TBDMSO~ - TBDMSO~"", 
o-C6H4(Cl)z. 180 QC MoO 
43% 46 48a 
Scheme 3 
A mixture of diastereoisomeric adducts 48a and 48b in a 1:3 ratio was obtained, 
unfortunately a yield of only 43% resulted from this method. 
Several dienophiles derived from (y-methylene)tetronate 47 were used in another 
of the first syntheses of Chlorothricolide. The best result was obtained with 49 (R 
= 2,4-ChC6H3COZ), a ratio of 61:24: 15 of three isomeric adducts 50a, SOb and 51, 
respectively endo, exo and a regioisomer were obtained (Scheme 4).100 
40 
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49 
83% 
HO 
Scheme 4 
Attempted synthesis by the Page group 
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One of the initial proposals for the synthesis in the Page group included a Diels-
Alder reaction of the hydroxydiene 52 with nitroethylene 53, followed by a Nef 
reaction to yield to the substituted cyclohexenone 55 (Scheme 5).101 
j; toluene, r.t. RO~ Nef RO~ TMSCN 36 h 
NO, 0 
35-50% 
52 53 54 55 
R=HorPG 
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56 
SchemeS 
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The Nef reaction was more difficult to perform than it was originally anticipated, 
and the complete lack of any of the desired product suggested a failure to form the 
nitronate anion, necessary for subsequent transformation to the keto group. The 
difficulty thus came probably in the deprotonation of 54. Changing the procedure 
gave decomposition of the starting material, and the anion, if formed, was very 
unstable. 
Alternatively, another route leading to the ketone 55 involving a Pummerer 
rearrangement was planned.lOl The use of phenyl vinyl sulfoxide as dienophile 
was envisaged, to give the Diels-Alder product 57 in Scheme 6. 
~ I toluene, 170 'C r" sealed tube, 3 days BnO S(O)Ph 
35% 
RO~_Pum_A_:_:_re_r_~  
S(O)Ph 0 
57 55 
Scheme 6 
The subsequent Pummerer reaction failed and the ketone 55 could not be 
prepared.IOI 
1.7.2.1.2. Indirect approaches 
Synthesis of the exo-spirotetronate 63 proved to be quite challenging. Indeed, 
direct Diels-Alder constructions of intermediates such as 62 are complicated by 
the fact the carbomethoxyl substituent is trans to the C-20 side chain (kijanolide 
numbering system), a stereoarrangement which requires an exo-mode of 
cycloaddition. The development of indirect approaches has been introduced: since 
a direct Diels-Alder route to the exo-Diels-Alder adduct 60 has not yet been 
devised, the use of the readily available endo product 59 was developed by Roush 
et al. 102,103 and introduced by Marshall and Xie.104 
42 
Marshall and Xie used this strategy in the scheme below (Scheme 7).104 
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63 
The oxazaborolidine 58 reported by Corey and Lohl05 gave exclusively the endo 
product 59 with an enantiomeric excess of 72%. Inversion of the very hindered (l-
bromoaldehyde stereocentre of compound 59 allowed access to the e.xo-Diels-
Alder adduct 60 but at the cost of several extra steps. Oxidation of 60 gave 61, 
43 
which was esterified with diazomethane to give product 62. Completion of the 
synthesis was effected through the Dieckmann cyclisation of 62 by treatment with 
LiN(TMS)2, using DMPU as the cosolvent. 
A similar route was proposed by Roush et al. in their synthesis of the exo-
spirotetronate that corresponds to the agalacto fragment of quartromicins A3 and 
D3. The Diels-Alder reaction, employing dichloromethylaluminium 65 as a 
catalyst, provided 96% yield of a 96:4 mixture of endo and exo-cycloadducts 66a 
and 66b (Scheme 8).102 
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The exo-spirotetronate 67 targeted was then synthesised from 66a, with excellent 
diastereoselectivity, by following a similar sequence to the one proposed in 
Scheme 5. 
Roush et al. have improved the diastereoselective Diels-Alder reaction of the 
acyclic tetrasubstituted diene 64 in a third generation synthesis of 67,103 The 
enantioselective preparation of this fragment was thus achieved to avoid 
44 
production of diastereoisomers m the coupling reaction affording the 
quartromicins. 
Like the former route, the synthesis started with a MeAICIz-promoted Diels-Alder 
reaction, where exo-cycloadduct 69 was obtained with 7: 1 diastereoselectivity by 
using the N-acryloyl sultam 68 (Scheme 9). 
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Compound 69 was transformed into its derived aldehyde, which was treated with 
trimethyl silyl triflate and triethylamine to provide the enol silane 70. Bromination 
of 70 with bromodimethylsulfonium bromide gave a separable 5:1 mixture of the 
endo-bromide 66a and its exo-diastereoisomer in 82% yield. 
In addition to the two syntheses described above, Roush et at. also developed a 
second generation synthesis to afford the iso-exo tetronate 67.102 This strategy was 
based on the control of the stereochemistry of early intermediates. 
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The C-5 a-acetoxy ester stereocentre in 74 was expected to be introduced 
stereoselectively by an enantioselective hydroxylation of the ester enolate (Scheme 
10).106 
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AI: 1 mixture of diastereoisomers 72 was obtained by subsequent Claisen 
rearrangement of 71 foIlowed by esterification of the carboxylic acids with 
TMSCHN2. Unfortunately. the a-hydroxylation of the mixture of diastereoisomers 
72 was non-stereoselective and provided a 1: 1 mixture of the diastereoisomeric a-
hydroxy esters 73. from which the desired isomer 73a was isolated 
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chromatographically. Several reactions provided the product 75, the precursor of 
67, which had already been synthesised in the previous examples. 
1.7.2.2. Utilisation of the chiral dienophiles (R)-76 and (R)-77 
The biggest success in the synthesis of the exo-spirotetronates was the highly exo-
selective Diels-Alder reactions of trienes with chiral dienophiles (R)-76 and (R)-77 
mainly used by Roush and different coworkers.107•113 The sterically demanding 
C6Hl1 and tert-butyl substituents offer exceptional diastereofacial selectivity for 
the Diels-Alder reaction (Figure 12). 
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Figure 12 
This class of dienophiIe also exhibits a tendency to undergo highly exo, rather than 
endo, Diels-Alder selectivity. 
This apparently strange phenomenon has been explained by BersonY4 He found 
that, for cyclopentadiene with methyl acrylate and related compounds, the 
47 
permanent dipole moment obtained in the case of the endo transition state is 
greater than in the case of the exo transition state. It follows that the dipole 
moments in exo transition state 78a, leading to 79a, would largely cancel out; the 
endo transition state 78b, leading to 79b, would contain a larger permanent dipole 
moment, and thus be higher in energy and disfavourable (Scheme 11).1l4 
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79b 
Mattay et al. confirmed this hypothesis by observing a similar preference for exo 
cycIisation in a Diels-Alder reaction involving the (S)-isomer of 77 to give 80a 
and 80b (Scheme 12).115 
48 
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Roush and Brown achieved the first highly diastereo- and enantioselective 
synthesis of the spirotetronate substructure of kijanolide by using this method. 1D7 
The Diels-Alder reaction of 81 and the non racemic dienophile (R)-77 provided a 
13-14:1 mixture of the desire exo-cyc1oadduct 82a and the endo isomer 82b 
(Scheme 13).107 
49 
823 
81 
49 
CH3CN,BHT 
135-140 'C 
69-75% 
82a 82b 
DlBAL IQ~::DPlS TBDMSCI, DMF, imidazole AQ~:,:DPS KZC03 
HO~"" :::::.....' 
CH2Cl2, HO' ""f' 2, Swern oxidation 0"" ""0 MeOH 
-78 'C to -30 'C O-t"C,H, TBDMSO O+c,~ 
ii 81-85% from 82a ii 89% 
OTBDPS 
~urBDPS 60TBDPS 1. LiN(TMS)z, """ L"", r", """ AC20, DMAP r """ HMPA-THF TBDMSO~ ", r ( :; NEt3, CHzC12 ~"'" "" -78 'C to 23 'C MOMO" 
TBDMSO M,O,C 'OH TBDMSO M,O,C OAc 2, MOMCI ~ 
98% o 
86% 
83 
Scheme 13 
Several reactions gave the product 83 from 82a, The significance of this synthesis 
lies in the selectivity obtained during the Diels-Alder reaction by using (R)-77, 
Therefore, (R)-77 was used in the synthesis of the top half spirotetronate subunits 
of tetronolidelOS,109 and chlorothricolide,llO,1l1 showing similar results to these 
reported in Table 7, 
50 
84 
OTBDMS 
TBDMSO~ 
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Table 7: highly selective Diels-Alder reactions using chiral dienophiles (R)-76 and 
(R)-77. 
Diene Dienophile Yield Ratio endo : exo Ref 
(%) 
84. R'=COzMe, R"=H, (R)-77 64-70 15 : 1 IIU 
R3=CHzOTBDMS, 84 6: 1 III 
R4=Me 
84, R'=COzEt, R'=Me, 
R3=CHzOTBDMS, R4=Me (R)-77 69-75 93: 7 107 
84, R '=COzMe, R"=Me, 
R3=H, (R)-77 72 93: 7 108,109 
R4= CH20TBDMS 
84 R'=(CH2)SOTBDMS, 
R2=H, R3=CHzOTBDMS, (R)-77 78 14: 1 110.111 
R4=Me 
85 (R)-76 46 7: 1 "" 
To conclude the retrospective of different routes leading to the exo-spirotetronates, 
the enantioselective total synthesis of (-)-Chlorothricolide has been completed 
using a route involving the tandem inter- and intramolecular Diels-Alder reaction 
of polyene 86 and the chiral dienophile (R)-77. This reaction, which establishes 
seven asymmetric centres in a single operation, raises questions about regio- and 
diastereoselectivity. Taking into account all possible endo, exo, diastereofacial and 
regiochemical possibilities afforded by the diene-dienophile combinations, there 
are ninety-six distinct double Diels-Alder adducts that could be produced. 
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Fortunately, the (C-2)-(C-3) dienophile is the most activated of the three 
dienophiles of 86 and results shown in Table 7 prove that the rates of Diels-Alder 
reactions of dienophiles (R)-77 and (R)-76 with acyclic dienes (like 84) are 
considerably lower than the corresponding reaction with conjugated trienes. On 
this basis, the (C-8)-(C-ll) diene is unlikely to react. It is also possible that the 
intramolecular reaction is much faster and takes place first. This would imply that 
(C-8)-(C-ll) diene is no longer available since it has already reacted. In addition, 
(R)-77 proceeds with high exo, regio and diastereofacial selectivity (Scheme 
14 ).ll2,J\3 
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The tandem Diels-Alder reactions provided the targeted double cycloadduct 87 in 
40-45% yield, 19% of other cycloadduct isomers and 25-20% of the IMDA adduct 
87b. Compound 87b was recycled by treatment with additional (R)-77. The overall 
yield reached 55-59%. 
As described above, Dieckmann closure of the spirotetronate was accomplished by 
treatment of 88 with LiN(TMS)2 followed by the addition of MOMCl to give 89. 
The total synthesis proceeds the 20 steps in approximately 2% yield, and is still the 
only reported synthesis of (-)-chlorothricolide. 
Attempted synthesis by the Page group 
The aptitude of (R)-77 to undergo highly exo-selective and highly stereofacial 
selective Diels-Alder reactions inspired a modified synthesis to yield the 
spirotetronic acid part of tetronothiodin (Scheme 15).116 
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Scheme 15 
Unfortunately, the Diels-Alder reaction did not proceed as planned, despite testing 
of many different reaction conditions. The main problem was the instability of the 
54 
precursors. In the case of the dienes, this was perhaps due to the size of the 
molecules, and the ease with which some dienes may polymerise. In the case of 
the dienophile, dioxolane rings may have been unstable under certain conditions 
used, such as the presence of Lewis acid. This pathway to the oxaspirobicydic unit 
was consequently discontinued. 
1.7.2.3. Atypical routes leading to the spirotetronate unit 
1.7.2.3.1. The attempted Intamolecular Claisen reaction 
In the studies towards the first synthesis of the upper fragment of tetronolide, 
Y oshii et al. proposed an unusual route to the elaboration of the exo-spirotetronate 
subunit. The key step was an intamolecular Claisen condensation of the a-acetoxy-
y-lactone 92 (Scheme 16).117 
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The attempted oxidation of 93 to the aldehyde 94, the aldehyde being required for 
elongation of the side chain, resulted in concomitant loss of the MOM group, 
presumably by p-elimination. The synthesis was not carried on further by this 
route. 
1.7.2.3.2. The attempted Schmidt spiroannulation reaction 
Another method proposed by Y oshii was based on two key steps: a Schmidt 
spiroannelation and a selective regio- and diastereoselective dihydroxylation. 
Schmidt spiroannulation of 95 gave 97 by using the P-dichlorocerium derivative of 
methyl trans-p-methoxyacrylate 96. The choice of this organocerium compound 
allowed a better yield than a Grignard or a lithium reagent, because of its low 
basicity which prevents enolisationY8 The remaining task was solved by a 
selective regio- and diastereoselective dihydroxylation of the endo double bond of 
99 to give 100. Finally, the diol100 was first converted to the bis-methoxymethyl 
ether, and then treated with methanolic potassium carbonate to afford y-
methoxymethoxy-a,p-unsaturated aldehyde 101 (Scheme 17).119 
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1.7.2.3.3. The attempted Intramolecular Diels-Alder (IMDA) reaction 
The synthesis using an IMDA reaction of compound 102 was developed. This 
route is unfortunately lengthier and suffers from poor diastereoselectivity owing to 
competitive olefin isomerisation, which led to three cycloadducts 103a, 103b and 
103c. Only a 13% yield of 103c was obtained, which was the second most 
abundant product (Scheme 18).120 
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2. MOMCI, HMPA 
TBDPSO 
78~94% 
104 
104 was obtained after five more steps from compound 103c. This route was too 
inefficient for use in a total synthesis of the quartromicins, both in terms of 
chemical yield and stereoselectivity. 
Attempted synthesis by the Page group 
Nevertheless, the IMDA reaction has been considered by the Page group,116 
because it has advantages of being able to accelerate the rate of reaction compared 
58 
to the intermolecular Diels-Alder reaction. IMDA reactions also prevent 
regiochemical problems due to ring constraints (vide supra).l2l The process was 
improved in the group by Hindley, Batchelor and Vahedi to give the two synthetic 
plans (Schemes 19 and 20).101.116,122 
The Nef and Pummerer routes to generate a carbonyl group at the pro-spiro 
position as in ketone 55 was replaced by the coupling of the hydroxydiene 111 
with diphenylchlorovinyl silane 105 followed by an efficient IMDA outlined by 
Sieburth et al. to give 107 (Scheme 19),123 
t:,~ NEt), CH2CI2 &: Toluene, 170 'C &£ H,,, r.t.,16h 96h ..... SiP~2 
HO 82% 0 95% 0 
111 105 106 107 
I. KHeOl , THF-MeOH, H20 2 R PDC, CH2CI2 P 2. TBDPSCI, imid., DMF Lt., 16 h R=TBDPS r.t., 16 h RO 
86% 108 89% SS 
Scheme 19 
The intramolecular Diels-Alder reaction of triene 106 gave 107 in a 95% yield, 
107 firstly underwent a Tamao-type oxidation followed by the protection of the 
primary alcohol, and finally oxidation of 108 with PCC gave 55 in 59.6% overall 
yield, 
Cyanohydrin formation from 55 proved to be poorly stereoselective, and other 
methods of functionalisation were low yielding. In addition this route was rather 
lengthy, and the group subsequently found a more efficient approach. 
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This synthetic approach involves the stereoselective synthesis of oxaspirobicycJic 
116 as a diastereoisomeric precursor of 30 (Scheme 20). 
Research conducted has established much of the chemistry of this promising, rapid 
route to the oxaspirobicyclic tetronic acid moiety 116. In initial racemic studies, it 
has been found tbe Diels-Alder cycloaddition between diene 111 and acrolein to 
be tbe key in constructing tbe cycJohexene ring suitably functionalised for 
conversion to the target spirocycJe 30. The previous researchers have shown that 
tbis Diels-Alder reaction proceeds efficiently in water with a high degree of regio 
and stereoselectivity. PDe oxidation product 113 was isolated as the only isomer 
observed. The conversion of 113 to 116 was effected by the formation of (J.-
hydroxy lactone 114, followed by acylation to give 115 and final Dieckmann 
cyclisation with concomitant lactone ring opening. (J.-Hydroxylation of 113 witb 
(IS)-(+)-(camphorsulfonyl)oxaziridine afforded 114, which was identified by 
single-crystal X-ray crystallography. 
The stereochemistry of the compounds was established through lH NMR analysis. 
Thus the stereo structural assignment for the diene 111 was based on the coupling 
constant value between H-3 and H-4 (h4= 18 Hz), which is consistent with tbe E 
stereo isomer. Also, tbe stereochemical assignment of lactol112 based on tbe small 
coupling constant between H-4 and H-8 (hs= 4.5 Hz), which is consistent witb tbe 
cis configuration (Scheme 20). 
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2 2, 
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This route has led to spirocycle 116, which is a diastereoisomer of the target 30. 
H~ o~ 
EIO=t-ZO 
o 
30 
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This stereochemical outcome is the result of the a-hydroxylation occurnng 
exclusively from the least hindered face of the enolate of 113. Access to the upper 
face is clearl y hindered by the two methy l groups (Fi gure 13). 
cl o 0 
113 
FigUl'e 13 
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Chapter 2 
Results and discussion 
2. Results and Discussion 
The proposed route plan would repeat the work previously achieved in the group 
until the formation of the lactone 5. This route has led to spirocycle 8 (Scheme 1). 
. ! 1. n-Buh I 
2. trans-2-methyl-2-butenal 
72% HO 
PPh3 .-HO~Br ----HO~PPh3 , Br 
toluene 
95% 
1 2 
propenal (5.0 eqUi~')& + 
'''H 
H20, r. t., 26 h o OH &: PDC (3 equiv.) '''H-DMF, overnight o III'OH 
76% 2:1 
4 
64% 
1. NaHMDS (3.0 equiv.) v Cl)UOEt {& 00 "'OH 2. (lS)-( + )-(Carnphorsulfonyl) 26-di-t-butyl-4-methylpyridine 
oxaziridine (3.0 equiv.), _78°C 0 0' CH Cl 5 h ' 2 2, 
57% 6 98% 
2. oxidation 
91% 
8 
Scheme 1 
3 
cS! o 0 
5 
7 
Formation of the diene 3 would follow the synthesis of the Wittig salt 2. 
Compound 3 would then undergo the Diels-Alder reaction leading to a mixture of 
diastereoisomers 4. Compound 4 would afford the lactone 5 by oxidation. using 
PDC. 
1 
The key feature to this new route would be to modify the a-hydroxylation step. 
This would result in either compound 9 pure or a mixture of 9 and its 
diastereoisomer 6. 
Acylation of 9 would give 10 with the correct stereochemistry. The final 
Dieckmann cyclisation with concomitant lactone ring opening would afford the 
target compound 11, which is a diastereoisomer of the target 8 (Scheme 2). 
HO~B,--PP_h_3--HO~;Ph3' B,- l.n-Buli ~ 
toluene 2. trans-2-methyl-2-butenal j' 
HO 
1 2 3 
propenal (5.0 eqUiV.)cl + 
"'H 
H20, r. t., 26 h cl 
POC (3 equiv.) cl 
OMF, overnight 
o OH 2:1 O 
,
"""OHH ------- 0 "'OH 
alpha hydroxylation using 
O2 or MoOPO 
o 0 
Cl~OEt 
4 
9 M -- - - - - --- --- - -- - -- - --- - .-- - - - - -- ---
2,6-di-t-butyl-4-methylpyridine, 
CH2CI2, 5 h 
5 
a o 0 + a o 0 
9 
~ o 0 O~OEt o 0 
10 
Scheme 2 
11 
2 
2.1. Optimisation of the synthesis 
We repeated the process up to the oxidation step giving the lactone 5. This allowed 
us to raise the yield and to increase the scale by optimisation of the reactions 
conducted. 
2.1.1. Synthesis of the Wittig salt 2 
The synthesis of Wittig salt 2 has been scaled up from 25 g of bromo alcohol 1 to 
100 g without any problems (Scheme 3). 
HO~Br 
1 
2.1.2. Synthesis of the diene 3 
2.1.2.1. The Wittig reaction 
toluene 
97% 
Scheme 3 
2 
The Wittig reaction, first reported in 1953/ utilises a phosphonium ylide (or 
phosphorane) as nucleophilic entity. These ylides are usually stable but highly 
reactive. They can be represented by two resonance forms, ylide 12a and ylene 
12b (Scheme 4). 
RI RI 
):-=-P(R3)3 ~ ~==P(R3h 
R' R' 
12a 12b 
yJide ylene 
Scheme 4 
3 
Their stability is partly due to the resonance between these two structures. 
However, NMR spectroscopic studies and theoretical calculations proved the 
dipolar structure of the ylide 12a to be largely predominant. The carbanion 
electrons are delocalised towards the positively charged phosphorus, thereby 
increasing the stability of the charges.2 
The reaction of a phosphonium ylide 12 with an aldehyde or a ketone 13 forms an 
olefin 14 in place of the carbonyl (Scheme 5). 
RI 
;C':....t(R3h + 
R' 
12 13 14 
SchemeS 
The mechanism starts with addition of the nucleophilic carbon of the ylide 12 to 
the carbonyl group of 13. The phosphonium ylide 12 is usually prepared by 
deprotonation of the corresponding phosphonium salt 15. These entities are weak 
acids and a strong base must be used to deprotonate them to yield 12. 
Trialkylphenylphosphonium salts 15 are commonly used, obtained by the reaction 
of triphenylphosphine with alkyl halides 14. Triaryl and trialkylphosphines are 
also encountered, but less frequently (Scheme 6). 
base 
14 15 12 
X=I. Br, Cl 
Scheme 6 
4 
Phosphonium ylides bearing non-polar substituents, such as proton or alkyl and 
aryl groups, are unable to stabilise the negative charge and are highly reactive. 
They are called non stabilised ylides. 
Salts containing electron-withdrawing groups at the a-position are much more 
acidic and can be transformed into ylides by using weaker bases. If the electron-
withdrawing group is strong such as in ~-ketophosphonium ylides or phosphonate 
ylides (Homer-Wadsworth-Emmons reaction),3.4 the ylide is stabilised. Semi-
stabilised ylides are obtained if the substituents are only weakly conjugating such 
as phenyl group. The resulting stabilised and semi-stabilised phosphonium ylides 
are less reactive towards carbonyl compounds and the reaction conditions must be 
more vigorous (Scheme 7).5.6 
{CCCHO 1 I 
o h OH 
+ 
n-BuLi, THF. -78°C ~Me 
X 
74% 
benzene, reflux 
2h 
(2 equiv.) 
86% 
Scheme 7 
Two mechanisms have been proposed for the reaction of the ylide with carbonyl 
groups. 
The first stipulates the formation of an unstable zwitterionic intermediate called 
betaine 16 followed by its rapid cyclisation to a four-membered ring 
oxaphosphetane intermediate 17. Elimination of the phosphine oxide 18 and 
formation of the alkene 14 complete the reaction, 
5 
In an alternative mechanism, the fonnation of betaine does not occur and the 
nucleophilic addition of 12 to 13 leads directly to the oxaphosphetane 17 (Scheme 
8).7 
route 1 
r(R3);~t_t R' 0 16 12 
betaine + + 
R' )=0 
R' 18 
13 route 2 17 
oxaphosphetane 
SchemeS 
Oxaphosphetane intennediates 17 have been observed by NMR spectroscopy at 
low temperature in the case of the reaction of non-stabilised ylides with aldehydes, 
but the existence of salt-free betaines still remains unclear because they are neither 
stable nor observable by available techniques.8,9 
The simplest Wittig rationale accounts for high eis-selectivity. The process has the 
plane of the aldehyde tilted with respect to the ylide plane to minimise non-bonded 
interactions, and also has the C-O bond of the carbonyl and C-P bond of the ylide 
crossed to maintain reasonable C"'C and P"'O bonding distances. 
However, there are variations in observed Wittig reaction stereochemistry which 
are attributed to dominant kinetic control. There is probably not a single 
mechanism for all Wittig reactions. 
6 
~-------------------------------------------------------- -- --
For the non-stabilised ylide, the first step is irreversible and kinetically controlled. 
The stereochemistry follows from the approach of the two reagents. This affords a 
predominant cis-disubstitued oxaphosphetane 17a which quickly collapses 10 a 
stereospecifically syn manner to give primarily the (Z) alkene 14a. 
In contrast, with stabilised ylides, the first step is reversible and fast, leading to the 
most stable trans-oxaphosphetane 17b (Scheme 9).10.12 
slow irr7 
12 
+ 
~ 
reversible 
13 
fast 
cis-oxaphosphetane 
= 
17h 
trans-oxaphosphetane 
RI bigger than R2 and R4 bigger than R3 
Scheme 9 
14a 
(Z)-isomer 
14b 
(E)-isomer 
The limiting geometries, 17a puckered eis-selective and 17b planar trans-selective 
have been presented, but there are intermediate cases due to interplay of 1,2 and 
1,3 steric interactions which determine which diastereoisomeric oxaphosphetane 
will be favoured. 1O,13,14 
The stereoselectivity depends not only on the structure of the ylide but also on the 
structure of the carbonyl substrate, the nature of the base used for the 
deprotonation of the phosphonium salt, the solvent and on the reaction conditions. 
7 
In a general pattern, reactions will favour Z-olefination if they involve non-
stabilised ylides (especially if they are obtained by deprotonation by sodium bases 
rather than by corresponding lithio bases), aprotic solvents such as 
tetrahydrofuran, diethyl ether or dimethoxymethane and low temperature. IS 
2.1.2.2. Application of the Wittig reaction in the synthesis of 3 
In this Wittig reaction, 3-hydroxypropyl phosphonium salt 2 reacted with the 
trans-isomer of 2-methyl-but-2-enal to afford the diene 3. The stereostructural 
assignement for this diene, based on the coupling constant value between H-3 and 
H-4, was consistent with the E stereoisomer (h4 = 15.6 Hz) (Scheme 10). 
+ HO~PPh3 Br 
2 
I. n-Buli 
2. trans-2-methylbut-2-enal 
74% 
Scheme 10 
F 
3 
While diene 3 is obtained as the product of the olefination in good yield, the 
triphenylphosphine oxide by-product, proved difficult to separate from 3. 
In order to avoid this problem, during work -up, an extract of the reaction mixture 
was poured into a solution of tert-butoxymethyl ether from which 
triphenylphosphine oxide precipitated. Subsequent purification of the crude 
product by Kiigelrohr distillation was more successful than flash column 
chromatography. Indeed, the distillation was simpler and faster than 
chromatography and afforded increased yields. Finally, this step was scaled up 
four times which gave a slight increase in yields compared to previous results 
obtained in the group. 
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2.1.3. Synthesis of the factol 4 
2.1.3.1. The Diels-Afder reaction 
The Diels-Alder reaction is the addition of an olefin to a diene leading to the 
formation of a cyclohexene unit, first reported in 1928 and developed by Diels and 
Alder.16 
This pericyclic reaction involves four It-electrons of the diene and two It-electrons 
of the alkene (dienophile). It is a [4 + 2] cycloaddition, following the rule of 
aromatic resonance proposed by Hiickel: ne- = 4n + 2e·. Six electrons allow 
stabilisation by delocalisation of the transition state. 
Experiments carried out on numerous substituted substrates have shown that the 
Diels-Alder cycloaddition can generate up to four new asymmetric centres 
controlled by a syn-suprafacial stereospecificy (Figure 1).17 
/B 
~c 
D 
Figure 1 
No loss of stereospecificity is observed indicating that a concerted reaction is 
occurring. Indeed, an intermediate would imply the formation of one bond before 
the other and the possibility of bond rotation, leading to the formation of 20 
(Figure 2). 
9 
A 0' A"B H ~B + H)( ~; le": = '" C H X 
D D D 
18 I 
tI;x 9: _ = x C :: H H3C D D 
19 20 
supra-supra addition non-observed 
Figure 2 
The existence of intermediate 18 would suggest its formation to be so quick that 
the rotation would not have time to occur. Numerous theoretical analyses confirm 
the improbability of this hypothesis and the validity of the concerted process. 18 
2.1.3.2. The Alder endo rule 
When there are one or more substituents in the olefin, two possible transition states 
can arise. When the substituents of the dienophile are directed towards the diene, 
the transition state is termed endo in opposition to the exo transition state (Figure 
3). 
R 
r> R addition endo R ~H 
addition exo ~~ 
R~X 
Figure 3 
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The endo system is obviously more hindered. Therefore, the exo transition state 
should be favoured. Nevertheless, the reaction usually adopts the endo 
configuration. The addition of benzoquinone 22 to cyclopentadiene 21 is a famous 
example of this fact (Scheme 11).19 
0 
(> y addition endo ~ + benzene, 40 QC 0 0 
21 22 85% 
Scheme 11 
Molecular orbital theory can be used to explain why the endo orientation is 
favoured. The orbitals involved in a Diels-Alder reaction are the Highest Occupied 
Molecular Orbital (HOMO) of the electron-rich diene and the Lowest Unoccupied 
Molecular Orbital (LUMO) of the electron-poor dienophile. The overlap of these 
two frontier orbitals is necessary to allow formation of the new bonds. The 
simplest system butadiene-ethene, illustrates this principle (Figure 4).20 
~ H Antisymmetric 
Antisymmetric ~ 
~ + 
Figure 4 
11 
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The closer the energy levels of the HOMO of the diene and the LUMO of the 
dienophile, the stronger the interaction between the frontier orbitals. Hence the 
cycloaddition is more favourable. 
Secondary molecular orbital interactions between the substituent of the dienophile 
and the It-electrons of the diene, present in the endo transition state, enhance the 
overlap between the frontier orbitals and so the most stable transition state in the 
Diels-Alder reaction, the one which contains maximum orbital overlap, is the one 
leading to the endo product. 21 
In reversible Diels-Alder reactions, the exo stereoisomer is also found. The endo: 
exo ratio does not depend only on the secondary orbital overlap but also on steric 
effects, dipolar interactions, etc. 
For example, reaction of cyclopentadiene with methyl acrylate gives 90% of the 
endo adduct 23a in methanol and affords predominantly the exo adduct 23b, which 
is the thermodynamically more stable product, with methyl methacrylate (Scheme 
12).22 
0 H t4R t4cozMe + A c0 2Me + 
C02Me R 
23a 23b 
endo exo 
R=H 90% 10% 
R=CH3 22% 78% 
Scheme 12 
12 
2.1.3.3. Diene 3 is adapted for the Diels-Alder reaction 
Substituents on both reactants can affect the outcome of the Diels-Alder reaction. 
Orbital theory states that electron-donating groups on the diene increase the energy 
of the HOMO and electron-withdrawing groups on the dienophile decrease the 
energy of the LUMO, thus improving the HOMO-LUMO overlap and enhancing 
the reaction rate.23 
Consequently, the reaction is promoted by the inductive effect of alkyl groups, for 
example, at the Col and C-2 position in the diene, and by one or more electron 
withdrawing groups in the dienophile such as carbonyls and nitro groups (Scheme 
13). 
+ ~EWG 
EDG = electron-donating group 
EWG = electron-withdrawing group 
Scheme 13 
The Diels-Alder reaction between diene 3 and acrolein fulfils the conditions 
described previously and the reaction afforded two diastereoisomers of lactol 4 in 
a 2: 1 ratio (Scheme 14). 
3 
Propenal (5 equiv.) 
H20, r.t., 26 h 
86% 
Scheme 14 
~"~ CX:H CX:H 
2 1 
4 
13 
2.1.3.4. Choice of the water as the solvent 
The choice of solvent does not have a major effect on the reaction, because there 
are no ionic intermediates formed. However, in the 1980' s, adding of water to the 
usual organic solvent was shown to promote the Diels-Alder reaction. 
Lack of hydrophilic interactions between the reagents and the solvent causes a 
compressed transition state, resulting in improved reaction rate and selectivity 
(Scheme 15).24.25 
+ b)-+d. 
o 
248 24b 
emio exo rate 
isooctane 80% 20% 1 
water 96% 4% 700 
Scheme 15 
2.1.3.5. Limitations of the reaction 
Beyond 19 (7.9 mmol) of diene 3, formation of lactol 4 was often prevented by 
polymerisation of the acrolein. Dilution of the reaction mixture, so decreasing the 
concentration of acrolein, had no effect on the problem. Therefore, in order to 
prevent this polymerisation, acrolein was distilled and kept with hydroquinone, 
refrigerated and protected from light. HPLC grade water was used as the solvent in 
order to prevent any polymer initiation due to the pH or the presence of ionic 
species. Acrolein was added dropwise using a syringe pump in order to avoid high 
concentration in the mixture, and the reaction flask was covered by tin foil so as to 
prevent radical polymer initiation due to the light. All these precautions allowed 
14 
the Diels-Alder reaction to be scaled up by a factor of fourteen, and afforded a 
slight increase in yield after purification of the crude product by Kiigelrohr 
distillation. 
2.1.4. Synthesis of the lactone 5 
2.1.4.1. Problems linked to the oxidation 
&:' PDC (3 equiv.) a DMF, overnight o OH 67% o 0 
4 5 
Scheme 16 
The use of chromium (VI) in our synthesis has been introduced by Vahedi, a 
previous researcher of the group?6 
Using pyridinium dichromate (PDC) creates considerable purification problems. 
Initially, this reaction was impossible to perform on a large scale because of this. 
Chromium forms sticky aggregates and thus prevents efficient extraction and 
reduces yields. Consequently, the work-up was difficult and hazardous in relation 
to the high toxicity of PDC. 
2.1.4.2. Resolution of the problem 
We decided to perform the Swem oxidation, which has the advantages of low cost 
and toxicity, and affords relatively clean carbonyl compounds which can 
sometimes be used without purification to give high yields of products (section 
2.5.1.4.1.1.). Unfortunately, no significant results were obtained even at -40°C. 
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We next modified the work-up of the PDC oxidation. An increase in the yield and, 
more significantly, the scale of the reaction was afforded. A 67 % yield was 
obtained from l3.2 mmol of 4 whereas a maximum scale of 4.3 mmol of 4 
afforded a 64% yield with the previous work-up method. 
The new technique was based on the trapping of the chromium which is soluble in 
ethanol followed by precipitation in ethyl acetate and absorption by a mix of silica 
gel-Celite® of the chromium salts in order to free the lactone 5. The product was 
collected by filtration, and the waste chromium trapped in silica gel-Celite® was 
easily removed. The yield of the lactone 5 was increased by 5% and the oxidation 
step was achieved with three times more starting material. 
2.1.5. Summary of the initial steps 
The optimised results for the first steps, discussed above, are presented below 
(Scheme 17). 
/'0. /'0. /'0. /'--+ - I. n-Buli I PPh3 /, 
HO'" """" ~Br ---- HO'" ...........- -PPh), Br 
1 
lOOg, 0.72 mol 
toluene 2. trans-2-methylbut-2-enal 
97% 2 HO 3 
47.6 g, 0.12 mol 72% 14g, 0.11 mol 
a PDe (3 equiv.) _.-------""H DMF, overnight o 0 
67% 
5 
Scheme 17 
Propenal (5 equiv.) 
H20, r.t., 26 h 
86% 
2: 1 
4 
2.4g, 13.2 mmol 
16 
2.2. a-Hydroxylation 
Page group purpose was to synthesise one diastereoisomeric oxaspirobicyclic 
synthon in order to determine the absolute stereochemistry of tetronothiodin. 
To this end, the a-hydroxylation, carried out by Vahedi, occurred exclusively from 
the least hindered face of the enolate of5 (Scheme 18). 
&r o 0 
5 
1. NaHMDS (3.0 equiv.) 
2. (lS)-( + )-(Camphorsulfonyl) 
oxaziridine (3.0equiv.), -78 'C 
57% 
Scheme 18 
6 9 
100% 0% 
This was due to steric factors already described but also to the choice of the 
hindered oxaziridine as the hydroxylation reactant. 
2.2.1. Chiral oxaziridine oxidation 
2.2.1.1. Generality about oxaziridines 
This method has been first investigated by Emmons27 and Homer and 
Jurgens,28oxaziridines exhibit excellent reactivity for oxidation of a variety of 
substrates. 
Sulfonyl oxaziridines 25 are heterocyclic compounds containing oxygen, nitrogen 
and carbon atoms in a three-membered ring, and a large N-sulfonyl group, 
conferring them an unusual reactivity. 
17 
25 
Thus, the driving force for oxygen transfer by the oxaziridine unit incorporates 
both the relief of the three-membered ring strain and the enthalpy associated with 
formation of strong C=N bond (Figure 5). 
z 
Z: nucleophilic substrate 
Figure 5 
...:. &- 0+ N, 
I. :o--z 
c' I&-
The process is facilitated by the presence of the large N-sulfonyl group. Due to its 
powerfully electron-withdrawing effect, it is partly responsible for the highly 
electrophilic nature of the oxygen. Also, it shields the oxaziridine nitrogen atom 
from attack and stabilises any incipient charge in the transition state for 
sulfonimine displacement.29 
Reaction of carbonyl enolates 26 with these reagents produces an a-hydroxy 
carbonyl product 27 by direct nucleophilic attack on the ring oxygen and 
subsequent ~-elimination (Scheme 19). 
26 25 27 
Scheme 19 
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2.2.1.2. Stereospecific oxidation 
Camphorsulfonyl oxaziridine oxidation is commonly used for its reactivity and 
high stereoselectivity leading to a single diastereoisomer 6 due to the two methyl 
groups on the methylene bridge blocking the exo face of the C=N. The preparation 
of several diastereoisomerically pure oxaziridines 29 has been achieved by the 
Page group (Scheme 20).30.31 
Amberlyst 15 
MeOH 
99% 
99% 
28 
Se02 (2.0 equiv.) 
CH3C02H 
49% 
H20 2 (4.0 equiv.) 
K2C03 (4.0 equiv.) 
MeOH 
92% 
Scheme 20 
29 
This chiral oxaziridine afforded a-hydroxy carbonyl compounds in high optical 
purity through an open transition state, controlled by non-bonded steric 
interactions, which is responsible for the chiral recognition (Figure 6).32.33 
MeD OMe MeO OMe 
, 
. ·t~" 
N " + ~. 4a 
M 0- OR 
>€R H R' S 
0, 
8
0CHa 
4 8aOCH3 
SDi" iN 1 
3 0 
2 
Planar Spiro 
Figure 6 
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Davis and Haque have suggested that the geometry of the planar open transition 
state is favoured over the spiro form because of the reduced non-bonded steric 
interactions between the largest enolate group O'M+ solvent aggregate complex 
and the bridgehead 5-4a bond in 29.32,33 
In addition, higher diastereoselectivity was obtained because of the presence of the 
8-methoxy groups in 29. When using NaHMDS, the sodium enolate was formed 
and improved the diastereoselectivity (because sodium is larger than lithium, it is 
capable of forming more covalent bonds with oxygen).30 
Hydrogen peroxide treatment of dimethoxy ketal 28 in basic media produces 
diastereoisomerically pure oxaziridine 29 to be used in the a-oxidation of the 
lactone 5. This resulted in the formation of the a-hydroxy lactone 6 (Scheme 20). 
Transforming the stereospecificity of the reaction to stereoselectivity, allowing the 
formation of the desired o:-hydroxylactone 9 is the focus of the next section. 
2.2.2. Other a-hydroxylation methods 
Many methods have been devised for the preparation of a-hydroxy carbonyl 
compounds. The most practical methods are also the simplest and involve direct 
enolate oxidation. A number were considered but were shown not to be adaptable 
to our substrate 5. For instance, alkali metal based oxidants, such as potassium 
permanganate or potassium dichromate, would react with the olefin of the 
cyclohexene unit of 5.34 Methods based on peroxy acid reactions were rejected for 
similar reasons.35 
Two methods, using molecular oxygen and Vedejs' reagent, molybdenum 
peroxide-pyridine-hexamethylphosphoramide (MoOPH), were explored. 
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These two methods often exhibit a poorer stereoselectivity than does use of 
oxaziridine reagents and, they can afford a mixture of stereoisomers.36-39 Examples 
from the literature suggested that the desired diastereoisomer 9 might be obtained 
in a mixture with the most favourable diastereoisomer 6 already obtained. The 
synthesis of daunomycinone, a component of useful antitumor agents, is a . good 
example of this. 
Boeckman et at. carried out an a-hydroxylation by using LDN02/ P(OEt)3, which 
afforded a 1: 1 ratio of both epimers 30a and 30b (Scheme 21).38 
o OH 
~",'CO'Et 
WH 
OMe 0 0 ............... 6 
1. LDA (10 equiv,), 02' THF, -78 'C 
2. (EtO),P (2 equiv.), -78 'C, 2 h 
o OH OH ~CO'Et 
OMe 0 0 ............... 0 
75% 
30. 30b 
Scheme 21 
Further, Swenton et at. used LiCA/MoOPH to accomplish a related a-
hydroxylation and obtained a 2:3 ratio of epimers 31a and 31b (Scheme 22).36 
BltQQ::H' 0 1. LiCA, -70 'C, 1 h 
I '" '. ""H OCH3 ------------
"OH 2, MoOs.HMPA.Py, THF, -65 'C, 1.5 h 
OCR) H 
95% 
31. 31b 
2 3 
Scheme 22 
Unfortunately, these isolated examples cannot be considered as a pattern. 
Sometimes, more stereocontrolled introduction of a hydroxyl group is achieved 
21 
with these reagents. This is shown in the following example, where the lactone 
32, derived from (S)-glutamic acid, was used as a chiral template to construct 
acyclic polyols (e.g. 33a and 33b) with good stereochemical control (Scheme 
23).40 
TBDPSO, /0, __ &0 1. LiN(TMSh. THF, -78 QC, 30 min 2. MoOs.HMPA.Py, 1 h 
TBDPSO\ ..... 0'- __ &0 TBDPSO~ + ° 0 HO 
80% 
32 333 33b 
7 1 
Scheme 23 
Formation of diastereoisomeric mixtures in all these examples is an important 
point, which suggests that we may obtain the desired 9, albeit as the minor 
component of a mixture. 
2.2.2.1. a-Hydroxylation using Vedejs' reagent 
The first enolate oxidation by reaction with molybdenum peroxy complexes was 
reported by Vedejs.4l 
u-Hydroxylation is obtained by nucleophilic attack by the enolate 26 at a peroxy 
oxygen atom. Two pathways are possible, but the lack of u-hydroperoxy products 
suggests that the mechanism involves only 0-0 cleavage and go through 35 
(Scheme 24). 
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35 
0-0 cleavage 
Ar° ° 0, 11 R O-Mo-O L t"'':: '0' R' :C 
Mo-O cleavage 
The oxygenation has been shown to occur, in some cases, however using less than 
a stoichiometric amount of MoOPH. This indicates that both peroxy bridges can 
be available for the reaction. The ketone enolate is formed, and the reaction is 
carried out at low temperature (between -50 and -30 QC) in order to limit side 
reactions such as aldol condensation. 
Oxodiperoxyrnolybdenurn(pyridine)hexamethylphosphoramide (MoOPH) 34 
contains hexamethylphosphoramide (HMPA) which is a well known harmful 
carcinogen. Thus, an alternative reagent, MoOPD, was developed using 1,3-
dirnethyl-3,4,5,6-tetrahydro-2-(lH)-pyrimidinone (DMPU) 38 instead of HMPA, 
and can be used in the same way for the a-hydroxylation procedure. 
° P,II Q-Mo-Q 
L'"": yf 
L 
38 
L=DMPU 
L' == Pyridine 
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MoOPD and MoOPH have been compared as oxidants, and reactions involving 
tbem showed comparable yields.42 
MoOPD commonly requires a longer reaction time (2.5 hours against 30 minutes 
for MoOPH), however, by which time by-products are unfortunately also 
produced. This lower reactivity is believed to be due to its lower solubility. Thus 
reaction times must be increased compared to MoOPH reactions. 
Preparation of MoOPD 38 was achieved in our hands tbrough reacting 
molybdenum (VI) oxide 36 with hydrogen peroxide followed by addition of 
DMPU. Dehydration of the pale yellow crystals of the recrystaJlised 
monohydrated 37, under high vacuum and over P205, gave tbe very hygroscopic 
M005.DMPU. This was transformed into MoOPD 38 by treatment with pyridine. 
An overall 28% yield of the yellow solid 38 was obtained (Scheme 25).42,43 
36 
1. 30% H20 2 aq., 40°C 
2. DMPU, 10°C, 
recrystallisation (MeOH) 
96% 
37 
Scheme 25 
2. pyridine (1 eq.), THF 
29% 
o P ... II Q-Mo-Q L'~: ~o' 
L 
38 
L=DMPU 
L' == Pyridine 
A freshly prepared sample of MoOPD was used in each reaction because we were 
not able to store it without decomposition even in a refrigerator. 
A large excess, up to ten equivalents of the molybdenum reagent, is often used 
accordingly to the literature.44 However, using an excess of MoOPD did not show 
any improvement on tbe metbod we used, and subsequently only one equivalent of 
reagent was used. 
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Vedejs et al. have shown that aldol condensation can be minimised by inverse 
addition of the enolate to MoOPD.45 No such differentiation was noticed by us in 
the oxidation of 5, and the reaction gave a poor yield (14%). Only the unwanted (l-
hydroxy lactone 6 was obtained (Scheme 26). 
&: I. LDA, THF, -70 QC & 2. MoOPD, 0 QC o 0 o 0 
5 14% 6 
Scheme 26 
Reaction with molecular oxygen was next investigated 
2.2.2.2. a-Hydroxylation using molecular oxygen 
For suitable substrates, the use of molecular oxygen as the source of a hydroxyl 
group remains the method of choice due to high yields. 
First, molecular oxygen undergoes an electrophilic addition to the enolate 26 
activated by counter-ion complexation via a six-membered transition state 39. This 
step involves displacement of one of the solvent molecules by oxygen (Scheme 
27). 
26 39 
Scheme 27 
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This fact is important for the choice of the solvent and its specific effect. Thus, (-
butyl alcohol is normally chosen to be the solvent, because it is more easily 
displaced than primary and secondary alcohols, which show a greater tendency to 
form coordinate compounds.46 
Alternatively, Russell has proposed a radical chain mechanism as a possible 
alternative oxidation pathway, involving single electron transfer from the enolate 
to the molecular oxygen, generating an a-keto radical 40. This radical reacts with 
oxygen to give 41. Finally, the hydroperoxide 43 is formed by transfer of the 
radical hydrogen from the ketone 42 to compound 41, generating the radical 
species 40. The process is then reinitiated (Scheme 28).46 
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0 0 R~ + 0, R~' + 0, 
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26 40 
0 0 
R~' + 0, Ar°" R ° 
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0 0 0 0 
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Scheme 28 
The reduction of the hydroperoxide 43 is then accomplished with simultaneous 
oxidation of the triethyl phosphite 44 into triethyl phosphate 45, This species is 
easily removed by washing with water. This oxidation-reduction reaction is 
believed to proceed by an ionic mechanism. Indeed, the reaction is not affected by 
the presence of trinitrobenzene, which is well known as an inhibitor of homolytic 
reactions (Scheme 29).47 
26 
o 
RJYOH + (EtOJ,P=O 
R' 
43 44 45 
Scheme 29 
In the reaction with 5, increasing the amount of base and triethyl phosphite, as 
indicated in the literature38 did not improve the yield. This method was, however, 
much faster than MoOPD reaction.48 
Unfortunately, this reaction also led to the exclusive formation of the unwanted 
isomer 6. An average yield resulted from a messy reaction mixture where 
numerous by-products were formed, probably due to the high reactivity of oxygen 
radicals (Scheme 30). 
a 1. NaH,DMF & 2. P(OEt)3, O2, -25 QC o 0 o 0 
5 47% 6 
Scheme 30 
2.2.2.3. Explanation for the lack of efficiency of the above methods 
The poor yields observed may result from a number of reactions: 
• Reactions between carbonyls and oxygen can result from autoxidative 
cleavage of the carbon chain adjacent to the carbonyl group under basic 
conditions as shown in the following Scheme (Scheme 31).49 
27 
o )(OH 
46 47 48 
Scheme 31 
In this example, the ketone 46 absorbs one equivalent of oxygen to give pentanone 
47 and acetic acid 48. 
• Steric hindrance could be a reason for the loss of reactivity or the even no 
reactivity of these methods in our case. 50 
• The decomposition products of the intermediate a-hydroperoxy aldehyde 
can also pollute the reaction mixture, although this usually happens at 
higher temperatures. 51 
• Aldol condensation, most serious for relatively unhindered enolates, can 
occur by using MoOPD.45 
In our case, the real problem however, was not linked to the yield but to the high 
stereoselectivity, presumably due to the steric conditions imposed by the the 
substrate 5. The strategy to modify the stereocontrol in our approach thus had to be 
revised. The new pathway elaborated was based on an inversion of 
stereochemistry exemplified by Shi et al.174 
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2.3. Reactions attempted on the bicyclic unit 
2.3.1. The a·acylation strategy 
2.3.1.1. Description of the strategy 
Initially we thought that a high degree of stereoselectivity might be available from 
a modified route to give target 11 in a highly stereoselective manner from 5 
(Scheme 32). 
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The plan was to trap the enolate of 5 under O-acylation conditions to give 49, 
which was predicted to be susceptible to highly stereofacially-selective 
epoxidation to give 50. The key step of this process was the stereoselective 
rearrangement of this enol ester epoxide to give 10, with inversion of 
configuration at the hydroxylated centre. 
This plan was based on the discovery by Shi of a dual pathway allowing one to 
synthesise either enantiomer of an a-acyloxy ketone from a single enantiomer of 
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an enol epoxide by the choice of reaction conditions. Under acidic conditions, the 
rearrangement of the epoxide 51 occurs readily. Retention of configuration 
prevails when strong Lewis acid is used, whereas complete inversion is observed 
with a mild Lewis acid or simple heating (Scheme 33).52 
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In pathway A, the complexation of a strong acid to the epoxide oxygen of 51 leads 
to cleavage of C1-O bond of 52 to form the intermediate carbocation 53. 
Subsequent acyloxy migration with retention of configuration gives the acyloxy 
ketone 55a. 
In pathway B, the complexation of a weak acid to 51 weakens both epoxide bonds, 
facilitating acyloxy migration with inversion of configuration (54) to give the 
acyloxy ketone 55b. 
Applied to our own approach, such a rearrangement with inversion of 
configuration would provide the desired product 10 (Scheme 34). 
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Successful completion of this stage of the work would thus provide the possibility 
to synthesise the diastereoisomeric oxaspirobicyclic synthon 9, starting with 0-
acylation of the lactone 5. 
Compound 49 was therefore the next target for synthesis. It was expected to be 
obtained by a simple O-acylation of the lactone 5 (Scheme 35). 
a-
° 0 
5 
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2,C'Y10Et 
o 0 
56 
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2.3.1.2. Attempts under basic conditions 
49 
Reactions were carried out under the most favourable conditions for an 0-
acylation to take place. In this respect, the counter-ion of the base must be 
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dissociated from the oxygen anion created. Thus, potassium and sodium bases 
were used as priority. 
For this reason also, dimethylformamide was chosen as a solvent due to its polarity 
and as it offers good solubility. It is an aprotic solvent, which prevents solvation, 
which would decrease the nucleophilicity of the anion, due to hydrogen bonding. 
Dimethylsulfoxide and THFIHMPA are also appropriate solvents but the hazards 
linked to THFIHMPA made this solvent less attractive. 
Finally, according to the HSAB (Hard-Soft-Acid-Base) effect, O-acylation is 
favoured with electrophiles bearing hard leaving groups (tosylate, triflate or even 
anhydride), over these containing halogens. 
Taking the aforementioned considerations into account, the lactone 5 was added to 
a base (potassium bis(trimethylsilyl)amine or potassium hydride (3 equiv.» in 
dimethylformamide or tetrahydrofuran. The solution was stirred at 0 °C under a 
nitrogen atmosphere. Despite the fact that halide groups are not favoured in our 
case, the commercial availability of ethyl 3-chloro-3-oxopropanoate 56 persuaded 
us to use it. 56 was added to the enolate. All the reactions afforded only starting 
materials. 
The lactone 5 and the propanoate 56 possess acidic protons Ha and Hb 
respectively (Scheme 36). Hb (pKa ",13) is more acidic than Ha (pKa "'20). It is 
therefore likely that the enolate formed did not attack the acyl chloride 
functionality, but deprotonated the propanoate 56. This acid-base reaction only 
gives starting materials (Scheme 36). 
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The easiest way to prevent the acid-base reaction was to avoid using a compound 
containing an acidic proton. In this respect, three solutions were suggested: the use 
of acetyl chloride, which would give an acetoxy ester, the preparation of a ketene 
from the propanoate 56, or the use of 4-methylidene oxetane-2-one. The second 
and third propositions would afford the desired compound, and were the first 
attempted (Scheme 37). 
Cl GEt ~+ EI,O • 
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The carboethoxyketene 57 was generated in situ by using three equivalents of 
triethylamine in diethyl ether at 0 QC, according to the experimental procedure 
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reported by Newman.53 When the mixture was added to the potassium enolate of 
5, a precipitate of triethylammonium salt 58 was formed and the IR spectrum of 
the reaction mixture showed an absorption at 2120 cm'l (v C=C=O).54 These two 
facts support the formation of the ketene 57. However, after work up, the NMR 
spectra of the reaction mixture were complex, and the reaction was considered to 
have failed (Scheme 38). 
&: o 0 I.KHMDS • starting materials 
5 
Scheme 38 
4-Methylideneoxetane-2-one 60 is a compound which does not contain any acidic 
protons. In the following example, the hindered tertiary alcohol 59 failed to be 
acylated under a variety of conditions. However, reaction with diketene 60, in the 
presence of a catalytic amount of DMAP proceeded smoothly to afford the ~-keto 
ester 61 (Scheme 39).55 
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These conditions were investigated with compound 5, but again the reaction failed. 
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The O-acylation reaction planned was thus unsuccessful. Various protocols were 
examined. Numerous solvents, conditions, bases and electrophilic species were 
used but no significant positive results were obtained (Table I). 
a o 0 solvent + base + x y tOe I time 
5 
Bases X Solvents Temperatures Times Y 
KHMDS ketene THF -78 QC to r.t. 4h Complex mixture 
l.l equiv. 1.3 equiv. o QC to r.t. 
DMAP 60 THF r.t. Overnight Starting materials 
Cat 1.5 equiv. 
Pyridine AC20 Pyridinel AC20 110 QC 3h Decomposition 
NEt3 AcCl/DMAI DCM r.t. 20h Starting materials 
3 equiv. 1.5 equiv. 
KH AcCl/DMAI DMF OQC Overnight Starting materials 
l.l equiv. 2 equiv. 
NaH AcCl DMF OQC Overnight Complex mixture 
3 equiv. 1.2 equiv. 
NaHMDS AcCl THF -78 QC Overnight Complex mixture 
3 equiv. 3 equiv. 
NaHMDS Me! THF -78 QC Overnight Trace of 
3 equiv. 3 equiv. C-alkylation 
Table 1: Attempts to O-acylate 5. 
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In some cases, a catalytic amount of 4-dimethylaminopyridine 62 was added. This 
formed a highly reactive l-acylpyridinium intermediate 63, which was expected to 
facilitate the reaction (Scheme 40).56 
+ Ace} ,er 
62 63 
Scheme 40 
No improvements were noticed. Only a reaction carried under conditions expected 
to induce a C-alkylation (sodium bis(trimethylsilyl)amine, tetrahydrofuran, 
overnight! -78°C), gave traces of the C-alkylated product, which could not be 
isolated. This fact suggests that the enolate was formed. Therefore, the problem 
would not be in the enolate formation but in the reaction itself. Nevertheless, this 
deduction is subject to caution because we did not obtain a high yield of C-
alkylated material. 
2.3.1.3. Attempts under acidic conditions 
As a base-mediated route to reach the acetoxy ether was unsuccessful, acidic 
conditions were investigated. In this connection, Shi has reported a method using 
perchloric acid.52 The oxopropanoate 56 (l.l equiv.) was added to the lactone 5 in 
hexane or dichloromethane at room temperature. The reaction was performed in 
the presence of a catalytic amount of perchloric acid. Only starting materials were 
recovered (Scheme 41). 
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Similarly, the lactone 5, trimethyl orthoformate (2 equiv.) and a catalytic amount 
of para-toluene sulfonic acid were dissolved in methanol and set to reflux 
overnight. The desired product was not obtained (Scheme 42). 
~ ex: 
5 
2.3.1.4. A possible explanation 
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• starting materials 
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Both basic and acidic methods for O-acylation reaction were unsuccessful. We 
have synthesised (4aS,7S)-6,7-Dimethyl-4,4a,7,8-tetrahydro-3H-isochromene 64. 
This compound is unstable and readily undergoes degradation or rearrangement 
(section 2.3.2.1.). Like 64, enol ether 49 possesses an electron-rich double bond. It 
is possible that 49 was formed but subsequently underwent a rapid degradation 
process. Attempts to test for a hypothetical short-term formation of 49 by 
performing the reaction in deuteriated solvent in a NMR tube were not conclusive. 
37 
2.3.2. New routes based on the synthesis of the enol ether 64 
Two new methods of attaining our objective were suggested and are discussed 
below. The first one was based on selenium chemistry (Scheme 43). 
~ .~~~~~~~~ ~ ...... ~~~.e~ .... _ (X'H ~ AgO,; .... /Et 
o OH 0 ~ ~ 
4 M 0 
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Scheme 43 
The conversion of olefin 64 to the acyloxy selenide 66 using a phenylselenenyl 
chloride or bromide and 65, followed by selenoxide elimination would provide the 
desired enol ether 49. 
The conversion of olefins to alkoxy selenides is trans-stereospecific, but the 
regioselectivity is usually poor with simple alkene substrates (Scheme 44).57 
U PhSeBr d SOPh dOH + Agoy OH SePh 
0 
45 55 
Scheme 44 
In the case of enol ethers, however, the mesomeric effect controls the reaction, and 
the process is highly regioselective (Scheme 45). 
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The conversion of enol ether 67 to the acyloxy selenide 68 proves the efficiency of 
the method. 
When there is a proton cis on the carbon atom alpha to the selenoxide in 69, and 
when the product structure is not strained, syn-eIimination occurs readily even 
below room temperature to give 70 (Scheme 46).58 
RSe H [0] RS+(O"--H RI R4 Rl,'H'~4 ~M~4 >=< + RSeOH R2 R R2 R3 
69 70 
Scheme 46 
The selenoxide elimination, which affords the enol ether 49, would follow this 
mechanism. 
The second method was grounded on an epoxidation inversion procedure as the 
key step, inspired by the following sequence of reactions described during a 
synthesis of an analogue of inositol (Scheme 47).59 
BoO ••• 0 I '1" 
",.0 
AcOH,Alz03 BnO",,(y0AC 
V""OH toluene, reflux 2. KZC03, MeOH 
Scheme 47 
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Treatment of the epoxide 71 with acetic acid under alumina catalysis selectively 
gives the hydroxyl acetate 72. Conversion to the corresponding mesylate. followed 
by treatment witb potassium carbonate, resulted in acetate hydrolysis and 
subsequent ring closure to form the inverted epoxide 73. 
Corresponding cleavage of 74 by a masked hydroxyl nucleophile would be 
followed by conversion of tbe resulting alcohol to a suitable leaving group. 
Subsequent ring closure under basic conditions would lead to 75 on the way to the 
synthesis of 10, without using tbe Shi rearrangement (Scheme 48). 
I. AcOH. A120 3• toluene. reflux 
2. MsCl. NEt3. CH2Cl2 e-
---------- -- -- - -- ------------- ------
3. K2C03• MeOH ° 
° 
64 74 7S 
[0] ~ 2,6-di-tertbutyl-4-methylpyridine 
OE! ~H . - ---- - - --- --_. ---- --- ---- - --. - - -- - - - - --. 
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Scheme 48 
Botb epoxidation and selenation routes depended on the successful synthesis of tbe 
enol etber 64. 
2.3.2.1. Synthesis of enol ether 64 
Mesylation of lactol4 followed by base-induced elimination of the mesylate of the 
intermediate 77 gave tbe alkene 64 after overnight stirring and purification. 
The problem of low yield due to the instability of this product had, however, still 
to be solved. Compound 64 was obtained in only 20% yield, whereas tbe 
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conversion was approximately 65%, established by NMR spectroscopy of the 
crude product. Therefore the low yield appeared to be linked with the purification 
process. 
Flash column chromatography, even after treatment of silica gel by triethylamine, 
was not efficient. This method of purification was successfully replaced by 
Kiigelrohr distillation of the product, and gave 64 in 63% yield (Scheme 49). 
8 MsCl, NEt) 8 c7 DCM 63% o OH overnight o OMs 0 
4 77 64 
Scheme 49 
When purified, the enol ether 64 had to be stored. Maximum precautions allowed 
this compound to be kept for two days in a refrigerator under nitrogen (the 
glassware was previously treated overnight by a solution of potassium hydroxide 
in isopropanol so as to avoid the acidic action of the glass). Afterwards the 
compound underwent degradation. 
The two new routes were based on compound 64, in which the double bond of the 
enol ether is activated by the vinylic oxygen of the ring. Further reactions would 
therefore involve this double bond, which is electronically enriched, rather than 
the other olefin, which is electron-poor. 
2.3.2.2. The selenium route 
The conversion of olefins to alkoxy or acyloxy selenides followed by selenoxide 
elimination provides a mild and efficient route to vinylic alcohols and enol ethers, 
and provided the impetus to test the following strategy (Scheme 50).60.61 
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Silver acetate was used to convert 64 to 78 instead of oxopropanoate 65 (Scheme 
43) due to the problem associated with the presence of the two acidic protons 
described previously in Scheme 36. A silver salt was used because of its solubility 
in organic solvents, and because the conditions required were mild. Only one 
equivalent of phenylselenenyl chloride was used to guarantee that over-reaction 
with the less reactive olefin was prevented. 
Two different procedures were investigated for the formation of the ~­
acetoxyalkyl selenide 78. First, acetolysis in acetic acid of a ~-chloroalkyl selenide 
79 initially formed across the double bond of the enol ether was envisaged and 
secondly, the direct addition of acetoxyphenyl selenide 80 to the enol ether unit 
was proposed (Scheme 51).57 
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Various reaction conditions were examined, and are described below, 
Unfortunately, all the different protocols gave complex mixtures, where acetoxy or 
hydroxy seIenide could not be identified. 
Several attempts were made following the procedure used by Perez and Beau in 
their synthesis of deoxyglycosides (Scheme 52).62 
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A solution of olefin 64 (1.22 mmol) in dichloromethane was treated with 
phenylselenenyl chloride (l equiv.). The reaction was stirred for 30 minutes before 
the addition of silver salt (1.5 equiv.). Instantaneously, a precipitate of silver 
chloride was formed and the solution passed from a yellowish to an orange colour, 
which seemed to indicate the success of the reaction. Unfortunately, after filtration 
of the precipitate and the evaporation of the solvent, a mixture of products was 
formed that was impossible to purify. Strangely, precipitation of the silver chloride 
did not appear upon exchanging dichloromethane for toluene, and the solution 
remained a yellow colour. Nevertheless, the starting material could not be 
retrieved and the reaction gave a mixture of products, perhaps due to the instability 
of 64. The inverse addition of the olefin to phenylselenenyl chloride was also 
attempted, but without success (Scheme 53).63 
c7 o 
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The generation of phenylselenenyl acetate followed by addition to the enol ether 
was attempted using the following conditions (Scheme 54).57 
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Phenylselenenyl acetate was readily generated in situ by reacting phenylselenenyl 
chloride (1 equiv.) with silver acetate (1.5 equiv.) in acetic acid. An orange 
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precipitate of silver chloride was formed. After stirring for 30 minutes, the phenyl 
selenyl acetate was added to a solution of olefin 64 (1.22 mmol) in 
dichloromethane. The solution was allowed to stir overnight. The crude product 
mixture obtained was too complex to be exploited (Scheme 55). 
cl o PhSeOAc complex mixture DCM, r.t., overnight 
64 
Scheme 55 
A hybrid reaction was also attempted where the reactants were added 
simultaneously at low temperature in etheral solution according to the an example 
from the literature (Scheme 56).57 
PhSeBr, AgOAc 
Et20, 2 h 
-10 cC to 0 cC 
96% 
Scheme 56 
Phenylselenenyl bromide (l equiv.) was added to a cold solution (-10 0c) of olefin 
64 (1.22 mmol), followed by an excess of silver acetate (1.2 equiv.) in 10 mL of 
diethyl ether. Here again a precipitate was formed, and after a night at room 
temperature, a mixture of products was obtained after filtration and solvent 
evaporation (Scheme 57). 
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The use of trifluoroacetoxy selenides 82 represented the last alternative method, 
where acetate is replaced by trifluoroacetate. Trifluoroacetate 81 is less basic than 
acetate, which prevents the following possible side reaction of elimination by 
deprotonation of the proton alpha to the selenenium ion (Scheme 58). 
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Trifluoroacetate 81 is the nuc1eophile in the addition reaction and opens the 
transitory 1,2-episelenonium ion (Scheme 59).64 
0 PhSeBr (X'Ol(F' KOH,EtOH aOH AgO",{CF3 SePb SePb 
81 ° 
90% 
Scheme 59 
Phenylselenenyl bromide (1 equiv.) was treated with silver trifluoroacetate (I 
equiv.) in 10 mL of toluene, Instantaneously, a precipitate of silver bromide was 
formed and the solution passed from purple to orange, which indicated the 
formation of phenylselenenyl trifluoroacetate. Olefin 64 (1.22 mmol) was added to 
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the mixture and the solution was allowed to stir overnight. The precipitate was 
filtrated and the solvent was evaporated. The reaction afforded a complex mixture, 
as did the previous examples (Scheme 60). 
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The formation of numerous products in each of these procedures may have been 
due to the instability of substrate 64, and perhaps the reactivity of the other olefin, 
was causing competition with the enol ether. 
Also, the formation of by-products such as allylic derivatives has been described. 
It has been even shown that, in some cases, there is a strong preference for 
elimination in the direction that gives the allylic derivative 82 rather than the 
vinylic product 83 (Scheme 61). 6S 
a:'Pb [0] U x + U x 
82 83 
X= OH 98.8 0.2 
X=OAc 97 3 
X=OMe 98 2 
X=Cl 51 49 
Scheme 61 
Compound 66 possesses three protons alpha and cis to the selenium. In the best 
case, the desired compound 49 would have been synthesised, but potentially mixed 
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with two other compounds. As shown in Scheme 62, the allylic products 84 and 85 
may be more favourable than 49 (Scheme 62). 
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This alternative strategy begins with the formation of 74 by simple epoxidation of 
the enol ether 64. Classic epoxidation conditions proposed by Baker et al. 59 and 
Arbelo et al.66 were repeated. However, we were unable to isolate 74 from the 
reaction mixtures. It is possible that the enol ether 64 was too unstable and 
decomposed or rearranged in situ before the epoxidation reaction could occurred 
(Scheme 63). 
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As a model and to provide experience, an epoxidation was attempted on ethyl 
vinyl ether 86 using meta-chloroperbenzoic acid. Sodium carbonate was added to 
the reaction mixture in order to prevent the attack of the m-chlorobenzoic acid on 
the epoxide 87 formed. The mechanism of the epoxidation reaction is presented 
below (Scheme 64).67 
86 
P Cl '7 I Na2C03h ,DNa o ~ Cl----. ~OH - 0 
inactive towards the epoxide 
active 
1---- + 
"butterfly" transition state 
Scheme 64 
The reaction was successful and we decided to continue the epoxidation chemistry 
by changing the strategy. 
This strategy was abandoned and replaced with a new route shown in the next 
section. It was thought to be a more sensible approach to work with a ring opened 
isomer. 
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2.4. Working with an opened ring 
Vahedi obtained the oxaspirobicyc le unit 8 with the wrong stereochemistry. This 
stereochemistry was due to the cis- fu sed bicyc lic unit where the access to the 
upper face was disfavoured in the enolate of' 5 (Figure 7). 
a o 0 
5 
Figure 7 
As the stereochemistry of the bicycle was causing the problem, we decided that it 
would be best to avoid its format ion. The opened-ring would be functionalised 
first, as it would offer more accessibility and reacti vity than the bicyc lic unit , 
before ring closure. 
2.4.1. Formation of a monocycle by different Diels-Alder reactions 
2.4.1.1. Nef reaction 
First, we decided to explore the Nef reaction which had been investi gated by a 
. l b ' I 1' 1 prevIous researc l er, ut Wit l OUt success. -
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2.4.1.1.1. Synthetic plan 
This reaction was a key step of the synthetic plan towards the synthesis of the 
required spirotetronate 9 illustrated in Scheme 65. 
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Scheme 65 
First a Diels Alder reaction between 3 and nitroethylene 88 would give the 
formation of the cyclohexene ring with the nitro functionality 89. The desired 
cyclohexenone 90 would then be obtained by converting the nitro group into a 
ketone. The Nef reaction is the conversion of a primary or a secondary nitroalkane 
93 into the corresponding carbonyl compound 94. Nef first reported the reaction in 
1894 (Scheme 66).68 
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A number of mechanisms have been proposed for the reaction. The simplest is 
illustrated below.69 Thus, the initial reaction consists of the deprotonation by a 
strong base (usually sodium hydroxide) of the nitro compound 93 to give nitronate 
95. A succession of protonation-deprotonation processes, nucleophilic attack by 
water and loss of water lead finally to the carbonyl compound 94 (Scheme 67). 
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Scheme 67 
It is important to mention that nitroalkanes are acidic by nature and form sodium 
salts. When a mineral acid is added, nitroalkanes are regenerated. However, the 
action is different when the sodium salts are added to an excess of acid. In this 
case, carbonyl compounds are formed with the evolution of nitrous acid. 
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2.4.1.1.2. Previous attempts on Nef reaction 
Previous researchers have tested numerous alternative methods, some of which 
involve mild conditions.70,71 
Many of these modem approaches utilised oxidising agents. Use of reagents such 
as ox one/potassium hydrogen persulfate,72 MoOPH,73 potassium permanganate74,75 
has been described in the literature. Oxidative cleavage of the nitronate by means 
of TMSCllm-CPBA,76 tert-butyl hydroperoxideNO(acac)2,77 and TPAP/NM078.80 
has been attempted by previous researchers of the Page group because they 
represent efficient methods which would not cause competing reaction of the 
olefin of the cyclohexene unit of 89 (Scheme 65). The selectivity of these methods 
towards the nitro functionality is shown below (Scheme 68).76,77,80 
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These reactions are successful but prevent working with substrates bearing a free 
alcohol due to the concurrent alcohol oxidation, Indeed, these oxidising reagents 
are commonly used for the oxidation of sulphides to sulfones and alcohols to 
I 
I 
I 
I 
I 
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carbonyl compounds. As depicted in Scheme 69, during the formation of 97 from 
96, the hydroxyl group was oxidised.8I 
TPAPINMO 
molecular sieves 
96 97 
Scheme 69 
Therefore the hydroxyl group of the nitro compound 89 had to be protected before 
such protocols could be attempted. All attempted oxidative cleavage reactions with 
benzyl-protected substrate 98, carried out by BatcheIor during his PhD, failed, and 
the starting material was recovered (Scheme 70).71 
~ !'t: HO 
89 
~ ~H 
BnO 
98 
oxidative cleavage 
procedures 
oxidative cleavage 
procedures 
Scheme 70 
complex mixtures 
starting material 
The oxidative cleavage methodology was not successful, and so reductive 
cleavage methodology was attempted. Only few reagents convert nitro compounds 
into aldehydes or ketones by reductive processes. The most widely used reductive 
modified Nef reaction uses aqueous titanium chloride.82-84 This reagent can be 
very acidic, and the reaction often uses an ammonium acetate or sodium acetate 
buffer to prevent any side reactions with sensitive compounds (Scheme 71).82 
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Other reagents such as tin complexes in conjunction with sodium hydrogen 
sulphate85 or vanadium (ll) chloride84 can also be used, but are less common. 
The failure of the process persuaded previous researchers to seek another route to 
the carbonyl compound 90 (Scheme 72).71 
~ j't,H 
HO 
TiCI3, THF, r.t., 18 h\/ If 
/\ 
HO 0 
89 90 
Scheme 72 
2.4.1.1.3. New attempts 
Extended work was carried out using the previous research 70,71 described in the 
previous section. 
2.4.1.1.3.1. Attempts towards the synthesis of compound 90 
The two steps presented in Schemes 73 and 74 had to be repeated. The formation 
of nitroethylene 88 showed to be more difficult than predicted. Whereas the 
previous researcher obtained a 57% yield, we managed to form only a poor 11 % of 
nitroethylene 88 (Scheme 73). 
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Scheme 73 
88 
Different attempts, including the use of the Kiigelrohr equipment, were very 
disappointing. In the same way, the Diels-Alder reaction between the hydroxy 
diene 3 and nitroethylene 88 led to 89 in a 20% yield compared with the 64% 
obtained by Batchelor (Scheme 74). 
&"' HO 88 toluene r. t., 36 h 20% 
Scheme 74 
89 
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The correct regioisomer 89 was exclusively afforded according to comparison with 
the data previously obtained and which fully characterised the product 89. 
Postulating that maybe the protocols used previously for the next reaction were too 
mild, we decided to carry on the Nef reaction as it was originally described, 
following the general procedure proposed by Culford Bell et al. 86 Compound 89 
was dissolved in a solution containing sodium hydroxide. Addition of sulphuric 
acid dropwise to the reaction mixture gave a complex mixture which could not be 
separated (Scheme 75). 
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This result may be explained by the fact that this procedure, using a base followed 
by sulphuric acid, is drastic and can produce a number of unwanted side reactions 
on sensitive substrates, as described by Pinnick,82 
Nitronate 95 is highly reactive towards' electrophiles at several sites because of the 
delocalisation of the negative charge. Addition of a proton to the a-carbon atom 
regenerates the nitro species 93 (Scheme 76). 
"I. 0- +W o~ + ",,0-
'N' N 
RI~R2 R1+RZ H 
H' 
95 93 
Scheme 76 
Also, nitrite ion can behave as a good leaving group and can be eliminated upon 
treatment of 93 with base. Substrate 89 bears a secondary nitroalkane group, the 
formation of a pseudonitrole 99 may be favoured by slow addition of the nitronate 
to the acid (Scheme 77). 
95 99 
Scheme 77 
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A new methodology proposed by Ballini 84 was also explored.87 This method 
consists on a one-step conversion of secondary nitro compounds into the 
corresponding carbonyl derivatives using DBU in acetonitrile. 
Direct cleavage of the nitronate anion under basic conditions is a rather uncommon 
process that has only been observed on dry activated silica gel,88 or when proton 
transfer is facilitated by a neighbouring group participation.89 
Davis et al. have demonstrated that DBU in acetonitrile is not able to efficiently 
convert nitroethane into the corresponding nitronate.9o The situation may be 
different when secondary nitroalkanes are used as substrates since they are slightly 
more acidic than the primary nitroalkanes. It is therefore possible that DBU is able 
to produce a complex 100 that behaves similarly to a protonated nitronic acid 
intermediate in the classical Nef reaction (Scheme 78). 
DBU 
-
100 
-HNO 
103 
101 102 94 
Scheme 78 
An equilibrium is achieved between the complex 100, the oxaziridine 101 and the 
hydroxynitroso derivative 102. The last intermediate eliminates hyponitrous acid 
103 affording the carbonyl derivative 94 as the final product. 
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This method offers usually good yields (54-80%) and preserves functionalities, 
whereas the previous methods did not. It was therefore possible to work with 89 
without protecting the hydroxyl group and without risking the integrity of the 
olefin. 
Treating one equivalent of nitro 89 with DBU (2 equiv.) in acetonitrile, and 
heating at 60°C, the secondary nitro compound was not converted into the 
corresponding ketone 90. Even after S days, only the starting material was 
recovered (Scheme 79). 
~ ~H 
HO 
starting material 
60 QC, 5 days 
89 
Scheme 79 
The Nef reaction was not the main focus of this project. Therefore, the lack of a 
positive result coupled with the time limitations did not allow us to perform 
another procedure such as the innovative utilisation of activated basic silica gel 
. I . d 88 prevIOus y menbone . 
2.4.1.1.3.2. Julia's reaction 
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Having planned for the success of the Nef reaction, we wished to explore the 
possibility of using a-alkoxyheteroaryl sulfone 107 in a Julili olefination reaction 
on ketone 90 to give 91 (Scheme 80), such as the reaction proposed by Charette et 
al. in their approaches to the formation ofE,Z-dienes (Scheme 81).91 
~CHO 
Ph 
LiHMDS, DCM, 25 'C 
BT = BenzoThiazoyl 
SchemeS1 
This olefination reaction was first reported in 1991 by Julili et at. as a new 
connective one-pot synthesis of alkenes involving the reaction of lithiated 
benzothiazolyl sulfones with carbonyl compounds.92 Julili olefination was chosen 
because it overcomes the problems linked to the formation of vinyl ethers through 
Wittig and Homer olefinations. These later methods can suffer from low yields, 
requiring a higher temperature in addition to the difficulty in removing phosphine 
oxide from the desired product. Also, alkoxymethyltriphenylphosphorane ylides 
are reportedly unstable and afford low yields of vinyl ethers with enolisable 
substrates.93 
Sulfone 107 was prepared in two steps from commercially available reagents 
chloro(methoxy)methane 105 and 2-mercaptobenzothiazole 104 according to the 
procedure described by Berthelette et at. (Scheme 82).94 
MeO ............... CI 
ccN I ;r-SH h s 105 0-'N;r-S __ H_2_0_2_(3_5_%_) __ • 0-'N;r-L\ NaH (60%), DMF, 0 'C ~S "-OM, NaW04, 2 H20 ~S g OM' 
104 106 MeOH,O'C 107 
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The oxidation of sulphide 106 to sulfone 107 was carried out with hydrogen 
peroxide, the catalyst being tungsten in its higher oxidation state. This method was 
shown to give relatively good yields.95 
Unfortunately, the synthesis of ketone 90 was not completed, and the fonnation of 
107 found an application only later in our researches (section 2.5.3.4.). 
2.4.1.2. Attempts to use l-cyanovinyl acetate 253 in a Diels-Alder reaction 
A Diels-Alder reaction involving 2-chloroacrylonitrile was accomplished by the 
previous researchers, but the conversion of the cyc10adduct fonned into the 
corresponding ketone was not achieved.121 
The relative success of the cyc1oaddition led us to try another dienophile which 
can be used as a ketene equivalent: the l-cyanovinyl acetate 108 in order to fonn 
109. The fonnation of the cyc1ohexenone 90 would then give a viable intermediate 
that could be converted to give the spirocyc1e as discussed earlier (Scheme 83). 
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The desired regiochemistry was afforded exclusively with 2-chloroacrylonitrile, 
suggesting that the compound 110 would not be fonned in appreciable quantity 
with our very similar choice of dienophile (Scheme 84). 
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The Diels-Alder reaction was carried out with heating, using toluene as the 
solvent. Attempts without solvents were also made (Scheme 85). 
toulene, reflux 
starting materials 
or neat 
3 108 
Scheme 85 
Only starting materials were recovered, even after the addition of titanium 
chloride. This suggested the diene to be insufficiently reactive, requiring the most 
forceful of conditions. The stability of the dienophile in these high temperatures 
and pressures however proved problematic. Decomposition of materials occurred, 
even when the reaction was carried out in a sealed tube. 
The failure of this route led to the following investigation. 
2.4.1.3. A voiding the ring closure 
Two different routes were planned, based on the formation of the aldehydes 111 or 
112, leading to 9 as a precursor for 11. 
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The first pathway is based on the Shi's rearrangement process. The synthesis 
would start with the formation of an acetoxy ester 113, which would be 
consecutively oxidised to give the epoxide 114. Shi's rearrangement followed by 
deprotection of the alcohol using TBAF would afford 115, having the correct 
stereochemistry. Oxidation of the alcohol and treatment with potassium carbonate 
would result in acetate hydrolysis to give 9. Three steps from 9 would then give 
the desired spirocycle 11 (Scheme 86). 
111: R= TBDMS 
112: R= TBDPS 
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The alternative is based on a chelated epoxidation using vanadyl 
bis(acetylacetonate)! t-butyl hydroperoxyde of 91 to give 116. Methoxy ether 91 
would be first synthesised from 111 or 112 using a methylating agent such as 
methyl triflate followed by deprotection of the hydroxyl group. Acidic treatment of 
116, followed by oxidation of the alcohol, would give 9 having the correct 
stereochemistry. As in the previous example, three steps from 9 would afford the 
desired spirocycle 11 (Scheme 87). 
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Scheme 87 
Formation of the aldehydes 111 or 112, which was attempted by protecting the 
alcohol of the hydroxy diene 3, would prevent the ring closure to 4. This would 
represent the first step of the new strategy presented in Schemes 86 and 87 
(Scheme 88). 
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The first step was to protect the primary alcohol of the compound 3 before trying 
the Diels-Alder reaction. 
2.4.1.3.1. Protection of the hydroxyl in compound 3 
Formation of silyl ethers, especially the more sterically demanding variants, is a 
standard method for protecting alcohols. The popular bulky tert-butyldimethylsilyl 
group was chosen to be the protecting group. This group is widely used and is 
stable except towards acid hydrolysis or in the presence of fluoride ions.96 The 
protected product 256 was obtained in a 65% yield by using tert-butyl 
dimethylsilyl chloride (1.1 equiv.) and imidazole in large excess (3 equiv.) 
(Scheme 89). 
TBDMSCI, imidazole 
DMF 
3 65% 117 
Scheme 89 
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The protection of the alcohol ensures that the formation of the hemiacetal 119, 
obtained during the reaction between 3 and acrolein 118, does not occur. Thus, the 
regiochemistry would not be fixed during the Diels-Alder reaction and both 111 
and 120 would be produced (Scheme 90). 
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2.4.1.3.2. The Diels·Alder reaction attempts 
Water was maintained as the solvent in order to force the hydrophobic reactants 
into a compressed transition state (section 2.1.3.4.) Diels-Alder reactions were 
attempted but no cyc1oaddition occurred (Scheme 91). 
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Using acrolein 118 or even methyl acrylate 121 led to recovery of starting 
materials. Allyl alcohol 122 used as the solvent was also a failure. In consequence, 
we understood that the formation of the hemiacetal followed by oxonium ion 
formation represented a key requirement of the reaction. 
2.4.2. Trapping the open chain isomer 
Nevertheless, the open chain isomer 4a exists in equilibrium with the ring-closed 
lactol 4 (Scheme 92). 
& 
o OH A HO 0 
4 43 
Scheme 92 
67 
Trapping the open chain isomer 4a was our new target. 
2.4.2.1. Ring opening by protection of the alcohol 
Two examples of an opened ring lactol isomer trapping by protection of the 
alcohol were found in the literature (Scheme 93). 
cl o OH A RO 0 
4 
Scheme 93 
2.4.2.1.1. Method used by Nicolaou 
The first method was reported by Nicolaou, during studies towards the total 
synthesis of antibiotic X-14S47A. It involved the treatment of a lactol123 with 
tert-butyl dimethylsilyl chloride and imidazole (Scheme 94).97 
TBDMSCl (1.5 equiv.) 
imidazole (1.5 equiv.), DMF, r.t. 
70% 
123 
Scheme 94 
o 
~OTBDMS 
The conditions used by Nicolaou were repeated, but the reaction furnished the 
lactol silyl ether 124 in 85% yield and not the silyl ether aldehyde 111 targeted. 
The expected faster reaction of the open-chain isomer did not occur even by 
reducing the temperature of the reaction (Scheme 95). 
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2.4.2.1.2. Method used by Hatakeyama 
(y 
a~ __ 
o OTBDMS 
124 
The second method was reported by Hatakeyama et al. in their synthesis of (-)-
pyrenophorin. The reaction of a lactol 125 with the phosphonoacetate 126 leads 
directly to formation of an aldehydophosphonoacetate 127 because the 
aldehydoalcohol 125a can undergo the esterification reaction much faster than the 
lactol125, presumably due to steric reasons (Scheme 96).98 
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Scheme 96 
The method was repeated several times on our substrate. Lactol 4 was allowed to 
react with 126 (1.2 equiv.) in the presence of a catalytic amount of 4-DMAP in 
refluxing toluene for 2 weeks. The evolution of the reaction was monitored by 
TLC, which indicated that no reaction had occurred even after two weeks (Scheme 
97). 
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2.4.2.2. Ring opening by reaction of the carbonyl group 
As an alternative to protection of the hydroxyl group of the ring-opened hydroxy 
aldehyde, we decided to investigate reaction of the carbonyl group. 
2.4.2.2.1. Thioacetalisation 
Two routes, leading to open chain thioacetals 128 and 130 were envisaged 
(Scheme 98). 
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Route 1 was inspired by Paquette and Fetizon. The thioacetal 128 would be 
converted into the parent aldehyde 129 for example by methyl iodide in moist 
acetone according to the mechanism shown in Scheme 99,99.100 or by other 
thioacetal hydrolysis protocols. 
H'O/H R 
R Mel R ~ -HI S .. >r"R' H+ R R' 
S .. ~R· 9k-.... R f.R' ____ ! OH ---- 1(0 l./--- L.$S-CH3 __ -o!,' (f I 
r ~ ............... S""Me S-CH3 
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Scheme 99 
Route 2 would afford compound 131 which could allow for a subsequent chelated 
epoxidation and deprotection to presumably afford a mix of 132 and 133. 
Protection of the hydroxy group of the isolated 132, followed by aqueous acidic 
treatment, would generate the dihydroxy compound 134. The subsequent oxidation 
of the primary alcohol and deprotection of the protected hydroxy group would then 
give 9 (Scheme 100). 
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Nevertheless, the deprotection in route 2 (Scheme 98) involves a Birch reaction to 
give compound 131. This kind of reaction has not been reported in the literature. 
Also, this route requires the formation of lactone 5 from lactol 4, therefore route I 
was shorter and was first investigated. 
Dithiols were used because they are more likely to capture the masked aldehyde as 
a ring-opened thioacetal than diols, due to the stronger nucleophilicity of sulfur 
compared with oxygen. 
A Lewis acid is usually used as the catalyst of the reaction. Most of the examples 
found in the literature use boron trifluoride etherate. Such protocol was related by 
Roush et al. in their synthesis of verrucarol, a natural product possessing a 
skeleton common to the trichlorotercene family of terpene antibiotics (Scheme 
101).101 
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These conditions proved to be ineffective for our substrate 4, and led to recovery 
of the starting material. In order to improve the process, we envisaged that Lewis 
acids based upon titanium reagents, capable of forming covalent bonds with 
oxygen and with thiols, with which titanium generates octahedral complexes, 
would probably best suit our purpose.102 Studies achieved by Paquette and PagelOO 
showed that such more forcing conditions are required in order to cleave the 
endocyclic carbon-oxygen bond of y-lactols, frequently recalcitrant to ring opening 
(Scheme 102).103,104 
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Replacement of the Lewis acid, however, did not give any more results and no 
reaction was observed when using either boron trifluoride etherate or titanium 
tetrachloride (Scheme 103). 
a o OH (] SH SH starting materials 
DCM 
4 
Scheme 103 
In the example depicted in Scheme 102, ethanedithiol has been used. It is a better 
reactant than propanedithiol due to the kinetically-favoured formation of five-
membered rings over six -membered rings as a result of entropic, enthalpic and 
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stereoelectronic factors. 105 A reaction involving ethanedithiol and titanium 
tetrachloride was therefore attempted. The lactol ring cleavage was unfortunately 
not obtained, and only the compound 135 was afforded. The reaction was 
attempted with hydrochloric acid (6M) at room temperature in place of titanium 
tetrachloride, as exemplified by Peng et al.,106 but the same product 135 was 
obtained in similar yields (Scheme 104). 
&r /\ &~. H5 5H TiC!4 cat., DCM o OH 
or HC! (6M) o 5 
4 46% 135 
Scheme 104 
The conversion of 135 to 128 was attempted by treating 135 with aluminium 
chloride. The reaction was carried out in dichloromethane or chloroform in 
compliance with the conditions used by Paquette, Page et al. 107 Even under reflux 
in toluene (in order to increase the temperature of reaction), the ring opening did 
not occur. 
An alternative procedure was therefore considered: the formation of ketene 
dithioacetal 130 by reaction of lactone 5 with a bis-dimethylaluminium salt 136, 
which is an activated derivative of alkanedithiol (Scheme 105).108.109 
&r \ /\ / J~ Al-S S-AI / \ 136 DCM 50 o 0 
4 130 
Scheme 105 
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The reaction between ethanedithiol 137 and trimethyl aluminium, reported by 
Corey,110.111 affords the very reactive species 136 (Scheme 106). 
A1Me3 (2 equiv.) \ 1\ / 
AI-S S-Al 
hexane, -78 QC to r.t. / \ 
137 136 
Scheme 106 
Unfortunately, reaction of 136 with lactone 5 was unsuccessful and the scheme 
was discontinued. 
2.4.2.2.2. Formation of an oxime 
We next proposed ring-opening of lactol 4 by formation of the oxime 138 (Scheme 
107). 
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Dorsey et al. used this pathway in their synthesis of glycosylamines (Scheme 
108).112 
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The conversion of the tetra-O-benzylglucose 139 into the corresponding oxime 
141 was almost quantitative. The dehydration under conditions described by 
Vasella was the next step.1I3 The procedure of oxime giving nitrile was repeated 
on the lactol4. 
The hydroxylamine hydrochloride salt 140 (1.6 equiv.) was added at 60 cC to a 
stirred solution of sodium in 96% aqueous ethanol, followed by addition of the 
substrate 4 (1.65 mmol). A complex mixture of products was formed. It seems that 
the substrate was decomposed. Less forcing conditions, avoiding the heating, still 
gave decomposition products (Scheme 109). 
c1 o OH + H3NOH, er 140 Na, EtOH, 60 cc complex mixture 
4 
Scheme 109 
Both aldehyde and alcohol had trapping failed. The next plan was based on 
nucleophilic attack of the carbonyl group by the phosphite 142 (Scheme 110). 
2.4.2.2.3. Nucleophilic addition of a phosphite to the carbonyl 
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4 
THF P, RO OEt 
143 
Scheme 110 
The first step of the reaction sequence involves the addition of a phosphite 142 to a 
carbonyl group and is known as the Abramov reaction. Wr6blewski et al. reported 
an efficient Abramov reaction procedure in their search for structural analogues of 
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paclitaxel, an important anti-cancer agent used for the treatment of various 
tumours (Scheme 111).114 
:rjHBoc ~HBoc 
~P(O)(OEth + ~P(O)(OEt), Ph Ph = 
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(EtOhP(O)H, NEt3 65% 75 25 
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Scheme 111 
The coupling of diethyl phosphite and the aldehyde is usually carried out in the 
presence of triethylamine. Employing lithium diethyl phosphonate gave a drop of 
diastereoselectivity but afforded better yield, which is precisely our aim. 
Both of these protocols were reported by Wr6blewski et al. and tested on lactol 
4.115 The first procedure was to simply mix lactol 4, diethyl phosphite 142 (op :: 
7.8 ppm) and triethylamine, which were stirred at room temperature for 24 hours. 
The second protocol consisted of cooling a solution of lactol 4 in tetrahydrofuran 
to -78°C and adding dropwise a solution of lithium diethyl phosphonate in 
tetrahydrofuran at -78°C). The reactions were monitored by 31p NMR 
spectroscopy. After one day the 31 p NMR spectroscopy disappointingly, revealed 
only the presence of the starting material 142 (Sp:: 7.8 ppm) (Scheme 112). 
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The failure of the Abramov reaction led us to try a modified procedure, commonly 
known as the Pudovic reaction. 
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Diethyl phosphite 142 in dichloromethane was silylated with trimethylsilyl 
chloride in the presence of triethylamine at 0 °C to produce a nucleophilic 
phosphorus species, diethyl trimethylsilyl phosphite 144 (op = 117.3 ppm) 
(Scheme 113).116 
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144 was allowed to react overnight with lactol 4 (2.05 mmol, 0.7 equiv.) in 
refluxing dichloromethane.l17 31 P NMR spectroscopy did not reveal anything else 
apart from the starting material 144 (Scheme 114). 
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This route was abandoned after the first step, as neither of the two protocols gave 
any promising results. The Wittig reaction was the last rraction on the carbonyl 
group attempted and showed more success as it as been reported in the next 
section. 
2.5. Two new routes leading to intermediates 111 and 112 
A new strategy, however, allowed the opened ring to be trapped. The open chain 
isomer could now finally be obtained using the two methods in Scheme 115, 
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leading to compounds 111 and 112 precursors of 9 (section 2.4.1.3.) (Scheme 
115). 
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Reduction of the open chain isomer of 4 allowed the formation of the diol 145. 
Selective protection of one of the primary alcohols gave 146 or 147. Finally, the 
oxidation of these compounds gave respectively 111 or 112. 
Wittig reaction on the open chain isomer of 4 afforded compound 148. The alcohol 
functionality was protected to give 149 or 150. A selective oxidation of these 
compounds led to 111 or 112. 
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2.5.1. Formation of 111 and 112 through route 1 
,Jy reduction ,Jy protection ,Jy 
a~ .. ~ !Y~ .. -f'6. 
o OH HO OH RC OH 
oxidation Il 
"H 
"-RO 0 
4 145 146 or 147 111 or 112 
Scheme 116 
2.5.1.1. Ring opening by simple reduction of 4 
Ring opening of lactols by reduction has been reported in numerous literature 
examples using various conditions (Scheme 117)Ys 
TBDPSOl ...... o, ~ &OH 
# .... OH 
o TBDPsol/OH ~ LAH, THF, -78 C V OH 
........ OH 
Scheme 117 
The first route began with the reduction of the lactol 4. Use of lithium aluminium 
hydride in tetrahydrofuran at 0 QC, could perform this task. However, the hazard 
linked to the use of this powerful reducing agent and the messy aqueous work-up 
using sodium potassium tartrate, was avoided by a reduction using sodium 
borohydride instead (Scheme 118). 
-j{ 
HO OH 
145 
+ EtONa 
HO C" 4 \ 
-
+ EtOBH4 
_ H-OEt 
H3B H 
, 
\ 
Etcm 
Scheme 118 
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This much weaker hydride donor allowed an easier procedure and work-up. The 
expected diol 145 was obtained with 90% yield after filtration though silica gel 
(Scheme 119). 
&r NaBH4,EtOH h 3 h, r.t. "H o OH HO OH 
4 90% 145 
Scheme 119 
2.5.1.2. Selective protection of the less hindered hydroxy group of 145 
A HO OH protection A RO OH 
145 146 or 147 
Scheme 120 
The selective protection of one of the hydroxyl functionalities was essential in our 
strategy. The next step involved the oxidation of the least hindered alcohol closest 
to the ring. The other alcohol had to be protected first so it was not also oxidised 
(section 2.5.1.2.). 
The selective protection of one hydroxyl group in the presence of another can 
often be readily achieved. This process, however, becomes more complicated if 
the hydroxyl groups are similar. The diol 145 indeed possesses two primary 
alcohols. Nevertheless, the particular hydroxyl group that we aimed to protect is 
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sterica lly more accessib le and might be differentiated from the other hydroxyl 
group (Figure 8). 
Figure 8 
lY-
fl'~ .  HO OH 
145 
Only few methods are described in the literature, which are predominantly based 
on the use of sil yl reagents. The O-alkylsi lyl ether protect i ve groups are stable 
under ox idat ive conditions and the desilylation does not affect other 
functionalities, such as alkenes or enol ethers, which is essential in order for us to 
complete the nex t steps. 
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Three methods had shown potential in the literature: 
• Pearson et al. used tert-butyl dimethylsilyl ether as protecting group in the 
context of a synthesis of (-)-slaframine, a substance with potential beneficial 
effects on ruminant digestive functions (Scheme 121).1\9 
151 
TBDMSCl ,py, DMAP cat. 
DeM, 0 °e to r.t., 12 h 
85% 
Scheme 121 
152 
Selective silylation of 151 leading to 152 occurs presumably because of the 
differing steric and electronic environments of the two hydroxyl groups. 
As well as Pearson, Oestreich et al. achieved a regioselective silylation, using 
refluxing dichloromethane as solvent. Compound 153 led to 154 in a 76% yield 
(Scheme 122).120 
153 
TBDMSCl (I. 2 equiv.), DMAP 
NEt3 (1 equiv.), DeM, reflux 
76% 
Scheme 122 
We applied these reactions to the dio1145. 
HO~~BDMS 
NBnz 
154 
Monoprotected diol146 and diprotected diol 155 were obtained in a 2: 1 ratio with 
similar yields. The second method, which uses triethylamine and dichloromethane 
under reflux, has the advantage of being much faster (only 3 hours, against 18 
hours for the method used by Pearson) (Scheme 123). 
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A BO OH 
145 
pyridine, DMAP, TBDMSCl, 
DCM, 0 'C, 18 h 
(Pearson) 
62% 
NEt3, DMAP, TBDMSCl, 
DCM, reflux, 3 h 
(Oestreich) 
60% 
~A·R; 
TBDMSO OH TBDMSO OTBDMS 
146 155 
2 1 
Scheme 123 
We aimed to improve the degree of selectivity in this reaction. With this in mind, 
tert-butyl dipbenylsilyl chloride proved it was the ideal reagent, as it allowed us to 
improve the regioselectivity of the silylation by following the protocol reported by 
Walton et al. (Scheme 124).118 
TBDPSCl (I. 2 equiv.), imidazole 
DeM, 0 'C to r.t. 
45% 
Scheme 124 
OH 
TBDPS~ 
This can be explained by considering that TBDPS is a larger silyl protective group 
than TBDMS. The steric repulsion effect is significantly increased and the 
regioselectivity will increase as well. Dilution, temperature and the rate of addition 
of tert-butyldiphenylsilyl chloride were optirnised to give a final 3:1 ratio in favour 
of the monoprotected adduct 147 and 20% of recovered starting material. We 
obtained a 60% yield of 147 (Scheme 125). 
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~---------------------------------------------------------------------------------, 
0.: H)C:H 
145 
TBDPSCI, imidazole 
DCM, r.t., overnight 
80% 
J2:.Jtr 
TBDPSO OH TBDPSO OTBDPS 
147 156 
3 1 
Scheme 125 
Diol145 was recovered efficiently by deprotecting compounds 155 and 156 using 
tetra-butyl ammonium fluoride (Scheme 126). 
H 
fY~_ 
RO OR 
155: R=TBDMS 
156: R=TBDPS 
TBAF, THF 
75% 
82% 
Scheme 126 
2.5.1.3. Attempts to synthesise 131 
H 
fY~ .. 
HO OH 
145 
As we proceeded with route 1, we ventured a shortcut in the synthesis of 9 (see 
Scheme 100). The first step of the strategy was to successfully synthesise 131 
(Scheme 127). 
H 
fY~. 
TBDPSO OH 
147 
MsCI, NEt3 ~ 
TBDPSOf( 
131 
Scheme 127 
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The elimination reaction from 147 to 131 was carried out according to the reaction 
conditions used to synthesise 64 (section 2.3.2.1.). No reaction occurred when 
mesyl chloride followed by triethylamine was added to a solution of the alcohol 
147 (Scheme 128). 
MsCI,NEt3 
starting material 
DCM 
overnight 
147 
Scheme 128 
After several unsuccessful attempts, the formation of 131 was abandoned in favour 
of the synthesis of 112. 
2.5.1.4. Oxidation to the carbonyl 112 
The last step ofroute 1 was the oxidation ofl47 to 112. 
~ oxidation A f'f .. - '''H 
TBDPSO OH TBDPSO ~o 
147 112 
Scheme 129 
Several different methods of oxidation, which will be described in the following 
section, were attempted. It was rather surprising to see that they led to only poor 
yields or even no reaction. 
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2.5.1.4.1. Oxidations using a stoichiometric amount or an excess of oxidant 
2.5.1.4.1.1. Dimethyl sulfoxide oxidation procedures 
The nucleophilic nature of the sulfinyl oxygen of sulfoxides has been used in the 
oxidation of primary and secondary alcohols into aldehydes and ketones with 
activated dimethyl sulfoxide.121 Its use in the oxidation of primary alcohols to 
aldehydes has been particularly recognised. Pfitzner-Moffatt and Swern 
procedures were the two reactions attempted from the large variety of dimethyl 
sulfoxide oxidations. Oxysulfonium ylide 157 is the key intermediate of these 
procedures, as we report in the following section. It reacts intramolecularly to give 
the desired carbonyl product 158 (Scheme 130) 
157 158 
Scheme 130 
The main advantage of Swern and Pfitzner-Moffatt procedures is the fact that they 
are carried out at low temperature (at -60°C and -78 °C respectively). This allows 
one to minimise the formation of by-products, which consist mainly of 
methylthiomethyl (MTM) ethers 161. 
Formation of 160, possible through dissociation of activated ylides 159 and 
subsequent alkylation of the alcohol, appears to be too slow to occur at low 
temperature (Scheme 131).121 
ocr 
159 160 
Scheme 131 
ROH 
ROGH,SCH, 
161 
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This contrasts with other dimethyl sulfoxide oxidations, that use acetic 
anhydride,122 pyridine/sulfur trioxide,123 or phosphorus pentoxide,124 which require 
higher temperatures and longer reaction times. 
2.5.1.4.1.1.1. Swern oxidation 
Swem oxidation was the first to be attempted. Two main reasons explain our 
choice. First, Swem oxidation, based on activation of dimethylsulfoxide by oxalyl 
chloride, has the advantage of low cost. Like activation with trifluoroacetic 
anhydride. l25 it usually gives better yields than other dimethyl sulfoxide oxidation 
procedures, and prevents the formation of trifluoroacetate. 126 Secondly, Swern 
oxidation affords relatively clean carbonyl compounds which can sometimes be 
used without purification to give high yields of products. Indeed, the side-products 
formed are carbon monoxide, carbon dioxide, dimethylsulfide and triethylamine 
hydrochloride. They are easily removed from the reaction mixture in vacuo 
(Scheme 132). 
JL ,Cl 
Cl' Ir 
o 
DMSO ~tQ+ ~CI""'I(~""'~ 
o 1"--.--
Cl 
162 
Cl' I NEt 
...... s ......... H •• 3 O+0~ 
RI):::' "---E-tN-'-H-C-l-
163 
Scheme 132 
157 
Cl 
1+ Cl· 
H3C ..... 
S 
...... CH3 
159 
The mechanism of Swern oxidation involves the formation of an initial adduct 
162, which collapses to a dimethylchlorosulfonium salt 159. Reaction of 159 with 
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an alcohol at -78 QC produces the alkoxysulfonium ion 163, which is converted 
into the product by reaction with an amine base to give ylide 157, which 
undergoes a rearrangement. In our case, Swem oxidation gave no results at -78 QC, 
despite the fact that all reactants were distilled. The temperature of the reaction has 
been increased to -40 QC, the standard temperature for Swem oxidation, and 
triethylamine was replaced by diisopropylethylamine which, in some cases, allows 
the reaction to work. The reaction was still unsuccessful, and only starting material 
was recovered (Scheme 133).127 
(y 
!'C~ .. TBDPSO OH 
147 
oxalyl chloride, DMSO, NEt3 
-78°C 
Scheme 133 
2.5.1.4.1.1.2. Pfizner-Mofatt oxidation 
starting materials 
The Pfizner-Mofatt reaction was then attempted. This choice may seem strange 
because it was the first reported reaction of this class of oxidation before the 
considerable improvements which led to the Swem oxidation. However, this 
reaction has been shown to be efficient in some cases where all other reactions of 
the same group have been unsuccessful. 121 The reaction requires the use of DCC 
164, which is by far the most used diimide. The large excess of DCC required 
leads to the biggest drawback of the procedure: the residue is difficult to remove 
during the work -up. The excess reagent can be converted by oxalic acid into the 
highly insoluble dicyclohexylurea, which is removed by filtration (Scheme 134). 
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DMSO 
o J.l + S(CH,l, 
R' R' 
165 157 158 
Scheme 134 
In this procedure, oxygen transfer occurs from DMSO to generate the 
dicycIohexylurea 165. The reaction is completed by the intramolecular hydrogen 
transfer in 157 to give 158. Unfortunately, the reaction did not occur in our case 
(Scheme 135). 
(y 
f'C~ .. TBDPSO OH 
147 
\/ A -------/~ "'H 
r.t. 
TBDPSO ~o 
DCC,DMSO 
112 
Scheme 135 
The cause of the ineffectiveness of these oxidations remains unknown, especially 
as we were working with a saturated primary alcohol. The high lability of the 
substrate or product may have caused this lack of success. As the dimethyl 
sulfoxide oxidations did not work, we next used the more vigorous conditions of 
chromium (VI) based reagents. 
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2.5.1.4.1.2. Oxidations using chromium (VI) 
Comforted by its success (67% yield) in the oxidation of lactol 4 to lactone 5 
(section 2.1.4.), we felt pyridinium dichromate (PDC) to be the reactant of choice. 
Use of PDC or PCC (pyridinium chlorochromate) avoided the drastic or hazardous 
conditions of Jones, Sarett or Collins oxidations and their numerous drawbacks 
such as the labour to prepare the reagents, the tendency to overoxidise primary 
alcohols,128and the cost and problems of purification linked to the large excess of 
reagent used to achieve rapid reactions. 
PDC 
Figure 9 
o 
N 
I 
H 
PCC 
These chromium (VI) reagents are widely used and offer the advantages of 
commercial availability and effectiveness in near stoichiometric amounts. They 
oxidise alcohols to aldehydes and ketones when they are used as a suspension in 
methylene chloride or as a solution in N,N-dimethylformamide following the 
oxidation process presented in Figure 10. 
R2CHOH + Cr (VI) R2CHO + Cr (IV) 
R2CHOH + Cr (IV) R2GOH + Cr(llI) 
. 
R2COH + Cr (VI) R2CHO + Cr(V) 
R2CHOH + Cr (V) R2CHO + Cr (Ill) 
Figure 10 
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Both methylene chloride and N,N-dimethylformamide were tried as solvents for 
PDC and PCC reactions. 
To prevent overoxidation at room temperature, association of PDC (0.7 equiv.) 
with acetic anhydride (3 equiv.) in DMF or DCM as co-solvent gave rise to a 
strong but mild, neutral oxidant.l29 Both conditions led to similar results. 
Dichloromethane was adopted because it is easy to remove in vacuo at the end of 
the reaction. These conditions afforded the aldehyde 112 in only 10% yield in the 
best attempt. The rest of the material was mostly some unreactive starting material 
(Scheme 136). 
H 
j'(~ .. 
TBDPSO OH 
147 
PDC (0.7 equiv.), AC20 (3 equiv.) 
DeM, r.t. 
10% 
H !t~ TBDPSO ~ 
112 
Scheme 136 
PDC is much milder oxidizing agent than PCC, and is complementary to PCC for 
alcohols containing acid-sensitive groups. Nevertheless, PCC gave the aldehyde 
112 without oxidizing the silyl-protected alcohol. 
To achieve the reaction, the PCC suspension was buffered by the use of sodium 
acetate. We also added molecular sieves, known to give rate enhancement of the 
reaction, and this allowed us to work under less drastic conditions than the reflux 
in tolueneyo.13! The reaction did not occur in dichloromethane but afforded the 
aldehyde 112 in 8% yield when PCC was dissolved in DMF (Scheme 137). 
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147 
PCC (3 equiv.) 
DMF, overnight 
8% 
Scheme 137 
fr rc~ TBDPSO ~ 
112 
After the disappointing result of the DMSO oxidation attempts, the more powerful 
chromium reagents PCC and PDC gave poor 8% and 10% yields. Problems 
inherent to the difficulties in product isolation because of the formation of 
insoluble chromium salts may have contributed to the poor yield of 112, despite 
the improvements made in their elimination during the oxidation of 4 (section 
2.1.4.). In addition, the moderately high cost of these reagents led us to try other 
oxidations. -
2.5.1.4.1.3. Fremy's salt (F.S.) oxidation 
Fremy's radical (potassium nitrosodisulfonate) 166 is a widely used reagent. It is 
particularly valuable for oxidizing phenols, naphthols or anilines to the 
corresponding quinones.132-136 It is also known to be an oxidant for conversion of 
benzylic alcohols to aldehydes and of amino acids to a-keto acids.137 The 
nitrosodisulfonate radical anion 167 is one of the most long lived nitroxyl radicals. 
This radical, purple in solution, is formed by virtually complete homolysis of its 
commercially available orange solid dimer 166, called Fremy's salt which 
dissolves in polar solvents (Scheme 138).138 
166 167 
Scheme 138 
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Because of its radical character, Fremy's salt is a rather unstable compound. It was 
stored in a desiccator in the presence of ammonium carbonate to provide an 
ammoniacal atmosphere, limiting the hazards of spontaneous decomposition 
resulting in a violent explosion. The decomposition is dependent on the hydrogen 
ion concentration. Therefore, a control of the pH was necessary. To this end, a 
range of buffers (mainly sodium carbonate pH 10, phosphate buffer pH 7.2) was 
used in all our reactions. Unfortunately, even under the most favourable 
conditions, using a large excess of Fremy's salt (6 equiv.) and a reaction time of 
one week, no results were obtained and the starting material 4 was recovered. 
Addition in two batches of Fremy's salt did not affect the result. The process is 
shown in scheme 139. 136.137.139 
S-H F.S. 
S = substrate 
Scheme 139 
Despite all our efforts, the oxidation did not occur (Scheme 140). 
fr !Y~ .. TBDPSO OH 
147 
'O-N(SO¥)2 
167 
Scheme 140 
starting material 
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2.5.1.4.1.4. Oxidation using hypervalent iodine (V) reagents 
Our interest was next focused on hypervalent iodine (V) derivatives. Organic 
chemists are increasingly appreciating the oxidizing properties of such compounds 
because they are mild, they prevent from using possibly toxic or expensive metals, 
and they do not produce toxic or noxious by-products. 
2.5.1.4.1.4.1. Oxidation with Dess Martin Periodinane 
The most famous hypervalent iodine (V) reagent is the Dess-Martin periodinane 
(1, 1,1-triacetoxy-l,1-dihydro-l,2-benziodoxol-3(IH)-one) (DMP) 169. 
AeO OAc 
GqM\/_OAC I '0 h 
o 
DMP 
169 
This method, involving DMP, has attracted particular attention because it has 
several advantages over other commonly employed oxidizing reagents, such as 
chromium (VI) and dimethylsulfoxide. It has found a wide acceptance for the 
selective oxidation of primary and secondary alcohols to carbonyl compounds.140 
It is also one of the mildest reagents available for the conversion of alcohols to 
carbonyls. It is used in nearly stoichiometric amounts and offers simple work-up. 
Thus it provides an alternative of great value. The mechanism is not fully 
understood but involves first an exchange of an acetate ligand on the iodine with 
the alcohol. The intermediate then collapses to form the carbonyl compound, a 
reduced iodine compound, and acetic acid. 
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This method gave good results on a large scale, and afforded 26% of carbonyl 
compound 111 and 30% of carbonyl compound 112 without any modification in 
the procedure. The rest of the material was mostly some unreactive starting 
material (Scheme 141). 
A DMP (1.5 equiv.), DeM, r.l., overnight A "'H "'H RO OH RO "0 
146 R=TBDMS 
147 R=TBDPS 
26% 
30% 
Scheme 141 
111 
112 
The yield was improved by 5% and the scale by 6.8 times by using freshly 
prepared reagent (following a modified route associating the Ireland141 and 
Schreiber142 preparations of DMP). This preparation involves the formation of the 
mx intermediate which can also be used as an oxidant. 
2.5.1.4.1.4.2. Oxidation with rnx 
In the same range of compounds derivate from o-iodoxybenzoic acid, I-hydroxy-
1,2-benziodoxol-3-one-l-oxide (mX) 168 represents a new oxidizing reagent, 
inexpensive to prepare, easy to handle, which can tolerate moisture and water, and 
generally gives very good yields. This iodinane oxide is a direct precursor of DMP 
169 (Scheme 142), and shares with it the fact that they oxidise primary alcohols to 
aldehydes without overoxidation to carboxylic acids.140.143 
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IBX 
168 
I. AC20, AcOH, 85°C 
2. r.t., 24 h 
AeO OAc \1 ~I_OA' I '0 ~ 
o 
DMP 
169 
IBX and DMP are explosive when dried 
Scheme 142 
rnx is highly insoluble except in polar aprotic solvents as DMF or DMSO. It is 
then capable of oxidation at room temperature in few hourS. 144 A possible 
mechanism for the oxidation of alcohols by rnx is based on a two-step reaction 
mechanism involving a fast pre-equilibrium step leading to an alkyloxyiodinane 
oxide 170, the reactive intermediate, with concomitant release of a water molecule 
through a process of ligand exchange at iodine, followed by a rate determining 
step giving iodosobenzoic acid 171 as shown in Scheme 143.140 
R' 
0-;\ 
R' fast -t"/,,"\· A" 
,>-OH + IBX ~~o- + H2O 
R' 
0 
170 
alkoxyiodinane oxide 
OH, 
R' ~"'" ~ \""-0 slow 
>=0 + I 0' + H2O 170 R' h 
0 
171 
IBA : iodosobenzoic acid 
Scheme 143 
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IBX was found to be less reactive than DMP, and the best result, obtained by using 
DMSO as a solvent, afforded 11 % of aldehyde 112 (Scheme 144). 
fr jy.~ .. 
TSDPSO OH 
147 
IBX 
DMSO, r.t., overnight 
ll% 
Scheme 144 
fr !'C~ TBDPSO "0 
112 
This yield was obtained on 0.64 mmol of substrate 147; as soon as we tried to 
scale-up the reaction, yields dropped significantly. IBX could thus not replace 
DMP oxidation. 
2.5.1.4.1.5. Oxidation of aIcohols by silver carbonate on CeUte® (Fetizon 
reagent) 
The advantages of this reagent lie in its selectivity, the mild conditions necessary 
to carry out the oxidation, and the ease with which the products can be isolated by 
simple filtration of the oxidising salt.145,146 The reaction can be schematised as 
follows (Figure 11). 
A + Fo A-Fo - P-F, = P + F, 
Figure 11 
The letter A represents the free alcohol in solution, P a molecule of the product, 
and Fo and F, the oxidised and reduced forms of the silver carbonate reagent. 
Consequently, A-Fo represents the adsorbed alcohol on the oxidised form of the 
reagent and P-F, the adsorbed product on the reduced form of the reagent. 
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The mechanism postulated for this reaction is presented below (Scheme 145) 
172 174 
173 
Scheme 145 
RI 17~ 
, "R 
H,·'iC' + ? H 
Ag Ag 
01(0-
° 
After the reversible adsorption of the alcohol 172 on the surface of the oxidant 
support 173 the oxygen electrons form a bond with the silver ions to give 174, and 
carbon-hydrogen bond is orientated so that the HCOH groups are coplanar and 
perpendicular to the silver carbonate/Celite® surface, A concerted shift of electrons 
then occurs to generate reduced silver atoms, hydrogen ions and a protonated 
carbonyl compound 175, Finally, these species collapse to product 176 with the 
carbonate ion acting as a hydrogen ion acceptor, thereby generating carbonic acid 
which is immediately decomposed to carbon dioxide and water. 
This method has been shown to oxidise the high molecular weight alcohols fastest 
because they show a better adsorption than lighter ones, 
It has been postulated that an increase in temperature increases the rate of 
oxidation and desorption of the product from the salt, while leaving the 
concentration of chemisorbed alcohol virtually unaffected, Thus, we carried out 
the oxidation at reflux. 
Fetizon's group reported the use of heptane or hexane as solvents.146 Reaction 
under such conditions led to poor yields (<10%) in our case. The literature shows 
that benzene was also used.145.147 In this instance, the solid surface is covered with 
benzene molecules which form Tt complexes with the silver ions in the reagent. 
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Consequently the alcohol must displace the benzene molecules from the 
adsorption sites before binding, which leads to longer reaction times. 
In order to avoid using benzene because of its toxicity, toluene was chosen for our 
reactions. The choice of this solvent allowed us to improve considerably the yield 
of the oxidation, even though the reaction time was very long. 
We also developed a modification to the preparation of the salt originally proposed 
by Fetizon.147 The method used is responsible for increasing the number of active 
sites on the surface. The process of drying the salt was modified. The procedure 
was considerably improved by exchanging a three days pre-drying of the reagent 
under vacuum146 for an elimination of the water over one night on a rotary-
evaporator followed by a one hour reflux of the reagent in toluene using a Dean-
Stark head to remove completely the water from the reaction mixture. The 
substrate was then added subsequently to the dry oxidant salt in toluene. Oxidation 
was achieved after four days and afforded a maximum 50% yield (Scheme 146). 
(y 
!Y~. TBDPSO OH 
147 
toluene, reflux 
4 days 
50% 
Scheme 146 
(y 
~ TBDPSO ~ 
112 
The yields of the reaction were not reproductible and varied from 35 to 50%. 
Indeed, in this particular system, there are some important reaction parameters 
which are impossible to control. 
To begin with, it is impossible to achieve absolute uniformity in the size and shape 
of the adsorbent particles. Such variations are known to affect significantly the 
course of heterogeneous reactions.146 
Secondly, it has been established that the rate of agitation greatly influences the 
rate of oxidation.146 
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Finally, while we always utilised pre-dried silver carbonate/Celite® reagent by 
following the same procedure every time, there is no way of assessing 
quantitatively the amount of moisture which was retained by the samples in each 
case. 
The yield of our product may have been limited by several other factors. First, all 
the groups undergoing bond change in 112 must adapt a coplanar configuration 
and be perpendicular to the plane of the solid surface of the oxidizing reagent. In 
this orientation, there could be interaction between the methyl group in C-4 and 
the solid surface of the oxidant. This observation could explain a loss of reactivity. 
Moreover, the oxidation begins with the chemisorption of the hydroxyl group on 
surface the silver ions of the oxidant. Our molecule contains an olefin which, as 
another 1t electron system offering alternative mode of adsorption on the solid 
surface, could represent another limiting factor (Figure 12).146 
~R ~i- °147 H3C : 
'--": Q-H )---=--:--:-'-----1 
: : R=TBDPS 
Figure 12 
2.5.1.4.2. Oxidations using a catalytic amount of oxidant 
The other methods tested followed catalytic procedures. Catalytic oxidations allow 
working with small amount of oxidizing agents, which may be expensive, toxic, 
and quite often both. Catalytic procedures require a co-oxidant. 
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2.5.1.4.2.1. Oxidation with TEMPO 
The first catalytic system investigated involved the use of 2,2,6,6-
tetramethylpiperidin-I-oxyl (TEMPO) 177. This oxidizing agent is often used for 
the mild conversion of primary alcohols to aldehydes. 
>0< 
I 
o· 
TEMPO 
177 
2.5.1.4.2.1.1. TEMPO! bleach oxidation 
In our case, TEMPO was used as a catalyst dissolved in dichloromethane, with 
aqueous sodium hypochlorite as co-oxidant and potassium bromide as co-catalyst 
in a two-phase system reaction.148 This reaction requires an efficient cooling 
system (below 10-15°C) to avoid the decomposition of the catalyst. The bleach 
was buffered at pH 8.5-9.5 by adding the appropriate amount of sodium 
bicarbonate (Scheme 147). 
fy 
rc~. 
rBDPSQ OB 
147 
TEMPO cat., NaOCl aq. (1.25 equiv.) 
DCM, NaHC03, KBf (O.lequiv.) 
19% 
Scheme 147 
fy 
!"C~ TBDPSO ~o 
112 
At this pH, hypochlorous acid is the co-oxidant and is transformed into 
hypobromous acid, which is more efficient in the oxidation of nitroxide 177 to 
oxammonium bromide 178. This salt is the active species in the oxidation process 
(Scheme 148). 
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I 
0' 
177 
HOBr I KBr >G< 11 -o Br 178 
HOC] oxammonium bromide 
Scheme 148 
>Cl 
I OH 
The system operated rapidly. After only few minutes, the aldehyde appeared, but 
the reaction did not reach completion. The addition of more oxidant and catalyst 
did not improve the yield. The yield was only 19% even when the reaction was 
carried out under a strict control of the temperature at 0 QC. 
2.5.1.4.2.1.2. TEMPO! trichloroisocyanuric acid oxidation 
In order to employ an easier procedure and to try to improve the yield, bleach was 
replaced by a molar equivalent of 1,3,5-trichloro-2,4,6-triazinetrione 179, as co-
oxidant.149This compound, also named trichloroisocyanuric acid, is a very cheap 
reagent. The procedure follows the mechanism shown in Scheme 149 and was 
reported to allow quantitative and rapid oxidation. ISO 
TCCA 
177 178 
179 
Scheme 149 
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Unfortunately, after numerous attempts, no positive results were obtained (Scheme 
150). 
N 
!Y~. TBDPSO OH 
147 
'il 
0o/N~O 
I I 179 
CI/NyN'Cl h 
TEMPO cat., 0 (1.1 equiv.\J r 
DeM, r.t. /\ "'H 
>-. 
TBDPSO 0 
112 
Scheme 150 
We were concerned that the catalyst might be destroyed under the reaction 
conditions. To leave no stone untumed, we thereafter tested the reaction with a 
stoichiometric amount of TEMPO. This was not successful either. 
2.5.1.4.2.2. Oxidation with TPAPINMO 
Oxidation using catalytic tetra-n-propylammonium perruthenate (TPAP) was 
developed by Ley and Griffiths.79.151 It has a wide application due to its mildness 
and ease of execution. It involves a catalytic amount of the ruthenium complex. 
Ruthenium is famous for displaying the widest range of oxidation states of all the 
elements from Ru (VIII) to Ru (ll). Tetra-n-propylammonium perruthenate 
(TPAP) 180 was chosen because of the large organic cation of the salt (Pr4N)+, 
which gave the best results. It is a readily soluble and air stable oxidant, with N-
methylmorpholine N-oxide (NMO) 181 usually used as the co-oxidant (Figure 13). 
NMO 
Figure 13 
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The oxidation process involves ruthenium passing from oxidation degree 7 to 4. 
NMO is reduced to the amine, reoxidizing the ruthenium back to Ru (VI) (Figure 
14).79 
Ru (VII) + 2e' 
2Ru (V) 
R2CHOH + Ru (VI) 
NMO + Ru (IV) 
Ru(V) 
Ru (IV) 
R2CHO 
+ 
+ 
Ru (VI) 
Ru (IV) 
N-methylmorpholine + Ru (VI) 
Figure 14 
This method respects silyl ether integrity.152 With our substrate, only the alcohol is 
oxidised and the double bond of the ring is not cleaved. The reaction was carried 
out at room temperature in presence of a slight excess of NMO. The reaction is 
autocatalytic. This is due to the formation of RU02, which coordinates with 
[RU04r. Water binds RU02 particles and reduces the number of sites available to 
[RU04r. This retards the autocatalysis and water must therefore be trapped. In this 
regard, activated powered molecular sieves were introduced to remove both the 
water formed during the oxidation, and the water of crystallisation of the NMO.79 
combination of dichloromethane-acetonitrile in a ratio 10: 1 was employed as 
solvent (Scheme 151). 
~ fYH 
TBDPSO OH 
147 
TPAP (5% mol.), NMO (1.5 equiv.) 
DCM 10:1 ACN, r.t. 
25% 
Scheme 151 
~ 
f'C: TBDPSO ~ 
112 
On a small scale, we obtained about 25% oxidation. The oxidation did not reach 
completion, perhaps because the alkene interfered with the oxidation by binding to 
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the metal and inhibiting the catalytic process. Therefore. more catalyst was added 
but without success. The reagent is sterically demanding and the access to the 
hydroxyl could be difficult and explain the poor reactivity. On large scale. we 
moderated the reaction by cooling it and by adding TPAP and NMO slowly and in 
portions, dissolved in dichloromethane and predried with magnesium sulfate. 
Many by-products were formed. The reaction which was clean and efficient on a 
small scale became capricious on a large scale. This method was not deemed 
appropriate for further work. 
Table 2 gives a summary of the oxidations attempted. 
Method Fetizon DMP TPAP! TEMPO! IBX Cr(VI) Swem TEMPO! Fremy's 
NMO Bleach TCCA Salt 
Scale (mmo] 
of 11.80 161.0 2.10 0.90 0.64 1.04 0.76 0.47 0.47 
substrate) 
Yield (%) 50 30 25 19 11 10 SM SM SM 
Table 2: Summary of the oxidation attempts 
The use of silver carbonate on Celite® as oxidizing reagent was the best of these 
tested, and allowed the passage to the next step. Overall, this route led to 112 in 
three steps from 4 in a 27% yield. 
In the meantime, a second route leading to our first target was discovered. 
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2.5.2. Formation of 111 and 112 through route 2 
a 
+ 
.,If!( )( CHr PPh3,Br 1. Protection Wittig 2. [0] 
4 148 111 or 112 
Scheme 152 
2.5.2.1. Ring opening by Wittig reaction 
Wittig reaction on the aldehyde of the open chain isomer of 4 was attempted in 
order to afford compound 148. 
Several methods found in the literature were investigated. The processes were 
quite similar and based on the use of methyl triphenylphosphonium bromide. with 
n-butyllithium or potassium tert-butoxide in tetrahydrofuran. 
A typical example was reported by Pearson in his total synthesis of (-)-slaframine 
(Scheme 153).119 
+ -
n-BuLi, CH3PPh3, Br 
TIIF, -78 'C, 14 h 
~ OBOM ~ 
72% 
Scheme 153 
Most of the time, a large excess of ylide, from 2.5 to 10 equivalents molar, was 
used to perform the reaction. 
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A minimal amount of two equivalents of n-BuLi had to be used because it initially 
deprotonates the alcoho1.153,154 The corresponding alkene was finally obtained by 
following the procedure utilised by Posner et al. (Scheme 154),154 
Q 
OH 
+ -
n-BuLi, CH3PPh3,Br (2.5 equiv.) 
THF, -78 QC 
Scheme 154 
~H 
The lactol 4 was treated with 2.5 equivalents of Wittig salt at -78°C followed by 
warming to room temperature overnight (Scheme 155). The desired alkene 148 
was isolated in 87% yield. 
a + 'j~ n-BuLi, CH3PPh3, Br THF, -78 OC 
4 87% 148 
Scheme 155 
2.5.2.2. Protection of compound 148 
The next step was the protection of the hydroxyl group of 148. Silyl groups were 
chosen to be the protecting groups. These groups are widely used and stable, 
except under hydrolysis or in presence of fluoride ions. The protected compound 
149 was obtained in a 61 % yield by using tert-butyl dimethylsilyl chloride, and 
150 was formed in 58% yield with tert-butyldiphenylsilyl chloride (Ll equiv.). In 
both cases, imidazole was used in a large excess (3 equiv.). Most of the rest of the 
material was unreacted starting material (Scheme 156). 
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~ HO~ 
148 
RCI, imidazole 
DMF,OOC ~ RO~ 
149: R = TBDMS 61% 
150: R = TBDPS 58% 
Scheme 156 
2.5.2.3. Selective cleavage of the hindered double bond 
2.5.2.3.1. Osmium tetroxide 
Having generated the protected alcohol 149 and 150, the next step in the synthesis 
was to form compound 111 and 112 (Scheme 152). Sodium periodate-osmium 
tetroxide is commonly used for the direct oxidative cleavage of alkene bonds to 
give carbonyl compounds. It complements the classical method of ozonolysis of 
double bonds followed by reductive cleavage, with the advantage that sodium 
periodate-osmium tetroxide can be employed for the selective cleavage of 
unhindered double bonds in presence of more hindered ones, as was achieved by 
Cantor et al. (Scheme 157).155 
~\ 
MeO 0 OMe 
Scheme 157 
This type of selective oxidation was applied to the compound 150. Periodate 
serves to regenerate osmium tetroxide 182, and allows the use of this expensive 
and toxic reagent in a minimal amount. The reaction has been proposed to proceed 
through a [3 + 2] or [2 + 2] pathway to give the intermediate osmium (VI) 
109 
monoglycolate ester 183, which is then hydrolysed reductively to give the cis-I,2-
diol184 (Scheme 158).156 
)~ 
R 
~vm 
+ O=Os=O 
11 
o 
182 
[2 +2J 
R 
J-~~ R'II 
o 
[3 +2J 
(or ROH) 
183 
cyclic osmate diester 
Scheme 158 
R 
R''>=O 
R..x.0H + 
R' 1 
OH 
184 
During the work-up, excess of co-oxidant and osmium (VI) species 183 are 
reductively hydrolysed with sodium sulphite to form insoluble Os-sulphito species. 
The reaction was carried out in mixed aqueous solvent systems such as aqueous p-
dioxanelS7 and aqueous tetrahydrofuran.158 Indeed, water or an alcohol is required 
to hydrolyse the osmate intermediate. In both cases, the olefin ISO was dissolved 
in the corresponding solvent mixture and the osmium tetroxide (2.5 wt %) was 
added. After 30 minutes, the sodium periodate (2 equiv.) was added in portions to 
the reaction mixture. The reaction was subsequently allowed to stir for 1 to 5 hours 
before work-up. Despite the electrophilic nature of osmium tetroxide and its 
affinity for electron-rich double bonds, a complex mixture, probably due to the 
reaction of the other olefin was noted every time (Scheme 159). 
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R '''H TBDPSO :::::..... OS04 (2.5 wt %). NaI04 (2 equiv.) complex mixture THFIH20. 5 h or p-dioxaneIH20. 1 h 
150 
Scheme 159 
2.5.2.3.2. Double bond cleavage by dioxygen 
Transition metals such as vanadium or molybdenum form mononuclear 
peroxocomplexes with dioxygen. They are used as catalysts for the oxidation of 
organic substrates. 
Vanadium species have shown a promising selectivity in oxidative cleavage, for 
example by cleavage of the exocyclic double bond of limonene 185 without 
touching the endocyclic olefin. The corresponding ketone 186 was obtained in 
73% yield (Scheme 160).159 
:2 VCI). O2 • acetone :2 OH Meo2cy Cl Q 0 185 &OH 186 
1# SH 
(5 % mol.) (5 equiv.) 
73% 
Scheme 160 
This method proceeds under one atmosphere of oxygen, at room temperature, in 
the presence of a transition metal catalyst VCILz 189 and an excess of 4-
chlorothiophenol as the co-reagent. The preparation of the ligand L 188 was first 
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achieved from the reaction of 186 with 187. This afforded 188 in 90% yield. The 
corresponding complex 189 was formed in situ prior to the reaction of the 
substrate 150 with molecular oxygen (Scheme 161). 
OH OH ;y M'02Cy M'02Cy OH \ Me02cy /: 
~ 187 NH2 &OH VCl3 N-v-N &/b (--C02M' 1-& 90% 1-& 1 -& OH 
186 188 189 
Scheme 161 
The thiophenol 190 dimerises to give a disulfide 191, used as a catalytic thiyl 
radical precursor. The C=C bond cleavage results from the vanadium-catalysed 
decomposition of a j3-hydroperoxysulfide intermediate 193 formed in situ from the 
thiyl radical 192 addition to the olefin, followed by oxygen trapping (Scheme 
162). 
• SM 1. 02 pH VCly cat. 
RF ----- HI·j---('IH ----- Hj l-;: ------ RFO + 
MS' RI H 2. ArSH RI~ 
192 193 
bv 
2 ArSH (ArS)2 
190 191 
ArS= S--Q--CI VClL, : ;y OH \ M'02Cy /: N-V-N &'" / b (--C02M' 1 OH -& 
Scheme 162 
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The reaction was attempted using compound 149 as substrate. The olefin 149 was 
converted to the expected carbonyl 111 in 15% yield (Scheme 163). 
A '''H TBDMSO ~ 
149 
VCI). O2• acetone 
OH 
Moo2ey 
J:N~OH 
Q 
15% 
Scheme 163 
9 
SH 
H 
f'(~ 
TBDMSO ~ 
111 
The reaction was also achieved with DV irradiation using a medium pressure 
mercury lamp as described by Bauchere1 et al. 159 A similar result was obtained. 
Route 2 (Scheme 152) was thus achieved in three steps with a 6.6% overall yield, 
the oxidation step needing to be optimised. Therefore. route 1 (Scheme 116) was 
chosen to synthesise 112 because of the overall yield, which was 2.4 times better 
than by using route 2. 
2.5.3. a-Hydroxylation 
2.5.3.1. Direct a-hydroxylation 
2.5.3.1.1. a-Oxygenation using dioxygen 
Because a better accessibility to the upper face with the aldehyde 112 than with 
lactone 5 was possible, both molecular oxygen and MoOPD reactions, which 
afforded stereoselectively the less hindered a-hydroxy lactone 6 from 5, were 
thought to be promising for this case (section 2.2.2.). 
113 
Nevertheless, during a meeting, Vedejs advised us not to use MoOPD because it 
would exclusively afford 194. 
Also, attempts using molecular oxygen gave a very messy and complex mixture, 
probably due to decomposition and over reactivity of oxygen radicals, and neither 
194 nor 195 were obtained (Scheme 164). 
(y 
rc~ TBDPSO ::-"'0 
112 
1. NaR, DMF \( 
2. P(OEth, O2, -25 'c 7 TBDPS04··, + 'OH ~ 
194 
Scheme 164 
2.5.3.1.2. Novel one pot method for a-oxygenation 
TBDPSo4 OH 
~ 
195 
A new mild method for the a-oxygenation of carbonyl compounds has been 
recently reported by Tomkinson (Scheme 165).160 
78% 
Scheme 165 
This novel one pot method for the a-oxygenation is carried out in an aqueous 
environment in the presence of air which makes it easy to set up. The conversion is 
believed to proceed by condensation of the reagents to form the iminium salt 196, 
isomerisation to the enamine 197, rearrangement to give the a-acetoxyimine 198, 
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foIlowed by hydrolysis to regenerate the a-oxycarbonyl functionality 199 (Scheme 
166).161,162 
0 
+H2 ~ 
0 
H3C .... 
N
'O '~ ... oy 'N~ ........ Noy 0 6 cC 204 H2O aOA' -H2O 6 0 6J) '00 
196 197 198 199 
Scheme 166 
This method was our last hope for direct a-oxygenation of the aldehyde 112. First 
of all, the methylhydroxylamine hydrochloride salt 204 was synthesised foIlowing 
literature procedures (Scheme 167).161,163,164 
I. NH20H, NaOH, 0 °C 
acetic acid glacial 2. Mel, KOH, EtOH, reflux 0 0 0 
HO-N)lOJ.( H,N, )l'-A NaNOz N!-0'-A 92% N 0 H H20, DOC or CH3NHOH, NaOH, D °C \ Mo 
200 71% 201 79% 202 
AcCl, NEt3 ---{a 0 HCl anhydrous, Et20 H 0 
O-N)lOJ.( +' ~ 
DCM \ 3 days H3C ... 
N
,O 
Mo Cl-
97% 203 75% 204 
Scheme 167 
tert-Butyl carbazate 200 reacted with sodium nitrite to generate the azidoformate 
201. Two pathways were next tried. The longer one gives the 
hydroxy(methyl)carbamate 202 in two steps via the formation of a 
hydroxycarbamate intermediate. The shorter one afforded the 
hydroxy(methyl)carbamate 202 in a convenient one step process, but with a loss of 
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yield. After acetylation to 203, the salt 204 was obtained in a 47% overall yield by 
the longer route. 
The et-oxidation reaction was attempted on aldehyde 112. Aldehyde 112 was 
treated with one equivalent of O-acetoxy-N-methylhydroxylamine hydrochloride 
salt 204 in water (10 roL). The reaction was stirred at room temperature two days, 
but only starting material was recovered (Scheme 168). 
204 
starting materials 
112 
Scheme 168 
The reaction was repeated in dichloromethane to provide greater solubility, but 
without more success. 
2.5.3.2. Indirect a-hydroxylation 
We decided next to try to convert the aldehyde 112 to the corresponding enol ether 
in order to synthesise the a-hydroxy aldehyde. 
The enol acetates and methyl enol ethers were the first compounds that we 
attempted to synthesise. 
2.5.3.3. Alternative based on the synthesis of the acetoxy ester 113 
The following plan was developed. The first step is a simple transformation of the 
aldehyde 112 to the acetoxy ester 113. Oxidation should occur from the less 
hindered face to give 114. The Shi rearrangement would then afford the correct 
stereochemistry (Scheme 169). 
116 
R RO 0 
112 113 
R=TBDPS 
m-CPBA. ~ 
~. RO OAc 
1. Shi rearrangement &; 
o OH 
[0] & o 0 2. TBAF 
114 
Scheme 169 
During the Shi rearrangement, acetoxy epoxides deriving from enol acetates are 
rearranged by the action of heat or acid. The two conditions involve different 
mechanisms with opposite stereospecificity. 
The acid catalysed reaction occurs through an intramolecular rearrangement with 
retention of configuration at the a-centre of the acetoxy epoxide 205 to give 206b 
(Scheme 170).165 
205 206b 
Scheme 170 
In contrast, thermal (or weak acid catalysed) rearrangement leads to a-acetoxy 
ketone 206a with clean inversion of configuration (Scheme 171 ).165 
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~o 
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R' .)f 
R 
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_f"'IIOH 
R 
R' 
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Scheme 171 
= 
OH 
R'--S--0AC + W 
R 
11 
R,AO 
__ >,,\.OAC 
R 
206a 
/ 
Path A could be distinguished from paths Band C by 180 labelling of the epoxide 
oxygen. If the reaction follows path A, the label would be incorporated in the final 
carbonyl in 206a. If it follows path B or C, the label would reside in the acetate 
group of the product 206a. To our knowledge such an experiment has not been 
carried out. The inversion of configuration would follow the second protocol. 
The acylation reaction was expected to be really easy to achieve as it tends to 
occur at oxygen rather than at carbon. The tendency to attack through oxygen is 
the most marked with reactive acylating agents. The combination of a lithium 
enolate and an acid chloride usually gives an enol ester. Less reactive acylating 
reagents were also used to try to complete the first step of the strategy. These 
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attempts are recorded in Table 3. Unfortunately we could not achieve the 
transformation of 112 to 113. 
/{ ,."'.~ ·"H TBDPSO ~ 
112 113 
Conditions Yield 
AC20, pyridine (10 equiv.), DMAP, reflux Degradation 
AC20, K2C03, MeCN, 60°C SM 
.. AcCl, pyndme, DMAP, DCM, r.t. SM 
AcCl, LDA, THF, -78°C to 0 °C SM 
Table 3: Acylation attempts 
It is difficult to find an explanation for the lack of reactivity of 112 towards the 
acylation. Nevertheless, we had no other choice than to modify the route. 
2.5.3.4. Alternative based on the synthesis of the methoxy ether 115 
The strategy next proposed is illustrated in Scheme 172. The first target was the 
methoxy ether 115. A chelated epoxidation using vanadyl bis(acetylacetonate)/ (-
butyl hydroperoxide would potentially allow us to obtain the correct 
stereochemistry. 
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h I. Base/MeOTf !l . -- -- - --- - - - -- - -- -- - ----:H 2. TBAF I RO 0 HO OMe 
112 115 
R=TBDPS 
AcOHorTFA &; OH 
o OH 
[0] &; 
o 0 
----- -- - - -- - -". ---
Scheme 172 
Vanadyl bis(acetylacetonate) 207 is a catalyst used for the oxidation of several 
functional groups, usually using an alkyl hydroperoxide as the oxidant. 
207 
Hydroxyl-promoted epoxidation with high diastereofacial selection in homoallylic 
a1cohols occurs more effectively by the use of vanadium (V) complexes than by 
the use of titanium (IV).166.168 For example, 208 provides 209 as a single 
diastereoisomer (Scheme 173).166 
t-BuOOH, v5+ 
6h 
208 92% 209 
Scheme 173 
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Here, the idea is to direct the epoxidation with an alcohol separated from the 
double bond by four carbons. The spatial conformation of the molecule and the 
flexibility of the arm carrying the hydroxyl group is the key to the reaction's 
success. The objective was therefore to complete the synthesis of precursor 116 
through the epoxidation of the enol ether 115 by forming a vanadium-peroxo 
complex as the key step (Scheme 174). 
V(O) (acac), (5%)ITBHP 
chelation control 
115 116 
u "Jv- tBuOOH, v5+ 115 
M'~~ / _ 
uo~ 
116 
Scheme 174 
Vanadyl bis(acetylacetonate) 207 is quickly raised from the (IV) to (V) oxidation 
state by t-butyl hydroperoxide. The resulting organic soluble vanadium (V) 
complexes are the reactive species in the reaction, which involves a It-o" 
rearrangement process.169 The reactivity of alkenes increases with their 
nucleophilic character. Therefore, the reaction is highly regioselective in favour of 
vinyl ethers owing to the rigid metallacyclic intermediate.l7O 
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However, similar difficulties were encountered with the first step of this strategy 
to these experienced with the former route. 
Aldehyde 112 was first used in reactions involving iodomethane or trimethyl 
orthoformate in attempts to prepare the enol ether. The lack of success of these 
attempts led us to test more powerful methylating agents such as methyl 
trifluoromethanesulfonate. 
The use of the even more reactive Meerwein's trimethyloxonium salt, which is a 
hard electrophile with a highly polarized C-O bond and therefore reacts readily 
with hard oxygen atoms, was also investigated with no more success (Table 4). 
H j'(~ 
TBDPSO ~o -----TB--h:: 
112 210 
Conditions 
Trimethyl orthoformate, PTSA, MeOH 
MeI, NaHMDS, THF, r.t. 
MeOTf, NEt3 or Hunig's base, DCM or LDA in THF 
Meerwein's salt, Hunig's base, DCM, 0 °c to r.t. 
Table 4: Methylating attempts 
Yield 
SM 
SM 
SM 
SM 
The lack of success of these methods led us to consider that the problem may lie 
with the chemist rather than the chemistry. We therefore decided to repeat the 
exact procedure followed by Rozen et al. using the same substrate 211. The 
product 212 was obtained as described in the literature (Scheme 175).171 
122 
trimethyl orthoformate, PTSA, MeOH, reflux 
or Meerwein salt, Hunig's base, DCM, r.t. 
211 212 
Scheme 175 
Also, formation of 213a and 213b, in a 2:3 ratio, due to the polarity of 
tetrahydrofuran,172 in a modified Juliil reaction using the sulfone 107, proved the 
reactivity of the aldehyde 112 (Scheme 176). 
,.""~ o:
N 0 
I '<: )--~\ 
H s g OMe 
107 12: ~ OMe TBDPSO LiHMDS, THF, 0 QC 
62% 
112 213a 
2 
Scheme 176 
+ 
TBDPSO 
213b 
3 
OM, 
The reaction follows the mechanism presented below, where addition of the 
lithiated sulfone 214 to the aldehyde 112 takes place faster than self-condensation 
(Scheme 177).172 
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Q::N 1.0 ,>-S~ S IDMe 
Li 
112 
Li 
r0r,{,btR ~S1'S~oMe 0, 
214 215 
215 CtN I }-OLi .0 S + 
R= .A..,.. TBDPSO~ 
210 
Scheme 177 
Because of the two results described, we decided to continue working with the 
aldehyde 112. The formation of a silyl ether was the next target, based upon the 
strong affinity of the sHy! group for oxygen. 
2.5.3.5. Alternative based on the synthesis of the silyl enol ether 418 
After the failure of the direct a-hydroxylation methods and the failure of the two 
former indirect a-hydroxylation strategies, we decided to try perhaps the most 
convenient and reliable a-hydroxylation procedure, based on the treatment of the 
silyl enol ether 216 with a peracid. The initial epoxidation is followed by a silyl 
migration and the generation of the a-silyloxy carbonyl compound 219. The silyl 
migration may occur through the formation of either 217 or 218 (Scheme 178). 
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pathway A Xi:: R • 
a/SiR', / 
R' ~ /SiR23 a a 217 R~aSiR2, R~ 
R4, ~ / R' R' SiR23 219 216 a • R~a-
pathway B R' 
218 
Scheme 178 
Studies carried out during the total synthesis of sterpuric acid, by Paquette et aI., 173 
allowed the first isolation of the trimethylsilyloxy epoxide 220 (Scheme 179). 
m-CPBA. NaHC03• 
DCM,20 °C 
86% 
220 
221 
Scheme 179 
Associated with the observation of the formation of the rearranged compound 221, 
the mechanism shown in pathway A has been adopted, involving the formation of 
an oxocarbenium ion 217 in Scheme 178 (Scheme 180). 
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1-S~~2: 
R- + '( 
R' 
216 217 219 
Scheme 180 
u-Oxycarbonyl species 219 subsequently forms the hydroxy carbonyl species by 
rapid hydrolysis. The oxidation reactions are mostly performed using m-CPBA. In 
our case, the silyl enol ether 112 was treated with DMDO (section 2.5.4.2.2.). The 
u-silyloxy species was not isolated, and the reaction went straight to completion. 
Both (E) 222E and (Z)-isomers 222Z of the silyl enol ether 222 were produced in 
a 3:2 ratio. One-isomer was isolated from the mixture (Scheme 181). 
A TIPSOTf, NEt3 """~ ~~ + "'H DCM, 0 'C, overnight TBDPSO ~ I QTIPS TIPSO 
112 34% 222E 222Z 
Scheme 181 
The stereochemistry of 222 was not assigned by IH NMR nOe measurements. No 
presence of reciprocal nOe was observed between Hi and Hk or Hk' of the isolated 
isomer. This could indicate that these two substituents are far from each other and 
that the isolated isomer is 222E. But the absence of evidence did not allow us to 
give a firm conclusion. 
2.5.4. Working with a free alcohol 
First, the strategy proposed was a chelated epoxidation using vanadyl 
bis(acetylacetonate)l t-butyl hydroperoxide, as described previously (Scheme 182). 
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[0] a 
---- - - -- -- -- - .. 
OH 
o 0 
Scheme 182 
Unfortunately, the silyl enol ether 222 could not be used III the directed 
epoxidation by vanadium, which requires the presence of a free alcohol. 
Monodeprotection of the alcohol without affecting the integrity of the enol ether 
was not possible due to the greater instability of the silyl enol ethers towards the 
conditions used to deprotect silyl ethers. Consequently, the VO(acac)z reaction 
with 222 was not attempted and new strategies allowing the presence of a free 
alcohol directing the a-oxygenation were investigated. 
2.5.4.1.1. A sequence of protection and deprotection reactions 
A sequence of protections-deprotections was proposed, but aborted after the first 
step due to the length of the strategy (Scheme 183). 
~ HO/\OH ,PPTS ~ 
f'(~ - toluene, reflux -ri 1. deprotection of the alcohol ){ 
TBDPSQ 0 TBDPSO 0 0 
LJ 
2. new protection of the alcohol • 
RO 0 0 
LJ 
112 223 
I. deprotection of the carbonyl 
2. TIPSOTf, NEt3 
V(O) (acach (5%)lTBHP ~ __ d_ep_r_ot_ec_tl_'o_o_ 
chelation control ~ __ 
HO OTIPS 
Scheme 183 
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Nevertheless, it was interesting to see that the first step of the strategy, leading to 
the formation of 223, was successful even though the yield was only 26%, 
although without optimisation of the reaction (Scheme 184). 
h TBDPSO 0 0 PPTS, toluene, reflux 
26% LJ 
112 223 
Scheme 184 
2.5.4.1.2. Protection of primary alcohol using pivaloyl and trityl groups 
We decided that the silyl protections should be replaced by a different protecting 
group. We needed a very selective protecting group, able to differentiate the two 
primary alcohols of the diol 145, and which could also be removed under mild 
conditions, and respecting the integrity of the enol ether 222. Due to their high 
steric demand, pivaloyl esters and trityl ethers are generally used to selectively 
protect primary alcohols in the presence of one or more secondary hydroxyl 
groups. m The removal of pivaloyl is carried out by transesterification with sodium 
methoxide in methanol, anhydrous hydroxide, or by enzyme catalysed hydrolysis. 
The removal of trityl groups is accomplished with the aid of mineral or Lewis 
acids, or even with silica gel. Both can be deprotected in the presence of other 
alcohol protecting groups as in 146. 
Unfortunately, the usual protection procedures led to mixtures of different 
compounds, probably including the expected monoprotected alcohol 146 but also 
the other protected alcohols, in such a poor yield that they could not be isolated. 
Only the major diprotected compounds 224 and 225 and recovered diol 145 were 
isolated (Scheme 185). 
128 
A HO OH A RO OR 
145 
R= Piv (CH3l3CCOCl, pyridine, DCM, r.t., overnight 42% 224 
R= Tr Ph3CCl, DMAP, DMF, r.t., overnight 37% 225 
Scheme 185 
Changing the base or decreasing the rate of addition gave similar results. 
Decreasing the temperature afforded the recovery of the starting material. 
2.5.4.1.3. Alternative protection in route 2 
Route 2 (Scheme 152) could easily be modified to incorporate a protection other 
than sHyl in its second step. The protection chosen could be methyl or benzyl aryl 
ethers which can be deprotected under basic conditions,175 and which would allow 
the selective deprotection of the alcohol 222. The free hydroxy! group in 226 has 
the potential to direct the epoxidation of the eno! ether from the desired face. 
Similar directed epoxidations using vanadium have been described in the literature 
(Scheme 186)po 
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-'","" .. "",,,,,,". ;{ 
HO 10TIPS 
chelation control 
V(O) (acach (5%)1 TB HP 
226 
Scheme 186 
However, due to the lack of reliability and the poor yields obtained for the 
oxidation following the protection of 150, we decided to work with 222. 
2.5.4.2. Working with the protected alcohol 
2.5.4.2.1. Bromination 
Silyl enol ethers are known to be oxidised to a-hydroxy ketones upon treatment 
with reagents such as N-bromosuccinimide. SHyl ether 222 was treated with one 
equivalent of NBS in aqueous dioxane. After a 30 minutes reaction, all 222 have 
been consumed (TLC), however after work-up, the crode reaction mixture was a 
complex mixture of unidentified products (Scheme 187). 
R -H-2-0-~-di-:-xan-e-
TBDPSO OTIPS 
complex mixture 
222 
Scheme 187 
130 
2.5.4.2.2. Rubottom oxidation 
The a-hydroxylation of the mixture of enol silanes 222 was to be the key step in 
establishing the desired stereochemistry. The Rubottom oxidation employs m-
CPBA as the oxidant. In Scheme 188, a double Rubottom oxidation provides an 
example of the efficiency of the method.176 
I. m-CPBA, CH2Clz 
2. MeOH 
79% 
Scheme 188 
It is generally assumed that the first step is the formation of the corresponding 
epoxide 227 followed by rearrangement and solvolysis to the hydroxy ketone 228 
(Scheme 189).177 
Ar 
R,Si, o\~ R,Si, o~o X:r __ Pri_'I_e_zh_a_ev__ )J--~ U epoxidation U 
"butterfly" 
transition state 
Scheme 189 
-benzoic acid 
226 
hydrolysis 
227 
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This method produces acidic by-products by loss of benzoic acid. Because our 
substrate was acid sensitive, this protocol was modified by using 
dimethyldioxirane (DMDO) 228 instead of m-CPBA as the oxidant. This reagent 
has been used extensively for the oxidation of sHyl enol ethers. 176 The by-product 
of the DMDO oxidation is acetone, which of course is easily removed and 
prevents the formation of the acidic by-products obtained when using peroxy 
acids. As with m-CPBA, the epoxidation mechanism involves a concerted spiro 
"butterfly" type transition state 229 (Scheme 190).178 
Rro}-
..Y '0' 
228 
229 
"butterfly" 
transition state 
• 
Scheme 190 
R~O Y 
/' + 0 
R 
DMDO 228 was used freshly prepared because of its instability. The DMDO was 
prepared by the Oxone ® oxidation of aqueous acetone buffered with sodium 
hydrogen carbonate. It was co-distilled as an acetone solution and kept over 
molecular sieves (4 A) in a freezer for few hours before use (Scheme 191 ).179 
o 
A + NaHC03 
Oto 30'C 
Scheme 191 
228 
The concentration of the DMDO solution (usually between 0.05-0.08 M) was 
determined by iodometric titration (Scheme 192). 
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(2) 
Dimethyldioxirane 228 was first reacted with excess potassium iodide in an acidic 
medium to generate iodine. The redox process is described by equation (I). The 
amount of liberated iodine was then determined by titration with sodium 
thiosulfate solution according to equation (2). The end point was indicated by the 
total disappearence of the characteristic yellow colour of iodine. 
The silyl ether 222 was dissolved in a solution of dimethyldioxirane in acetone at 0 
DC. Only 1 equivalent of DMDO was added, as we did not want to oxidise the 
double bond in the ring even if tri-substituted double bonds are relatively 
unreactive, and even given that silyl enol ethers are electron rich and highly 
reactive. A mixture of two inseparable diastereoisomers 194 and 195 was obtained 
in a ratio 77:23 (Scheme 193). 
k DMDO (0.064 M) in acetone (1 equiv.) 4 + TBDPSQ '_, 10°C, overnight ;'OH TBDPSO OTIPS 0 TBDPS04 OH "'0 
222 194 195 
Scheme 193 
Nothing allowed us to determine which of the two diastereoisomers was our target. 
Nevertheless, it seems reasonable to think that 195 is the minor product because 
the a-hydroxylation occurs, in this case, on the most hindered face. A challenge 
with this step is obviously the purification of 195. However, as 194 and 195 co-
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elute on silica gel it is possible that the mixture can be carried forward and 
separated at a later stage. The five steps described by Vahedi need to be repeated 
on this material, which contains the correct stereochemistry in order to complete 
the synthesis of target 11 (Scheme 195). Since my PhD was coming to its end, this 
work could not be done and will have to be carried on by the next researcher. 
2.6. Conclusion 
The challenge proposed for my PhD was to complete the synthesis of the 
diastereoisomer 11 of the oxaspirobyciclic unit already synthesised in our 
laboratories. 
o~ HO ,-- 0 EtO~-{ 
11 
The desired stereochemistry was finally obtained by performing an epoxidation of 
a silyl enol ether 222 as the second stereochemical defining key step with the 
Diels-Alder reaction between diene 92 and acrolein. Finally, 222 was obtained in a 
5.7% overall yield from 90 and the sequence of reactions was achieved in an eight 
step strategy and afforded the a.-hydroxy lactone 195 as a diasteroisomeric mixture 
with 194 (Scheme 194). 
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194 
3 
195 
I 
After simple deprotection of 195, the next researcher will only have to perform the 
oxidation to the a-hydroxy lactone 9 and repeat the work achieved by Vahedi on 
material which will now lead to spirocycIe 11 with the same stereochemistry as 
that proposed for tetronothiodin (Scheme 195). 
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Chapter 3 
Experimental detail 
3. Experimental detail 
3.1. General experimental procedures 
3.1.1. Preparation of glassware 
Reactions were carried out in round-bottomed flasks which had previously been 
dried in an oven at 150 QC for a minimum of three hours. The flasks were allowed 
to cool in a desiccator over P20S, and were flushed with nitrogen before being 
covered with septum caps. Other equipment used, such as needles, syringes, 
distillation kits, magnetic stirrer bars and cannulas were dried and allowed to cool 
in a desiccator. All air-sensitive reactions were carried out under a nitrogen 
atmosphere; the solvents and reagents were introduced via syringe and cannula. 
3.1.2. Solvents and reagents 
Solvents, unless otherwise stated, were either obtained in an anhydrous form from 
commercially available sources. Dimethylforrnamide and dimethylsulfoxide which 
were bought in Sure Seal® bottles from Sigma Aldrich Chemical Co. Ltd., 
Lancaster Synthesis Ltd. and Strem Chemical Co. Ltd. 
The other solvents were distilled and dried over the following reagents: 
• Dichloromethane: distilled over phosphorus pentoxide or calcium hydride. 
• Diethyl ether: distilled over sodium and benzophenone. 
• Ethyl acetate: distilled over calcium chloride. 
• Light petroleum ether: distilled over calcium chloride. 
• Tetrahydrofuran: distilled over sodium and benzophenone. 
• Toluene: distilled over calcium hydride. 
Where applicable, deionised water was used in experiments. 
1 
3.1.3. Normal work-up procedure 
Reactions were usually worked-up by the addition of saturated aqueous 
ammonium chloride solution. Extraction of the aqueous layer was achieved with 
dichloromethane, diethyl ether or ethyl acetate. The combined extracts were dried 
over anhydrous magnesium sulfate or sodium sulfate which was removed by 
filtration. Solvents were removed by evaporation under reduced pressure. 
3.1.4. Purification methods 
Compounds were purified using flash column chromatography, recrystallisation or 
vacuum distillation methods. 
Flash silica gel column chromatography was carried out using Fluka Kiesel gel 60, 
0.04-0.063 mm particle size. Hand bellows were used when required to apply 
pressure. Samples were applied as liquids, saturated aqueous solutions of the 
appropriate solvents system, or pre adsorbed onto Celite®. 
Thin layer chromatography (TLC) was carried out using aluminium-backed plates 
coated with a 0.25 mm layer of silica gel 60 H containing fluorescer. The plates 
were visualised using ultra-violet light, and potassium permanganate on potassium 
molybdate dips. 
Purification by vacuum distillation was achieved using a Buchi GKR-51 
Kligelrohr as heat source for bulb-to-bulb distillations. Condensation of the liquid 
product was achieved by covering the bulb in acetone-soaked cotton wool. 
3.1.5. Spectra and analyses 
lH NMR spectra were recorded on a Broker DPX400 spectrometer. The internal 
standard used in the lH spectra was resonance of tetramethylsilane, assigned as 0 
2 
ppm. In the 13C spectra the internal standard used was the central peak of the 
deuteriochloroform triplet, assigned as 77 ppm. 
Chemical shifts (0) are given in ppm downfield of tetramethyl silane (TMS). 
Coupling constants (1) are measured in Hertz. Multiplicities are recorded as broad 
peaks (br), singlets (s), doublets (d), triplets (t), quartets (q), multiplets (m), and 
combinations ofthese, for example, double doublet (dd), double triplet (dt), etc. 
Infrared spectra were recorded on a Perkin-Elmer FI'-IR Paragon 1000 Fourier 
transform spectrometer or a Pye-Unicam SP2000 spectrophotometer, in the range 
4000-600 cm· l . All samples were run on sodium chloride plates as thin films of 
pure liquid, deuteriochloroform solutions or Nujol@ mulls. 
Electron ionisation (El), chemical ionisation (Cl) and fast-atom bombardment 
(FAB) mass spectra were recorded on a Jeol-SXI02. 
Melting points were recorded on a Stuart Scientific (melting point apparatus 
SMP3), the melting points are uncorrected. Elemental analyses were performed on 
a Perkin Elmer 2400 CHN elemental Analyser. 
3 
3.2. Experimental procedures and analyses data 
3.Hydroxypropyl triphenylphosphonium bromide 2 
A mixture of 3·bromo·l-propanol1 (25.0 g, 180.0 mmol) and triphenylphosphine 
(31.4 g, 120.0 mmol) in dry toluene (60 mL) was heated under reflux for 26 hours 
under a nitrogen atmosphere. The reaction mixture was allowed to cool to room 
temperature, filtered, washed with cold toluene, and dried in vacuo to yield 2 as a 
colourless solid (46.3 g, 97%); mp 232-233 QC (Found: M+, 400.05836. 
C2!H22BrOP requires 400.05916); Vrnax (neat)!cm·! 3444 (OH), 750 (ArCH); OH 
(400 MHz, CDCb) 1.7-1.8 (2H, m, 2Hg), 3.7-3.8 (4H, m, 2Hf, 2Hh), 4.8 (lH, br, 
OH), 7.5-7.8 (ISH, m, 15 H arom); Oc (400 MHz, CDCb) 21.3 (Cg), 26.3 (CD, 
60.2 (Ch), 120.5 (Cq), 128.2 (Cm), 128.8 (Cp), 135.1 (Co). 
4 
(E,E)-5-Methyl-hepta-3,5-dien-l-oI3 
b 
~ a 
e I d c 
g f 
HO h 
A solution of 3-Hydroxypropyl triphenylphosphonium bromide 2 (47.6 g, 118.4 
mmol) in dry tetrahydrofuran (l L) was allowed to cool to 0 QC under a nitrogen 
atmosphere. A solution of n-butyllithium (94.4 mL, 2.5 M solution in hexanes, 
236.8 mmol) was 'added and the mixture was stirred for 15 minutes followed by 
addition of trans-2-methyl-butenal (9.9 g, 118.4 mmol). The reaction mixture was 
stirred at 0 QC for 22 hours. Brine (80 mL) was added, the organic layer was 
separated and aqueous layer washed with diethyl ether (5 x 50 mL). The combined 
organic layers were dried over magnesium sulfate, and concentrated in vacuo. The 
product was then poured into a solution of tert-butoxymethyl ether in which a 
majority of the triphenylphosphine formed a precipitate. Three precipitations 
allowed a better subsequent purification. Purification of the crude product by 
KiigeJrohr distillation (75-90 QC under 0.1 mbar) afforded 3 as a colourless oil (5.4 
g, 72%) (Found: M+, 126.11001. CgH!40 requires 126.10447); Vmax (DCM)/cm'! 
3348 (OH), 3030 (=CH), 1047 (C-O); OH (400 MHz, CDCJ3) 1.70 (3H, d, 3 J 8.4, 
3Ha), 1.73 (3H, s, 3Hb), 2.2-2.4 (2H, q, 3 J 6.4, 2Hg), 3.6 (2H, t, 3 J 6.0, 2Hh), 5.4-
5.6 (2H, m, He, Hr), 6.2 (lH, d, 3J 15.6, He); Oe (400 MHz, CDCh) 12.3 (Ca), 14.1 
(Cb), 37.7 (Cg), 63.4 (Ch), 123.2 (Cc or Cr), 126.0 (Cc or Cr), 134.0 (Cd), 138.5 (Ce); 
mJz (El) 126 (M+, 30%), 108 (46), 95 (28), 77 (lOO), 67 (54), 55 (42), 41 (78). 
5 
6,7 ·Dimethyl-3,4,4a, 7,8,8a·hexahydro-lH·isochromen·t·ol 4 
b 
a 
Distilled propenal was added by syringe pump to a solution of diene 3 (2.8 g, 22.0 
mmol) in HPLC water (30 mL) in which hydroquinone (6.2 g, 5.0 equiv.) had been 
previously dissolved. The mixture was stirred for between 24 and 48 hours at room 
temperature under a nitrogen atmosphere. The mixture was dissolved by 
dichloromethane (40 mL) and the aqueous phase washed with dichloromethane (3 
x 20 mL). The combined organic layers were dried over magnesium sulfate and 
the solvent removed in vacuo. The residue was purified by Kiigelrohr distillation 
(130-150 °C under 0.1 mbar) to give the lactol 4 as a yellow oil (3.4 g, 86%) 
(Found: M+, 182.13068. CIlH180 2 requires 182.13068); Vmax (DCM)/cm- l 3399 
(OH), 2936 (=CH), 2877 (O-C-O); 3t! (400 MHz, CDCI3) 1.00 (3H, d, 317.2, 3Ha), 
1.45-1.56 (3H, m, Hg, 2Hk), 1.57 (3H, s, 3Hb), 1.60-1.90 (2H, m, Hj, Hg,), 2.20 
(!H, t, 3 J 4.0, Hc), 2.40 (lH, m, HI). 3.09 OH. br, OH), 3.40-3.50 OH. dt, 2J 11.2, 
3 J 4.4, Hh). 3.50-3.60 (lH, ddd, 2 J 11.2, 3 J 4.4, 3 J 2.4, Hh), 3.90-3.97 (lH, ddd, 2 J 
11.2. 3 J 4.4,3 J 2.4, Hh·), 3.97-4.10 OH, dt, 2 JI1.2, 3 J 4.4, Hh,), 4.80 (!H, d, 3 J 2.8, 
Hi), 5.00 (!H, s, Hi), 5.38 OH, d, 3J 4.6, He); 3c (400 MHz, CDCh) 20.1 and 20.3 
(Ca), 21.5 and 21.5 (Cb), 25.2 (Cg), 29.1 and 31.7 (Ck), 29.6 (Cf), 34.8 and 34.9 
(Cc), 37.9 and 39.0 (Cj), 56.2 and 59.6 (Ch), 96.8 and 97.9 (CD, 125.9 and 126.5 
(C.), 138.4 and 139.2 (Cd); mlz (El) 182 (M+, 40%), 164 (11), 149 (10), 136 (14), 
121 (30), 107 (51), 93 (lOO), 91 (41).77 (28), 67 (17),55 (14),41 (20). 
6 
The following isomer was isolated from the mixture: 
b 
a 
g 
o i OH 
OH (400 MHz, CDCI3) 1.00 (3H, d, 3 J 6.8, 3Ha), 1.43-1.67 (4H, m, 2Hg, 2Hk)' 1.61 
(3H, s, 3Hb), 1.79 (lH, dt,3 J 13.2,3 J 4.0, Hj)' 2.16-2.19 OH, m, He), 2.40 (lH, dt, 
3 J 5.2, 3 J 4.4 Hr), 3.53 (lH, ddd,2 J 11.0,3 J 4.6, 3 J 2.8, Hh), 3.79 OH, dt,2 J 11.0,3 J 
2.8, Hh·) 4.88 (lH, s, n), 5.37 OH, br d, 3 J 4.4, He); Oe (400 MHz, CDCh) 20.1 
(Ca), 21.4 (Cb), 29.3 (Cg), 30.0 (Cr), 31.8 (Ck), 35.02 (Cc), 37.9 (Cj), 59.8 (Ch), 96.8 
(Ci), 126.5 (Ce), 138.4 (Cd)' 
7 
6,7-DimethyI-3,4,4a, 7 ,8,8a-hexahydro-isochromen -I-one 5 
b 
a 
The mixture of the lactol4 (2.4 g, 13.2 mmol) and pyridinium dichromate 04.9 g, 
3.0 equiv.) in dry N,N-dimethylformarnide (30 mL) under a nitrogen atmosphere 
was stirred first at 0 QC for 1 hour, then at room temperature for 5 hours. The 
solvent was removed in vacuo. The residue was dissolved in ethanol (20 mL) and 
allowed to stir for 10 minutes. The solution was poured into ethyl acetate (50 mL). 
A mix of silica gel-Celite® (1:1) was added and the mixture stirred for 10 minutes. 
The product was collected by filtration, the waste chromium residues trapped in 
silica gel-Celite® were easily removed. The solvent was removed in vacuo. Flash 
column chromatography using dichloromethane/ethyl acetate (5:1) afforded the 
product 5 as a colourless oil (1.6 g, 67%) (Found: M+, 180.11490. Cl1H1602 
requires 180.11503); Vrnax (DCM)/cm'l 2962 (=CH), 1729 (O=C-O-C), 1066 (2 
bands, O=C-O-C»; ~ (400 MHz, CDCh) 1.00 (3H, d, 3J 7.1, 3Ha), 1.75 (3H, s, 
3Hb), 1.60-1.80 (2H, rn, Hg, Hk), 1.80-1.95 (JH, ddd, 2J 12.7, 3J 3.6, 3J 0.8, Hg.), 
2.00-2.10 (JH, ddd, 2J 13.1, 3J 4.6, 3J 1.3, Hd, 2.10-2.30 OH, br q, 3J 10.3, Hc), 
2.40-2.60 (JH, rn, HI), 2.70-2.90 (JH' rn, Hj ), 4.10-4.30 OH, td, 2 J 12.6,3 J 3.2, 
Hh), 4.30-4.50 (JH, ddd, 2 J 12.2,3 J 4.0, 3 J 1.6, Hh), 5.29 (JH, s, He); 8c (400 MHz, 
CDCh) 19.6 (Ca), 20.1 (Cb), 22.2 (Cg), 33.3 (Ck), 33.4 (Cl), 33.9 (Cc), 40.1 (Cj ), 
69.2 (Ch), 123.0 (Ce), 140.7 (Cd), 174.7 (C j); mlz (El) 180 (M+, 64%), 165 (20), 
152 (29), 121 (34), 107 (lOO), 93 (93), 77 (49),67 (21), 53 (20), 43 (62). 
8 
8a -Hydroxy -6, 7 -dimethyl-3,4,4a, 7 ,8,8a-hexahydro-isochromen-l-one 6 
b 
a-Hydroxylation using camphorsulphonyl oxaziridine 29 
In a dry flask was placed dry tetrahydrofuran (ID mL) at -78°C, followed by 
sodium bis(trimethylsilyl)amide (3.3 mL, 1.0 M solution in tetrahydrofuran, 3 
equiv.). The lactone 5 (0.2 g, 1.1 mmol) in tetrahydrofuran (3 mL), was added 
dropwise to the reaction mixture, and stirred for I hour, followed by addition of 
(IS)-(+)-(IO-camphorsulphonyl)oxaziridine 29 (0.8 g, 3.0 equiv.) in 
tetrahydrofuran (4 mL). The mixture was stirred for 1.5 hours at -78 DC, and I 
hour at -5 DC and quenched by adding brine (30 mL). The solution was acidified 
by hydrochloric acid to pH I, and the mixture was extracted with diethyl ether (3 x 
30 mL). The combined organic extracts were washed with brine (30 mL), dried 
over magnesium sulfate and the solvent removed in vacuo. Purification of the 
crude product by flash column chromatography using dichloromethane I ethyl 
acetate (7:1) afforded the hydroxylactone 6 as a colourless oil (0.1 g, 57%); 
a-Hydroxylation using MoOPDi 
A solution of dry diisopropylamine (1.6 mL, I equiv.) in dry tetrahydrofuran (10 
mL) was allowed to stir at -78 DC for 30 minutes. A solution of n-butyllithium (2.5 
M in hexanes, 5.5 mL, 1.2 equiv.) was added, and the reaction mixture warmed to 
o DC then stirred for 30 minutes. The solution was allowed to cool to -78 DC. A 
solution of lactone 5 (0.2 g, 1.1 mmol) in tetrahydrofuran (5 mL), was added 
9 
drop wise to the reaction mixture, and stirred for 30 minutes in a nitrogen 
atmosphere. MoOPD 38 (0.5 g, 1.3 equiv.) was added to the formed enolate and an 
orange colour developed as 38 slowly dissolved. After 1 hour at -70 DC, the 
cooling bath was removed resulting in a gradual colour change to blue. 
After the reaction mixture reached 0 DC, water was added and the product was 
extracted with diethyl ether (4 x 30 mL). The combined organic phases were 
washed with a solution of carbonate (5%) and hydrochloric acid (2%) to remove 
molybdenum salts and pyridine, dried over magnesium sulfate and the solvent was 
removed in vacuo. Purification of the crude product by flash column 
chromatography using dichloromethane I ethyl acetate (7:1) afforded the 
hydroxylactone 6 as a colourless oil (0.03 g, 14%); 
a-Hydroxylation using 02iP(OEt)3 
Triethyl phosphate (0.5 mL) was added to a solution of sodium hydride (10 mL) in 
t-butyl alcohol (2mL) and N.N-dimethylformamide (20 mL). The mixture was 
allowed to cool to -25 DC under an oxygen atmosphere. A solution of lactone 5 in 
tetrahydrofuran (8 mL) was added. The atmosphere of oxygen was continued for 
22 hours. A solution of sodium hydroxide (0.5 g) in methanol-water (2: I, 15 mL) 
was added; the mixture was stirred for I hour at room temperature. After 
acidification with acetic acid, the product was precipitated by addition of water, 
isolated by filtration, and dried over sodium sulfate. Purification of the crude 
product by flash column chromatography using dichloromethane I ethyl acetate 
(7: I) afforded the hydroxylactone 6 as a colourless oil (0.1 g, 47%); (Found: M+, 
196.10995. CllH!603 requires 196.10995); Umax (DCM)/cm'! 3431 (OH), 2964 
(=CH), 1722 (O-C=O), 1035 (2 bands O=C-O)); OH (400 MHz, CDCh) 1.06 (3H, 
d,3 J 7.1, 3Ha), 1.60-1.67 (!H, dd, 2J 13.7,3 J 10.5, Hk), 1.73 (3H, s, 3Hb), 1.73-
1.83 (!H, ddd, 2Jl4.7/ J 6.1, 3 J 4.5, Hg), 1.85-2.03 (!H, ddd, 2 J 13.7,3 J 5.6, 3 J 1.4, 
Hk')' 2.04-2.09 (!H, dddd, 2 J 14.7,3 J 4.6, 3 J 4.0, 3 J 3.3, Hg·), 2.45-2.50 (lH, m, Hc), 
2.50-2.60 (lH, m, Hf), 3.09 (!H, s, OH), 4.28-4.35 (!H, ddd, 2J 11.2, 3J 10.7, 3J 
10 
3.3, Hh), 4.37-4.44 (lH, ddd, 2 J 12.0,3 J 4.4, 3 J 4.1, Hh')' 5.30 (IH, s, He); lie (400 
MHz, CDCh) 18.6 (Ca), 21.0 (Cb), 29.9 (Cc), 30.1 (Cg), 39.3 (Cr), 39.9 (Ck), 68.9 
(Ch), 72.3 (Cj ), 121.2 (Cc), 138.8 (Cd), 177.3 (CD; mlz (El) 196 (M+, 22%), 178 
(30), 163 (19), 150 (44), 135 (31), 124 (33), 109 (100), 93 (44),77 (27), 67 (28), 
55 (20),41 (35). 
11 
(+)-[ (3,3-Dimethoxycamphoryl) sulfonyl]oxaziridine 292 
The oxaziridine was prepared as reported by Bulman Page and BetheII.2 Potassium 
carbonate (2.0 g, 14.5 mmol) was stirred in methanol (20 mL) at room 
temperature, and hydrogen peroxide (3.3 mL, 4.0 equiv.) was added, followed by 
(+)-[(3,3-dimethyIcamphoryl) sulfonyI]imine 28 (2.0 g, 1.0 equiv.). The mixture 
was stirred overnight. 
The organic layer was separated and the aqueous phase washed with 
dichloromethane (2 x 50 mL). The combined organic extracts were washed with 
saturated aqueous sodium sulfite (l0 mL) and dried over anhydrous magnesium 
sulfate. Removal of the solvent in vacuo, in a water bath with the temperature not 
exceeding 40°C, yielded 29 as a colourless solid (lA g, 92%), mp 188-190 °C 
(from EtOH); [aj20n +91.3 (c 3.39 in CHCb); Urnax (CHCh)/cm-1 1355, 1164; 
(Found: C, 49.92; H, 6.68; N, 4.71. Cl2Hl9NOsS requires C, 49.81; H, 6.62; N, 
4.84%); OH (300 MHz, COCI3) 1.06 (3H, s, CCH3), 1.32 (3H, s, CCH3), 1.76-1.98 
(5H, m, 2CH2, CH), 3.20 (2H, q, 4J 14, SCH2), 3.28 (3H, s, OCH3), 3.34 (3H, s, 
OCH3); oe (300 MHz, COCb) 11.9 (CH2), 20.5 (CCH3), 21.7 (CH2), 28.2 (CCH3), 
47.5 (SCH3), 50.5 (OCH3), 50.8 (OCH3), 53.0 (C4C), 54.6 (C3C), 102.9 (N-C-O), 
121.3 (O-C-O). 
12 
Oxodiperoxymolybdenum(water)-1,3-dimethyl-3,4,5,6-terahydro-2(lH)-
pyrimidinone 373 
A solution of Hydrogen peroxide (30%) (30 mL) was added to Mo03 36 (5.0 g, 
35.0 mmol). The mixture was stirred vigorously and the temperature maintained 
between 30 and 40 QC for 3.5 hours. The reaction mixture was allowed to cool to 
room temperature and filtered to remove solids. The yellow solution was cooled to 
10 QC. DMPU (4.2 mL, 1 equiv.) was added to the solution under stirring and the 
crystalline precipitate was collected and recrystalised from hot methanol (40 QC) to 
give MoOs.H20.DMPU 37 as a yellow crystalline solid (10.3 g, 96%); mp 76 QC 
(lit} 76 QC) (Found: C 22.49, H 4.14, N 8.71 %. C6H13MoNz04 requires C 22.37, 
H 4.38, N 8.70%); Vrnax (KBr disc»/ cm·l 1615 (=CO), 973 (Mo=O), 856 (0-0). 
13 
Oxodiperoxymolybdenum(pyridine )-1,3-dimethyl-3,4,S,6-terahydro-2(1H)-
pyrimidinone 383 
o P,II 
O-Mo-O 
V": ·0 
L 
L=DMPU 
L' = Pyridine 
MoOs.HzO.DMPU 37 was dried in a vacuum desiccator for 24 hours over PzOs to 
give MoOs.DMPU. A solution of MoOs.DMPU (5.2 g, 17.0 mmol) in dry 
tetrahydrofuran (30 mL) was allowed to cool to room temperature while pyridine 
(1.4 mL, 1 equiv.) was added dropwise. The yellow crystalline precipitate was 
collected, washed with dry tetrahydrofuran (5 mL), dry diethyl ether (5 mL) and 
dried in vacuo to give MoOs.Py.DMPU 38 as a yellow solid (3.0 g, 28%); mp 91-
92°C (lit.,3 94°C); (Found: C 34.40, H 4.48, N 11.04%. CllH!sMoN30 6 requires 
C 34.48, H 4.47, N 10.97%); v max (KBr disc»/ cm-! 2946 (=CH), 1631 (C=O), 951 
(Mo=O), 849 (0-0). 
14 
6,7-Dimethyl-4,4a, 7 ,8-tetrahedroydro-3H -isochromene 64 
b 
a 
To a solution of lactol 4 (3.1 g, 17.0 mmol) in dry dichloromethane (40 mL), 
mesyl chloride was added (2.9 g, 1.5 equiv.) followed by addition of triethylamine 
(4.0 g, 2.3 equiv.) at 0 QC, under a nitrogen atmosphere. The reaction mixture was 
allowed to stir overnight at room temperature. A saturated aqueous solution of 
ammonium chloride was added, and the aqueous phase was washed with diethyl 
ether (2 x 40 mL). The combined organic layers were finally dried over 
magnesium sulfate and concentrated in vacuo. Purification of the crude product by 
distillation (80-120 QC under 0.1 mbar) afforded 64 as a colourless oil (1.7 g, 
63%); Vmax (neat)/cm'l 2944 (=CH), 1260 (C-O); OH (400 MHz, CDCb) 0.93 (3H, 
dd, 3J 7.0, 4J 0.4, 3Ha), 1.43-1.48 (lH, m, Hg), 1.66 (3H, dd, 3J 2.0, 4J 0.3, 3Hb), 
1.75 (IH, dd, 2J 13.0, 3J 1.4, Hk), 1.78-1.90 (IH, dddd, 2J 13.3, 3J 5.9, 3J 2.4, 3J 
2.1, Hg.), 2.08-2.10 (lH, m, Hc), 2.31 (lH, ddt, 2J 13.4,3 J 5.5, 4J 1.8, Hk,), 2.77-
2.79 (lH, m, Hr), 3.87 (lH, dt, 2J 10.7, 3J 1.9, Hh), 4.12-4.17 OH, ddd,2J 1O.7,3J 
3.7, 3 J 2.5, Hh.) 5.22 (lH, d, 3 J 4.8, He), 6.17 (IH, br t, 4J 1.9, Hi); Oe (400 MHz, 
CDCh) 19.9 (Ca), 22.7 (Cb), 30.7 (Cg), 33.0 (Cr), 33.9 (Cc), 34.9 (Ck), 66.0 (Ch), 
110.1 (Cj), 123.2 (Ce), 138.1 (Cd), 139.3 (Ci); compound too unstable to obtain the 
mass data. 
15 
2-(Ethyloxy)oxirane 87 
o 
/"-O----<J 
A solution of butyl vinyl ether (0.3 g, 4.2 mmol) was added to saturated sodium 
carbonate (1.8 g, 4.0 equiv.) in dichloromethane (12 mL). The mixture was 
allowed to stir 20 minutes under a nitrogen atmosphere at 0 QC. meta-
Chloroperbenzoic acid (70%) (1 g, 4 equiv.) was added in portions every 5 
minutes. The reaction was stirred for 2 hours. The solution was washed 
successively with saturated aqueous sodium sulphite (2 x 20 mL), sodium 
hydrogen carbonate (4 x 20 mL), and brine (20 mL). The organic layer was dried 
over sodium sulfate and the solvent removed in vacuo. The epoxide 87 was 
afforded as a colourless crude oil. 
This reaction was only a test, IR and !H NMR are the only data, which have been 
taken; Vrnax (neat)/cm'! 2780 (epoxide), 1252 (epoxide); ~ (400 MHz, CDCh) 
1.26 (3H, d, J 7.0, CH3), 3.70-3.92 (4H, m, 2 CH20), 6.13 (lH, t, J 4.85, O-CH-
0). 
16 
Nitroethylene 88 
2-Nitroethanol (5.0 g, 54.9 mmol) and phtalic anhydride (12.9 g, 1.5 equiv.) were 
mixed in a distillation unit fitted with an ice-cooled receiver. The mixture was 
heated until it became homogeneous (bath temperature at 140-150 QC) and then the 
temperature was increased to 175-180 QC until the distillation had completed. This 
afforded 88 nitroethylene as a green oil (0.45 g, 11%) (Found: M+, 73.01638. 
C2H3N02 requires 73.15108); Vrnax (DCM)/ cm-1 1534 and 1368 (C-NOz); OH (400 
MHz, CDCh) 5.22 (!H, dd, 317.3, 2J 2.3, Hk), 5.93 (!H, dd, 3 J 14.8, 2J 2.3, Hk'), 
6.65 (!H, dd, 3 J 14.8, 3 J 7.3, Hj ); Oc (400 MHz, CDCh) 120.4 (Ck), 139.8 (Cj ). 
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1,6-Dimethyl-3-(2-hydroxyethyl)-4-nitrocyclohex-l-ene 89 
b 
Diene 3 (004 g, 3.6 mmol) was added to a solution of nitroethylene 88 (0.39 g, 1.5 
equiv.) in dry toluene (2 mL) at room temperature. The reaction mixture was 
allowed to stir for 36 hours under a nitrogen atmosphere. The mixture was then 
removed in vacuo. Purification of the crude product by flash column 
chromatography using light petroleum / ethyl acetate (4: 1) afforded compound 89 
as a green oil (0.14 g, 20%) (Found: M+, 198.88391. ClOHl6NOz requires 
199.12084); v max (DCM)I cm- l 3404 (OH), 2925 (CH), 1545 and 1376 (C-NOz); 
OH (400 MHz, CDCh) 1.11 (3H, d, 3 J 6.6, 3Ha), 1.48-1.54 (2H, m, 2Hg), 1.68 (3H, 
s, 3Hb), 1.84 (!H, dd, 3 J 14.9, 2 J 2.0, Hk), 2.24-2.27 (2H, m, He and Hk,), 2.99-3.01 
(!H, rn, Hf), 3.70 (2H, t, 3 J 604, 2Hh), 4.67 (lH, rn, Hj ), 5.50 (IH, d, 3 J 504, He); Oe 
(400 MHz, CDCb) 20.0 (Ca), 22.2 (Cb), 31.3 (Cg), 31.9 (Ck), 32.7 (Cc), 33.7 (Cf), 
5904 (Ch), 86.3 (Cj), 125.1 (Cc), 13604 (Cd)' 
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1,3-Benzothiazol-2-ylsulfanyl)methyl methyl ether 106 
(YN~S Vl--s L OMe 
A solution of 2-mercaptobenzothiazole 104 (1.0 g, 6.0 mmol) in N,N-
dimethylformamide (l5mL) was added dropwise over 5 minutes at 0 °C to a 
solution of sodium hydride (0.3 g, 1.3 equiv.) in dry N,N-dimethylformamide (15 
mL). When the addition was completed and gas evolution stopped, 
chloro(methoxy)methane (0.5 mL, 1.1 equiv.) was added dropwise over 5 minutes. 
The reaction was stirred overnight at room temperature. The reaction mixture was 
quenched with saturated aqueous ammonium chloride at 0 QC, dissolved with ethyl 
acetate and extracted with ethyl acetate (3 x 50 mL). The combined organic layers 
were washed with water (2 x 50 mL), saturated aqueous sodium chloride (50 mL), 
and dried over magnesium sulfate then concentrated in vacuo. The crude product 
was purified by chromatography on silica gel using light petroleuml ethyl acetate 
(95:5) as eluent to give the desired thioether 106 as a yellow oil (1.2 g, 86%) 
(Found: M+, 211.01244. C9H9NOSZ requires 211.01256); Vmax (DCM)/cm'l 1587 
(acetate SzC=N), 2821 (OCH3); ~ (400 MHz, CDCb) 3.50 (3H, s, OCH3), 5.43 
(2H, s, SCHzO), 7.33 (lH, ddd, 3J 8.3, 3J 4.6, 4JO.7 , H arom), 7.44 (lH, ddd,3J 
8.2,3 J 4.6, 4J 0.3, H arom), 7.77 (lH, dd, 3J 8.3, 4J 0.7, H arom), 7.93 (lH, dd, 3 J 
8.2, 4J 0.3, H arom); Bc (400 MHz, CDCb) 57.1 (OCH3), 76.5 (SCHzO), 121.0 
(CH arom), 122.0 (CH arom), 124.6 (CH arom), 126.2 (CH arom), 135.6 (S-C 
arom), 153.0 (N-C arom), 165.2 (N=CSz); mlz (El) 211 (M+, 100%), 196 (78), 181 
(55), 168 (87), 108 (50), 69 (33), 45 (lOO). 
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1,3-Benzothiazol-2-yl methoxymethyl sulfone 107 
To a solution of (I ,3-benzothiazol-2-ylsulfanyl)methyl methyl ether 106 (1.0 g, 4.7 
mmol) in methanol (85 mL) at 0 QC, sodium tungstate dihydrate (0.8 g, 0.5 equiv.) 
was added, followed 5 minutes later by addition of hydrogen peroxide (35%) (1.6 
mL, 4 equiv.). The reaction was stirred overnight at room temperature. The 
reaction mixture was quenched with sodium meta-bisulfite (2.7 g) in water (30 
mL) at 0 QC, dissolved with dichloromethane (160 mL) and extracted with 
dichloromethane (3 x 50 mL). The combined organic layers were washed with 30 
mL of brine, dried over magnesium sulfate and concentrated in vacuo. The crude 
product was purified by chromatography on silica gel using light petroleum! ethyl 
acetate (3:1) as eluent to give the desired product 107 as a colourless oil (0.85 g, 
61 %) (Found: MW, 244.01065. C9H9N03Sz requires 244.01022) (Found: C, 
45.24; H, 8.37; N, 10.47. requires C, 45.13; H, 8.33; N, 10.53%); Vrnax (DCM)lcm-1 
1507 (acetate SzC=N), 2838 (OCH3), 1320 (S02); ~ (400 MHz, CDCb) 3.74 (3H, 
s, OCH3), 4.98 (2H, s, SCHzO), 7.67 (2H, m, 2H arom), 8.05 OH, dd, 3J 7.4, 4J 
1.4, H arom), 8.27 (lH, dd, 3J 7.3, 4J 1.5, H arom); Dc (400 MHz, CDCI3) 61.5 
(OCH3), 87.1 (SCH20), 122.3 (CH arom), 125.7 (CH arom), 127.7 (CH arom), 
128.2 (CH arom), 132.6 (S-C arom), 152.9 (N-C arom), 157.0 (N=CSOz); mlz (El) 
244 (M', 27%), 219 (46), 176 (90), 154 (100), 138 (lOO), 107 (97), 77 (95), 55 
(66),41 (54). 
20 
2-(2-{ [1-(1,1-Dimethylethyl)-l,l-dimethylsiIyIJoxy }ethyl)-4,5-
dimethylcyclohex-3-ene-1-carbaldehyde 111 
b 
a 
Oxidation with vanadium complex! dioxygen 
Molecular oxygen was allowed to bubble in a solution of vanadium (III) chloride 
(25.0 mg. 0.05 equiv.) and ligand 188 (71.0 mg. 0.1 equiv.) in acetone (IS mL). 
The mixture was allowed to stir for 30 minutes at room temperature. A solution of 
olefin 149 (880.0 mg. 2.4 mmol) and 4-chlorothiophenol (2.2 g. 5.0 equiv.) in 
acetone (IS mL) was added and the mixture was allowed to stir for IS hours at 
room temperature. After removal of the solvent in vacuo. the residue was purified 
by Kugelrohr distillation (bp=140-150 cC; ImmHg). to give the crude aldehyde 
111 purified by chromatography on silica gel using light petroleum! diethyl ether 
(98:2) as eluent. 111 was obtained as a colourless oil (30 mg. 15%); 
The reaction was also achieved in an annular Pyrex reactor. equipped with a diving 
mercury medium-pressure lamp 250W. in ethyl acetate. The solution was 
irradiated under oxygen bubbling. 
Oxidation with DMP 
Dess-Martin Periodinane 169 (0.4 g. 1.5 equiv.) was added to a solution of 146 
(0.3 g. 0.9 mmol) in dry dichloromethane (10 mL) and the solution was allowed to 
stir overnight at room temperature. The solution was washed with saturated 
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sodium carbonate (2 x 10 mL). The aqueous phase was washed with diethyl ether 
(2 x 20 mL). The combined organic layers were finally dried over magnesium 
sulfate. The solvent was removed in vacuo. Purification of the crude product by 
flash column chromatography using petroleum ether I ethyl acetate (100: I) 
afforded 111 as a colourless oil (71.0 mg, 26%) (Found: M+, 295.20913. 
C17H3zOzSi requires 296.21716); Vrnax (DCM)/cm-1 2931 (CHO), 1723 (CHO), 836 
(C=CH); OH (400 MHz, CDCb) 0.01 (6H, s, 6Hml, 0.86 (9H, s, 9Hn), 0.99 (3H, d, 
3J 6.8, 3Ha), 1.24-1.31 (lH, m, Hk), 1.31-1.40 OH, m, Hg), 1.40-1.58 (1H, m, Hg·), 
1.62 (3H, S, 3Hb), 1.94-1.98 (!H, dd, 317.1, 3J2.6, Hk·), 1.98-2.02 (1H, dd, 2Jl9.5, 
3J 2.6, Hk·), 2.02-2.10 (lH, m, He), 2.52-2.56 (1H, dd, 3J 17.3, 3J 2.8, Hj ), 2.56-
2.60 (!H, dd, 3 J 7.l, 3 J 2.8, Hj ), 2.70-2.80 (!H, br q, 3 J 4.3, HI), 3.59-3.67 (2H, m, 
2Hh), 5.48 (lH, dt, 3 J 5.3, 3 J 1.6, He), 5.50 (!H, dt,3 J 5.5, 3 J 1.6, He), 9.72 (IH, s, 
Hi); Cc (400 MHz, CDCb) -5.30 (Cm), 18.3 (Cl)' 19.8 (Ca), 21.4 (Cb), 25.9 (Cn), 
27.5 (Ck), 31.3 (Cl), 33.9 (Cc), 35.5 (Cg), 50.9 (Cj ), 61.2 (Ch)' 124.3 (Ce), 138.7 
(Cd), 205.l (Ci); mlz (El) 296 (M+, 5%),271 (6),255 (12), 183 (11), 133 (40), 121 
(35), 107 (34), 93 (24),75 (100), 59 (17), 41 (17). 
22 
2-(2-{ [1 -(1,1 -Dimethylethyl)-1,1 -diphenylsilyljoxy }ethy 1)-4,5-
dimethylcyclohex-3-ene-1 -carbaldehyde 112 
n yg +s. h 
n ~: 
Vrn 
p 
Oxidation with silver carbonate!Celite@ 
b 
a 
In a lL flask equipped with a Dean-Stark head, Fetizon's salt 173 (20.0 g) was 
heated under reflux for Ih and dried out. A solution of alcohol 147 (5.0 g, 11.8 
mmol) in dried toluene (20 mL) was added to the reaction mixture which was 
allowed to stir for a period of 4 days. The mixture was allowed to cool and the salt 
residue was filtered off on Celite®. The solvent was removed in vacuo. Purification 
of the crude product by flash column chromatography using petroleum ether / 
diethyl ether (50:1) afforded aldehyde 112 as a yellow oil (2.1 g,42%). 
Oxidation with DMP 
Dess Martin Periodinane 169 (l3.7 g, 2.0 equiv.) was added to a solution of 147 
(6.8 g, 161.0 mmol) in dry dichloromethane (135 mL) and the reaction mixture 
was allowed to stir overnight at room temperature. The solution was washed with 
saturated sodium carbonate (2 x 50 mL). The aqueous phase was washed with 
diethyl ether (4 x 50 mL). The combined organic layers were finally dried over 
magnesium sulfate. The solvent was removed in vacuo. Purification of the crude 
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product by flash column chromatography using petroleum ether I ethyl acetate 
(100:1) afforded 112 as a colourless oil (20.5 g, 30.2%). 
Oxidation with TPAPINMO 
To a solution of 147 (0.9 g, 2.1 mmol) and 4-methylmorpholine N-oxide (0.4 g, 
2.0 equiv.) in a mixture of dichloromethane-acetonitrile 9:1 (18 mL), molecular 
sieves (4 A, 0.10 g) and tetrapropylammonium perruthenate (37.0 mg, 0.05 equiv.) 
was added. The mixture was allowed to stir for 6 hours at room temperature under 
a nitrogen atmosphere. The reaction mixture was filtered through a short pad of 
silica gel using dichloromethane or ethyl acetate as eluent. The resulted filtrate 
was removed in vacuo. Purification of the crude product by flash column 
chromatography using light petroleum I diethyI ether (25: 1) afforded 258 as a 
colourless oil (0.22 g, 25%). 
Oxidation with TEMPOIBleach 
To a mixture of 147 (0.4 g, 0.9 mmol), 2,2,6,6-tetramethylpiperidin-1-oxyl (l.4 
mg, om equiv.) and potassium bromide (0.1 g, 0.1 equiv.) in dichloromethane (l0 
mL) at 0 QC, was added an appropriate amount of a IM aqueous solution of 
sodium hypochlorite buffered with sodium bicarbonate (0.07 mL, 1.25 equiv.) 
until the mixture had a of pH 8-9. The solution was stirred for I hour at 0 QC. The 
organic phase was separated and washed with 10 mL of 10% hydrochloric acid 
containing 125 mg (0.75 mmol) of KI, 10 mL of 10% aqueous sodium thiosulfate 
and 10 mL of water. The crude was dried over magnesium sulfate and the solvent 
was removed in vacuo. Purification of the crude product by flash column 
chromatography using petroleum ether / ethyl acetate (50: I) afforded 112 as a 
colourless oil (70 mg, 18.5%). 
24 
Oxidation with mx 
rnx 168 (0.2 g, 1.1 equiv.) was added to a solution of 147 (0.27 g, 0.64 rnmol) in 
dimethyl sulfoxide (10 mL) and the reaction mixture was allowed to stir overnight 
at room temperature. Water (20 mL) was added to the mixture. The crude was 
filtrated and extracted with diethyl ether (3 x 50 mL), and the organic layers were 
dried over sodium sulfate. The solvent was removed in vacuo. Purification of the 
crude product by flash column chromatography using petroleum ether / ethyl 
acetate (50: 1) afforded 112 as a colourless oil (30.0 mg, 11.2%). 
Oxidation with PDC 
A suspension of pyridinium dichromate(1.2 g, 3.0 equiv.) was added to the alcohol 
147 (0.44 g, 1.04 mmol) in a mixture of dichloromethane (20 mL)-acetic 
anhydride (l.3 mL, 12.8 equiv.). The reaction mixture was allowed to stir for 1 
hour at 0 QC, and for 5 hours at room temperature under a nitrogen atmosphere. 
The solvent was removed in vacuo. The residue was dissolved in ethanol (20 mL) 
and allowed to stir for 10 minutes. The solution was poured into ethyl acetate (50 
mL). A mix of silica gel-Celite@I:1 was added and the mixture was allowed to stir 
for an additional 10 minutes. The product was collected by filtration and the waste 
chromium trapped in silica gel-Celite@ was easily removed. The solvent was 
removed in vacuo. Flash column chromatography using light petroleum / ethyl 
acetate (50:1) afforded the product 112 as a colourless oil (44 mg, 10%). 
Oxidation with PCC 
A mixture of alcohol 147 (0.44 g, l.04 mmol), pyridinium chlorochromate (0.7 g, 
3.0 equiv.) and molecular sieves (4A., 0.5 g) in N,N-dimethylformamide (10 mL) 
was buffered at pH 7 with addition of sodium acetate. The mixture was stirred for 
1 hour at 0 QC, then overnight at room temperature under a nitrogen atmosphere. 
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The solvent was removed in vacuo. The residue was dissolved in ethanol (20 mL) 
and allowed to stir for 10 minutes. The solution was poured into ethyl acetate (50 
mL). A mix of silica gel-Celite® I: I was added and the mixture was stirred for an 
additional 10 minutes. The product was collected by filtration and the waste 
chromium trapped in silica gel-Celite® was easily removed. The solvent was 
removed in vacuo. Flash column chromatography using light petroleum! ethyl 
acetate (50:1) afforded the product 112 as a colourless oil (35 mg, 8%); (Found: 
M+, 420.24612. Cz7H360zSi requires 420.24846); Vrnax (neat)!cm·1 2952 (CHO), 
1737 (CHO), 760 (ArCH); OH (400 MHz, CDCh) 1.03 (3H, d, 3 J 7.0, 3Ha), 1.05 
(9H, s, 9Hn), 1.50-1.53 (!H, m, Hk), 1.53-1.61 (!H, m, Hg), 1.61 (3H, s, 3Hb), 
1.61-1.70 (!H, m, Hg,), 1.79-1.88 (!H, ddd, 2J 13.1,3 J 9.6,3 J 5.7, Hk), 2.05-2.11 
(!H, m, Hc), 2.27-2.31 (!H, m, Hj), 2.63-2.66 (!H, m, HI), 3.67-3.75 (2H, m, 2Hh), 
5.25 (lH, m, He), 7.37-7.41 (6H, m, 4Hm, 2Hp), 7.64-7.68 (4H, m, 4Ho). 9.62 (!H, 
d,3 J 2.1, Hi); Oc (400 MHz, CDCl]) 19.2 (C1), 19.6 (Ca), 21.3 (Cb), 26.9 (Cn), 27.5 
(Ck ), 31.2 (Cl), 33.9 (Cc), 35.3 (Cg), 50.9 (Cj), 61.7 (Ch), 124.3 (Ce), 127.7 (Cm), 
129.8 (Cp), 134.3 (Cq), 135.6 (Co), 138.7 (Cd), 205.0 (Ci); mlz (El) 420 (M+, 47%), 
392 (13), 261 (80),224 (77), 199 (52), 165 (25), 135 (78), 121 (61), 107 (95), 91 
(77),77 (91), 57 (100),41 (88). 
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(1,1-Dimethyl)( dimethyl){ [(3E ,5E)-5-methylhepta -3,5-dienyl]oxy }-silane 117 
b 
tert-Butyldimethylsilyl chloride (2.6 g, l.l equiv.) and imidazole (3.2 g, 3.0 
equiv.) in dry N,N-dimethylformamide (20 mL) were added successively to a 
solution of diene 3 (2 g, 15.9 mmol), in dry N,N-dimethylformamide (15 mL) at 0 
QC under a nitrogen atmosphere. The mixture was stirred overnight at room 
temperature. The solution was concentrated in vacuo in order to evaporate N,N-
dimethylformamide, which is partly soluble in water. The product was dissolved 
by dichloromethane (30 mL) and washed with a solution of hydrochloric acid (0.2 
M) until the aqueous layer became acidic. The aqueous layer was washed with 
diethyl ether (2 x 30 mL). The combined organic layers were finally washed with 
brine (40 mL) and dried over magnesium sulfate. The solvent was removed in 
vacuo to give the protected alcohol 117 as a yellow oil (2.5 g, 65%) (Found: M+, 
210.31065. C12H220Si requires 240.19094); Vrnax (DCM)!cm·! 3031 (=CH), 964 
(HC=CH); Ot! (400 MHz, CDCi) 0.00 (6H, s, 6Hrn), 0.84 (9H, s, 9Hn), 1.65 (3H, 
d, 3 J 8.0, Ha), 1.66 (3H, s, 3Hb), 2.26 (2H, q, 3 J 6.4, 2Hg), 3.60 (2H, t, 3 J 6.2, 2Hh), 
5.40-5.60 (2H, m, Hc. Hr), 6.20 (lH, d, 3 J 15.6, He); Se (400 MHz, CDCi) -5.3 
(Cm), 12.0 (Ca), 14.1 (Cb), 26.2 (CD, 26.7 (Cn), 37.7 (Cg), 64.2 (Ch), 123.4 (Cc or 
Cr), 125.2 (Cc or Cr), 133.1 (Cd), 137.0 (Ce); mlz (El) 239 (M+, 52%), 213 (40), 
199 (44),115 (15), 95 (26), 89 (42), 75 (lOO), 57 (43). 
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{[6,7-Dimethyl-3,4,4a,7,8,8a-hexahydro-1H-isochromen-l-ylloxy}(tert-
butyl)dimethylsilane 124 4 
g 
h 
b 
a 
j k 
"'H m i O-,i+n 
To a solution of lactol 4 (52.0 mg, 0.3 mmol) in dry N,N-dimethylformamide (10 
mL) stirred at 25 cC under a nitrogen atmosphere, were added successively tert-
butyldimethylsilyl chloride (65.0 mg, 1.5 equiv.) in dry N,N-dimethylformamide 
(10 mL) and imidazole (29.0 mg, 1.5 equiv.) dissolved in dry N,N-
dimethylformamide (10 mL). The mixture was stirred overnight at room 
temperature. The solution was concentrated in vacuo in order to evaporate N,N-
dimethylforrnamide, which is partly soluble in water. The product was dissolved 
by dichloromethane (20 mL) and washed with a solution of brine (10 mL). The 
aqueous layer was washed with diethyl ether (2 x 10 mL). The combined organic 
layers were finally dried over magnesium sulfate. The solvent was removed in 
vacuo to give the protected alcohol as a colorless oil of 124 (75.0 mg, 85%) 
(Found: M+, 297.01436. C17H3z0zSi requires 296.21716); Vrnax (DCM)/cm·1 2766 
(O-C-O), 962 (C=CH); OH (400 MHz, CD Ch) 0.12 (6H, s, 6Hrn), 0.89 (9H, s, 9Hn), 
3 1.00 (3H, d, J 7.0, 3Ha), 1.42-1.53 (1H, m, Hk), 1.53-1.69 (3H, m, 2Hg, Hk), 1.60 
(3H, s, 3Hb), 1.72-1.78 (1H, m, Hj), 1.82-1.90 (lH, m, Hg.), 2.12 (1H, t, 3 J 4.4, Hc), 
2.36-2.40 (lH, m, Hr), 3.26-4.04 (2H, m, 2Hh), 4.98 (lH, s, Hi); 5.11 (lH, 2s, Hi); 
5.36 (IH, d,3 J 5.2, He); Oc (400 MHz, CDCh) -5.0 (Cn), 19.7 (Cl)' 20.1 and 20.3 
(Ca), 21.3 and 21.4 (Cb), 26.3 (Cm), 28.8 and 31.4 (Ck), 29.1 (Cr), 35.0 and 35.2 
(Cc), 39.1 and 40.0 (Cj), 56.2 and 57.9 (Ch), 92.8 and 94.0 (Ci), 124.7 and 126.1 
(Cc), 138.3 and 138.9 (Cd); mlz (El) 297 (M+, 32%), 181 (31), 164 (45), 135 (24), 
121 (52), 107 (100), 93 (72),77 (49), 67 (27), 57 (89), 41 (31). 
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2-{[ 6, 7 -Dimethyl-3,4,4a, 7 ,8,8a-hexahydro-lH -isochromen-l-yl]sulfanyl} 
ethanethiol135 
g 
b 
a 
k 
'''H t 
" -" ,SH o i 's' ......,., 
u 
To a solution of lactol 4 (0.7 g, 4.0 mmol) in dry dichloromethane (2 mL), 
ethanedithiol was added (1.1 g, 3.0 equiv.) and a catalytic amount of either 
titanium tetrachloride or 6N hydrochloric acid solution. The reaction mixture was 
stirred overnight at room temperature under a nitrogen atmosphere. The solution 
was neutralised by a saturated aqueous solution of sodium carbonate (30 mL). The 
aqueous layer was washed with dichloromethane (2 x 20 mL). The combined 
organic layers were dried over magnesium sulfate and the solvent removed in 
vacuo. The residue was filtrated on silica gel using a solution of petroleum ether/ 
ethyl acetate (9:1) to give 135 as a colourless oil (0.47 g, 46%) (Found: M+, 
258.11151. C13HzzOS2 requires 258.11121); Vrnax (DCM)/cm,1 2920 (=CH), 2548 
(SH); ~ (400 MHz, CDCI}) 1.05 (3H, d, 3J 7.0, 3H.), 1.51-1.58 (2H, m, 2Hg), 
1.58-1.63 (1H, m, Hk), 1.63 (3H, s, 3Hb), 1.67 (IH, m, SH), 1.69-1.77 (IH, m, 
Hd, 1.85 (lH, m, Hj), 2.10-2.20 (1H, m, Hc), 2.35-2.50 (1H, m, HI), 2.75 (2H, dd, 
2J 6.6,3 J 1.2, 2H,), 2.80-3.00 (2H, m, 2Hu), 3.55 (lH, ddd,2J 11.3,3 J 3.9, 3 J 2.7, 
Hh), 4.12 (lH, ddd, 2 J 11.3,3 J 4.0/13.7, Hh), 5.12 (lH, s, H;), 5.33 (lH, d, 3 J 5.6, 
He); Dc (400 MHz, CDCI3) 20.0 (C.), 22.4 (Cb), 25.6 (Cg), 29.6 (Ck), 30.9 (Cl), 
33.7 (Cu), 35.0 (Cc), 35.1 (Ct), 39.2 (Cj), 59.8 (Ch)' 86.8 (C;), 126.1 (Ce), 138.4 
(Cd); mlz (El) 257 (M+, 6%), 209 (5), 165 (100), 149 (35), 135 (17), 107 (47), 93 
(45),83 (38), 79 (28), 55 (22), 43 (54). 
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2-[ 6-(Hydroxymethyl)-3,4-dimethylcyclohex -2-enyl]ethan-l-ol145 
b 
a 
To a solution of lactone 5 (12.0 g, 65.8 mmol) in ethanol (120 mL) cooled 0 QC, 
sodium borohydride (5.2 g, 2.2 equiv.) was added in portions every 30 minutes. 
After the addition was complete, the reaction mixture was stirred at room 
temperature for 3 hours. The reaction was quenched by cooling the mixture back 
down to 0 QC and adding concentrated hydrochloric acid (11 mL), followed by 
water (lOO mL). The ethanol was removed under reduced pressure and the 
remaining aqueous solution extracted with ethyl acetate (5 x 50 mL). The 
combined organic layers were finally dried over magnesium sulfate and solvents 
removed in vacuo. Purification of the crude product was filtered on silica gel using 
a solution of petroleum ether / ethyl acetate (3:2) and afforded a colourless oil of 
the diol145 (10.9g, 90%) (Found: M+, 184.14022. CllH2002 requires 184.14633); 
Vmax (DCM)lcm'! 3340 (OH), 2929 (=CH); Ca (400 MHz, CDCI3) 0.93-1.02 (lH, 
m, Hk), 0.98 (3H, d, 3 J 7.0, 3H.), 1.28-1.31 OH, ddd, 2 J 15.3,3 J 9.9, 3 J 5.2, Hg), 
1.48-1.52 (lH, ddd, 2J 11.8, 3J 6.1, 3J 1.3, Hk,), 1.64 (3H, s, 3Hb), 1.64-1.71 (!H, 
m, Hg,), 1.88-2,00 OH, m, Hj ), 2.06-2,20 (!H, m, Hc), 2.32-2.40 (IH, m, Hr), 3.48-
3.55 (!H, d, 3 J 2.1, H;), 3.55-3.63 (!H, d, 3 J 5.0, Hi'), 3.58-3.67 (IH, ddd, 2J 10.4, 
3 J 9.1, 3 J 5.4, Hh), 3.68-3.77 OH, ddd, 2 J 10.4,3 J 6.5, 3 J 4.3, Hh,), 3.92 (2H, s, 
2xOH), 5.53 (!H, br d, 3 J 5.6, He); 3c (400 MHz, CDCh) 20,0 (C.), 21.8 (Cb), 31.7 
(Ct>, 32.2 (Cr), 33.7 (Cg), 35.1 (Cc), 40.2 (Cj ), 61.2 (Ch), 65.9 (q, 124.8 (Ce), 
138.4 (Cd); mlz (El) 184 (M+, 26%), 166 (39), 135 (84), 121 (84), 107 (95), 93 
(100),79 (53), 67 (47),55 (46), 41 (55). 
30 
[2-(2-{ [1-(1,1-Dimethylethyl)-l,l-dimethylsilyl]oxy }ethyl)-4,5-
dimethylcyclohex-3-enyl]methanoI146 
b 
a 
A mixture of diol 145 (0.8 g, 4.2 mmol), triethylamine (0.6 rnL, 1.0 equiv.), tert-
butyldimethylsilyl chloride (0.8 g, 1.2 equiv.) and dimethylamino pyridine (0.3 g, 
0.5 equiv.) in dry dichloromethane (10 mL) was heated under reflux for 2 hours 
under a nitrogen atmosphere. The reaction was allowed to cool to room 
temperature. The solution was washed with brine (10 mL), the organic layer was 
dried over magnesium sulphate and the solvent removed in vacuo. Purification of 
the crude product by flash column chromatography using petroleum ether / ethyl 
acetate (50: 1) afforded the monoprotected compound 146 as a colourless oil 
(0.50g, 40%) (Found: M+, 298.22971. CI7H3402Si requires 298.23281); Vmax 
(DCM)/cm-I 3363 (OH), 2356 (=CH); ~ (400 MHz, CDCh) 0.00 (6H, s, 6Hm), 
0.82 (9H, s, 9Hn), 0.91 (3H, d, 3 J 6.8, 3Ha), 0.92-0.96 (lH, m, Hk), 1.14-1.26 (!H, 
tdd, 2 JlO.!, 3 J 4.5/ J 1.2, Hg), 1.46-1.52 (!H, br dd, 2 J 8.6, 3 J 2.0, Hk,), 1.58 (3H, 
br q, 4J 1.2, 3Hb), 1.58-1.64 (lH, m, Hg,), 1.76-1.86 (lH, m, Hj ), 1.90-2.07 (!H, m, 
He), 2.15-2.25 (lH, m, Hf), 3.40-3.51 (2H, rn, 2Hi), 3.51-3.55 (lH, ddd, 2J 9.9, 3J 
6.7, 3J 4.5, Rh), 3.55-3.60 (!H, ddd, 2J 9.9, 3J 8.7, 3J 5.7, Hh,), 3.60-3.68 (IH, rn, 
Hh,), 5.42 (lH, d, 3J 5.6, He); Oc (400 MHz, CDCh) -4.93 (Cn), 19.8 (Cl), 20.3 (Ca), 
21.7 (Cb), 26.3 (Cm), 31.4 (Ck), 32.4 (Cr), 33.5 (Cg), 35.1 (Cc), 40.4 (Cj ), 62.2 (Ch), 
65.3 (Ci), 126.3 (Ce), 138.2 (Cd); mJZ (El) 298 (M+, 62%), 280 (43), 270 (12), 166 
(35), 156 (40), 121 (64), 115 (11), 107 (92), 93 (lOO), 77 (46), 67 (42), 55 (37), 41 
(67). 
31 
[2-(2-{ [1-(1,1-Dimethylethyl)-I,I-diphenylsilyljoxy }ethyl)-4,5-
dimethylcyclohex-3-enyljmethanoI147 
b 
a 
Q'-':: ~ g +s. h 
" 6: 
p 
tert-Butyldiphenylsilyl chloride (14.7 mL, l.l equiv.) was added dropwise with a 
syringe pump to a mixture of diol145 (9.6 g, 52.1 mmol) and imidazole (5.3 g, 1.5 
equiv.) in dry dichloromethane (120 mL) at 0 QC. The solution was then allowed to 
stir overnight at room temperature. The solution was washed with sodium 
bicarbonate (50 mL), the organic layer was dried over magnesium sulfate and the 
solvent removed in vacuo. Purification of the crude product by flash column 
chromatography using petroleum ether I ethyl acetate (50:1) afforded the 
monoprotected compound 147 as a colourless oil (13.2 g, 60%) (Found: M+, 
422.44377. C27H3s0zSi requires 422.26411); Vmax (DCM)/cm-l 3341 (OH), 708 
(ArCH); 8H (400 MHz, CDCb) 0.98 (3H, d, 3 J 6.8, 3Ha), 1.04 (9H, d, 9Hn), LlO-
1.30 (lH, m, Hg), 1.56-1.60 (lH, m, Hk), 1.60 (3H, s, 3Hb), 1.60-1.68 (2H, m, Hk" 
Hg·), 1.85-1.95 (lH, m, Hj)' 2_05-2.10 (lH, m, Hc), 2.33-2.45 (IH, m, Hr), 3.45-
3.51 (lH, dd, 2J 10.7,3 J 8.1, H;), 3.51-3_57 (lH, dd, 2 J 10_7,3 J 7.1, Hr), 3.68-3.73 
(IH, ddd, 2 J 10.2,3 J 8.4, 3 J 6.0, Hh), 3.73-3.78 (lH, ddd, 2 J 10.2,3 J 7.0, 3 J 4.6, Hh')' 
5_39 (lH, br d, 3J 5.6, He), 7.24-7.41 (6H, m, 4Hm, 2Hp), 7.65-7.70 (4H, m, 4Ho); 
Bc (400 MHz, CDCb) 19.6 (Cl), 20_2 (Ca), 21.8 (Cb), 27.3 (Cn), 31.5 (Ck), 32.4 
(Cf), 33.5 (Cg), 35.1 (Cc), 40.4 (Cj), 62_9 (Ch)' 65.6 (Ci ), 125_9 (Ce), 128.0 (Cm), 
130_0 (Cp), 134.3 (Cq), 136.0 (Co),138.3 (Cd); mlz (El) 423 (M+, 4%),405 (6), 395 
(12),331 (11),269 (11), 239 (23), 199 (100), 181 (59), 165 (46), 135 (100), 121 
(52),107 (100), 91 (94),77 (57), 55 (57),43 (87). 
32 
2-[6-Eth-l-enyl-3,4-dimethylcyC\ohex -2-enyIJethan-l-ol 148 
b 
a 
A solution of n-butyllithium (28 mL, 2.5 M solution in hexanes, 2.5 equiv.) was 
added to a solution of methyl triphenylphosphonium bromide (5.1 g, 28 mmol) in 
dry tetrahydrofuran (150 mL) at -78 cC under a nitrogen atmosphere. The mixture 
-
was allowed to stir for 15 minutes before addition of the lactol 4 (25.0 g, 2.5 
equiv.). The reaction mixture was stirred overnight at room temperature. Brine (40 
mL) was added, the organic layer was separated and aqueous layer washed with 
diethyl ether (5 x 30 mL). The combined organic layers were dried over 
magnesium sulfate, and concentrated in vacuo. The residue was purified by 
Kiigelrohr distillation (llO-130 cC under 0.1 mbar) to give the olefin 148 as a 
yellow oil (4.4 g, 87%); Vmax (DCM)lcm'! 3333 (OH), 3076 (CR2=C), 1639 
(C=C); ~ (400 MHz, CDCI3) 1.02 (3H, d, 3 J 7.0, 3R.), 1.25-1.28 (lH, m, Hk), 
1.28-1.41 OH, m, Hg), 1.66 (3H, s, 3Hb), 1.66-1.75 OH, m, Hg., Hk ,), 2.02-2.13 
2 OH, m, Hj), 2.13-2.20 (lH, m, Hc), 2.40-2.45 (lH, m, Hr), 3.63-3.70 OH, ddd, J 
24.9,3J 10.4, 317.3, Hh), 3.70-3.76 OH, ddd, 2J 10.4, 3J7.8, 3J5 .4, Hh,), 4.98-5.00 
(lH, ddd, 2J 1.2, 3J 1.3, 3J 4.8, Hr'), 5.01-5.04 (lH, ddd, 2J 1.2, 3J 1.3, 3J 1.9, Hr), 
5.48 (lH, dd, 3J 6.2, 3J 1.6, He), 5.50 (lH, dd, 3J 3.7, 3J 1.7, He), 5.81-5.90 (lH, 
ddd, 3 J 17.9,3 J 9.9, 3 J 6.7, Hi); Cc (400 MHz, CDCh) 19.9 (C.), 21.4 (Cb), 32.6 
(Ck), 32.4 (Cj), 32.5 (Cg), 35.7 (Cc), 41.2 (Cr), 61.7 (Ch), 113.6 (Cr), 125.5 (Ce), 
138.3 (Cd), 141.9 (Ci); m/z (El) 180 (M+, 35%), 162 (4), 147 (7), 133 (22), 126 
(lOO), 119 (23), 107 (31), 95 (89), 79 (29), 67 (21), 55 (21), 41 (25). 
33 
(1,1-Dimethylethyl)( {2-[ 6-eth-1-enyl-3,4-dimethulcyclohex -2-enyllethyl }oxy) 
dirnethylsilane 149 
b 
, tert-Butyldirnethylsilyl chloride (1.8 g. 1.1 equiv.) and imidazole (3.8 g, 5.0 
equiv.) dissolved in dry N,N-dimethylformamide (10 mL) were added successively 
to a solution of olefin 148 (2.0 g, 11.1 mmol) in dry N,N-dimethylformarnide (15 
mL) at 0 °C under a nitrogen atmosphere. The mixture was stirred overnight at 
room temperature. The solution was concentrated in vacuo in order to evaporate 
N,N-dimethylformamide, which is partly soluble in water. The product was 
dissolved in dichloromethane (30 mL) and washed with a solution of hydrochloric 
acid (0.2M) until the aqueous layer became acidic. The aqueous layer was washed 
with diethyl ether (2 x 30 mL). The combined organic layers were finally washed 
with brine (40 mL) then dried over magnesium sulfate. The solvent was removed 
in vacuo to give the protected alcohol 149 as a yellow oil (2.0 g, 61 %) (Found: 
M+, 294.25001. C IsH340Si requires 294.23789); Vmax (DCM)/cm,l 3077 (CHz=C), 
1639 (C=C); OH (400 MHz, CDCh) 0.00 (6H, s, 6Hm). 0.84 (9H, t, 3 J 3.0, 9Hn), 
0.96 (3H, d, 3J 7.1 Hz. 3Ha), 1.19-1.25 (2H, m, Hg, Hk), 1.60-1.67 (!H, rn, Hg,), 
1.67-1.70 (1H, ddd, 2J6.1, 312.8, 3J 1.1, Hk,), 1.60 (3H, s, 3Hb), 2.02-2.11 (lH, m, 
Hj ), 2.11-2.16 (lH, br q, 3J 5.0, Hc), 2.30-2.37 (lH, m, Hf), 3.54-3.60 (lH, dd,2J 
10.0, 3J 7.4, Hh), 3.60-3.65 OH, dd,2J 10.0, 3J 8.8, Hh·), 3.51-3.60 (lH, rn, Hh), 
4.92-4.94 OH, rn, Hr'), 4.96-4.97 (lH, rn, Hr), 5.42 (!H, d, 3 J 5.6, He), 5.76-5.85 
(lH, rn, Hi); Cc (400 MHz, CDCh) -4.9 (Cm>, 18.7 (Cl), 20.3 (Ca), 21.8 (Cb), 26.3 
(Cn), 31.5 (Ck), 34.8 (Cj ), 34.9 (Cg), 35.9 (Cc), 41.7 (Cf), 62.2 (Ch), 113.7 (Cr ), 
34 
126.4 (Ce), 137.9 (Cd), 142.5 (Ci); mJz (El) 325 (M+, 3%), 221 (4), 177 (48), 133 
(75),119 (60), 105 (54), 89 (100), 75 (100), 69 (36), 50 (55), 43 (77). 
(1,I-Dimethylethyl)({2-[6-eth-l-enyl-3,4-dimethulcyclohex-2-enyllethyl}oxy) 
diphenylsilane 150 
b 
To a solution of olefin 148 (2.0 g, 11.1 mmol) in dry N,N-dimethylforrnamide (15 
mL), were added successively tert-butyldiphenylsilyl chloride (3.1 mL, 1.1 equiv.) 
and imidazole (3.8 g, 5 equiv.) dissolved in dry N,N-dimethylforrnamide (20 mL) 
at 0 QC under a nitrogen atmosphere. The mixture was stirred overnight at room 
temperature. The solution was concentrated in vacuo in order to evaporate N,N-
dimethylforrnamide, which is partly soluble in water. The product was dissolved in 
dichloromethane (30 mL) and washed with a solution of hydrochloric acid (0.2M) 
until the aqueous layer became acidic. The aqueous layer was washed with diethyl 
ether (2 x 30 mL). The combined organic layers were finally washed with brine 
(40 mL) then dried over magnesium sulfate. The solvent was removed in vacuo to 
give the protected alcohol 150 as a yellow oil (2.7 g, 58%); (Found: M+, 
418.18566. C2sH3sOSi requires 418.26919) ; Vrnax (DCM)/cm-' 3069 (CH2=C), 
1638 (C=C); OH (400 MHz, CDCb) 1.00 (3H, d, 3 J 6.8, 3Ha), 1.04 (9H, s, 9Hn), 
1.10-1.38 (2H, m, Hg, Hk), 1.73 (3H, br q, 3 J 1.3, 3Hb), 1.62-1.79 OH, m, Hg" Hk')' 
2.03-2.17 (lH, m, Hj ), 2.21-2.30 (!H, m, He), 2.30-2.47 (IH, m, H f), 3.67-3.73 
(2H, m, 2Hh), 4.94-4.96 (lH, m, Hr'), 4.96-4.98 OH, br d, 3 J 1.3, Hr), 5.40 (lH, td, 
35 
3J 5.2, 3J 1.6, He), 5.77-5.90 (lH, rn, Hi), 7.36-7.40 (6H, rn, 4Hm, 2Hp), 7.65-7.69 
(4H, rn, 4Ho); Cc (400 MHz, CDCh) 19.2 (Cl)' 19.9 (Ca), 21.4 (Cb), 26.9 (Cn), 33.1 
(Ck), 34.2 (Cj ), 34.4 (Cg), 35.5 (Cc), 42.0 (Cl), 62.5 (Ch), 113.3 (Cr), 124.3 (Ce), 
126.0 (Cm), 127.6 (Cp), 134.0 (Cq), 134.1 (Co) 142.1 (Cd), 143.3 (Ci); mlz (El) 418 
(M+, 7%), 361 (35), 283 (23),255 (38), 239 (15), 225 (81), 199 (100), 183 (57), 
161 (16), 135 (26),105 (25), 91 (19),77 (18),43 (14). 
36 
tert-Butyl{2-[6-({[tert-butyl(dimethyl)silyl]oxy}methyl)-3,4-dimethyl-2-
cyclohexen-l-yl]ethoxy}dimethylsilane 155 
b 
The diprotected compound 155 was formed during the synthesis of 146: 
(Found: M+, 412.48547. C23H4S02Siz requires 412.31928); Vmax (DCM)/cm'! 1666 
(C=CH), 843 (C=CH); OH (400 MHz, CDCb) 0.01 (12H, 2 s, 12Hm), 0.86 (18H, s, 
18Hn), 0.94 (3H, d, 3J 6.8, 3Ha), 1.21-1.26 (IH, tdd, 3J 10.6, 3J 7.8, 2J 4.9, Hg), 
1.55-1.62 (3H, m, Hg, 2Hk), 1.60 (3H, br d, 3 J 1.2, 3Hb), 1.75-1.90 (lH, m, Hj ), 
1.95-2.05 (lH, m, Hc), 2.10-2.30 (IH, br q, 3J 5.0, Hf)' 3.39-3.45 (IH, dd,2J 10.0, 
3 J 8.0, Hi), 3.45-3.50 (!H, dd,2J 10.0, 3 n.l, Hr), 3.57-3.68 (2H, m, Hh), 5.43 (!H, 
dt,3 J 5.52, 3 J 1.58, He); Cc (400 MHz, CDCb) -4.9 (Cm), 18.7 (Cl), 20.0 (Ca), 21.8 
(Cb), 26.3 (Cn), 31.5 (Ck), 32.7 (Cr), 33.9(Cg), 35.1 (Cc), 40.4 (Cj ), 62.3 (Ch), 65.7 
(Ci), 125.1 (Ce), 138.3 (Cd)' 
37 
tert-ButyI{2-[6-({[tert-butyl(diphenyl)silylloxy}methyl)-3,4-dimethyl-2-
cyclohexen-t-yllethoxy}diphenylsilane 156 
b 
The diprotected compound 156 was isolated during the synthesis of 147: 
(Found: M+, 660.65417. C43Hs602Si2 requires 660.38188); Vrnax (DCM)/cm·l 2917 
(=CH), 726 (ArCH); ~ (400 MHz, CDCh) 0.98 (3H, d, 3 J 7.0, 3Ha), 1.04 (I8H, s, 
18H.), 1.04-1.56 (IH, m, Hg), 1.56-1.70 (3H, m, 2 Hk, Hg.), 1.59 (3H, s, 3Hb), 
1.81-1.88 (lH, m, Hj ), 2.05-2.10 (IH, m, He), 2.30-2.45 (lH, m, Hr), 3.49-3.56 
(2H, m, 2Hj ), 3.69-3.75 (2H, m, 2Hh), 5.39 (IH, m, He), 7.35-7.38 (l2H, m, 8Hm, 
4Hp), 7.63-7.66 (8H, m, 8Ho); Cc (400 MHz, CDCI3) 19.2 (Cl), 19.9 (Ca), 21.0 
(Cb), 26.7 (Cn), 31.0 (Ck), 31.8 (Cr), 32.6 (Cg), 33.2 (Cc), 36.5 (C), 62.0 (Ch)' 66.0 
(Cj ), 126.1 (Ce), 127.6 (Cm), 129.5 (Cp), 134.1 (Cq), 135.6 (Co), 137.9 (Cd). 
38 
I-Hydroxy-l,2-benziodoxol-3(IH)-one (IBX) 1685 
In a 1L, three necked, round-bottomed flask fitted with a mechanical stirrer, 
condenser and a thermometer in immersion, potassium bromate (40.0 g, 1.5 equiv) 
was vigorously stirred in 2M sulphuric acid (375 mL) at 60 QC. 2-iodobenzoic acid 
(40.0 g, 0.2 mol) was added in portions to the mixture over 40 minutes. The 
mixture was stirred for 2.5 hours at 65 QC and subsequently allowed to cool to 
OQC. Filtration and washing of the solid with 250 mL of cold distilled water and 
ethanol (2 x 40 mL) followed by a second washing with 250 mL of cold distilled 
water gave 168 as a colourless solid (73.5 g, 95%); mp 232-233 QC (lit} mp 233) 
39 
1,1,1-Triacetoxy-I,I-dihydro-I,2-benziodoxol-3(IH)-one (DMP) 1696 
AeO OAe 
\/ 
cqr"-OAe I '0 
.0 
o 
IBX 168 (20.1 g, 62.4 mmol) was added to a 250 mL round-bottomed flask 
containing acetic anhydride, para-toluenesulphonic acid monohydrate (0.1 g, 9.3 
mmol), and a magnetic stirring bar. The flask was equipped with a drying tube and 
was immersed in an oil bath at 80 QC. The mixture was stirred for 2 hours and then 
allowed to cool in an ice-water bath. The cold mixture was filtered through a 
fritted glass funnel and washed with anhydrous ether (5 x 50 mL) under a nitrogen 
atmosphere. The resulting white solid 169 (20.0 g, 75.5%) was quickly transferred 
to a nitrogen flushed glass pot and stored in a freezer: mp 135 QC (lit.,s 133-134 
QC); Vmax (neat)/cm·1 1732.4 (acetate C=O), 1721.5 (endocycJic C=O); ~ (400 
MHz, CDCh) 1.99 (6H, s, COCH3), 2.29 (3H, s, COCH3), 7.86 (IH, t, J 7.2, H 
arom), 8.04 (JH, t, J 8.5, H arom), 8.27 (lH, d, J 8.5, H arom), 8.29 (lH, d, J 7.2, 
H arom); oe (400 MHz, CDCI3) 20.2 (2 COCH3), 20.3 (COCH3), 126.8 (C arom), 
127.2 (CH arom), 131.6 (CH arom), 133.6 (C arom), 135.7 (CH arom), 141.9 (CH 
arom), 168.1 (endocyclic C=O), 172.5 (acetate C=O), 175.5 (2 acetate C=O). 
40 
Sodium carbonateJCelite® 1737 
The preparation of the reagent was reported by Fetizon et al.7 
The Celite® support (35.0 g) was washed with methanol (500 mL) containing 10% 
concentrated hydrochloric acid followed with distilled water until neutral (about 
500 mL).The purified Celite® was dried at 120 cC overnight in an oven. 
The dried purified Celite® (31.2 g) was added to a mechanically stirred solution of 
silver nitrate (35.4 g, 209.0 mmol) in distilled water (215 mL). Saturated sodium 
carbonate (11.3 g, 107.0 mmol) in distilled water (355 mL) was then added slowly 
to the resulting homogenous suspension. When the addition was completed, 
stirring was continued for a further 10 minutes. The yellow-green precipitate 
formed was filtered off and dried in vacuo overnight. The silver carbonate/Celite® 
reagent contains about lmmol of silver carbonate, 0.6 g.7 
41 
Methyl 3-hydroxy-2-{[(E)-(2-hydroxyphenyl)methylidene]amino}propanoate 
188 
To a solution of methyl D,L-serinate hydrochloride 186 (1.1 g, 7.0 mrnol) in 
ethanol (35 mL) were added successively, at room temperature, triethylamine (1.1 
mL, 7.9 mmol) and salicylaldehyde (0.8 mL, 1.0 equiv.). The mixture was allowed 
to stir for 5 hours. After removal of the solvent in vacuo, the residue was purified 
by chromatography on silica gel using acetonitrile as eluent. The ligand 188 was 
obtained as a yellow oil (lA g, 90%) (Found: M+, 223.08446. CllH13N04 requires 
223.08446); Vrnax (neat)!cm'! 3444, 1740, 1632, 1279; ~ (400 MHz, CDCh) 3.77 
(3H, s, CH3), 3.95 (lH, m, CH), 4.13 (2H, m, CHz), 6.90-6.98 (2H, m, H arom), 
7.22-7040 (2H, m, H arom), 8042 OH, s, CH-Ar), 12.85 OH, s, OH); lie (400 MHz, 
CDCh) 52.6 (CH3), 63.7 (CHzO), 72.6 (CH), 117.2 (CH arom), 118.6 (C arom), 
119.0 (CH arom), 132.0 (CH arom), 133.2 (CH arom), 160.9 (C arom), 168.6 
(CHPh), 170.5 (COzMe); mlz (El) 223 (M+, 62%), 192 (28),164 (38), 132 (lOO), 
107 (62),77 (33). 
42 
2-(2-{ [/erl-Butyl( diphenyl)silyl]oxy }ethyl)-I-hydroxy -4,5-dimethyl-3-
cycIohexene-l-carbaldehyde 194 and 195 
b 
a 
The siIyl ether 228 (0.5 g. 0.8 mmol) was added to a solution of dimethyldioxirane 
in acetone (0.064 M. 12.2 mL, I equiv.) at 0 cC. The solution was allowed to reach 
room temperature and stirred overnight. 
The reaction mixture was washed with 10 mL of brine and extracted with dietbyl 
ether (2 x 20 mL). The combined organic layers were dried over magnesium 
sulfate and concentrated in vacuo. The reaction afforded 194 and 195 as a yellow 
oil. The mixture was inseparable but characterised. 
The LCIMS (ACN 100%) 476.67 (C27H3603Si + ACN); Yrnax (neat)/cm·l 3429 
(OH). 2933 (CHO). 1716 (CHO); ~ (400 MHz. CDCh) 0.96 (3H, In, 3HJ. 1.12 
(9H, s, 9Hn), 1.20-2.00 (5H, m, 2Hk, 2Hg, Hc), 1.68 (3H, s, 3Hb), 2.40-2.50 (lH, m, 
Hr), 3.65-3.85 (2H, m, 2Hh), 5.35 (lH, m, He), 7.30-7.40 (6H, m, 4Hrn, 2Hp), 7.50-
7.62 (4H, m, 4Ho), 9.60 (0.3H, m, O.3Hj), 9.69 (0.7H, m, 0.7HD; Bc (400 MHz, 
CDCb) 17.7 (Cl), 19.0 (Ca), 19.2 (Cb), 25.6 (Cn), 31.7 (Cc or Cr), 34.5 (Ck or Cg), 
37.7 (Ck or Cg), 41.4 (Cc or Cr), 61.7 (Ch), 64.5 (C), 121.5 (Ce), 127.7 (Cm>, 129.6 
(Cp), 134.8 (Co), 135.2 (Cq), 135.6 (Cd), 204.7 (Cj). 
43 
fer/-Butyl azidoformate 2018 
A solution of tert-butyl carbazate 200 (100.0 g, 0.8 mmol) in glacial acetic acid 
(82 mL) and water (125 mL) was allowed to cool in an ice-bath. A solution of 
sodium nitrite (57.4 g, 1.0 equiv.) in water (80 mL) was added to the mixture over 
a period of I hour under vigorous stirring, keeping the temperature at about IQ DC. 
The mixture was allowed to stir in the ice-bath for 30 minutes and water (125 mL) 
was added. The yellow azide layer was separated and the aqueous layer extracted 
with dietbyl ether (4 x 40 mL). The combined organic layers were washed 
subsequently with water (3 x 50 mL) and IM sodium bicarbonate solution (3x 40 
mL). The light yellow solution was dried over magnesium sulfate and the solvent 
removed in vacuo. The compound 201 was obtained by Kiigelrohr distillation as a 
light yellow oil (76.8 g, 71 %); bp 74°C (70mmHg); Vrnax (DCM)/cm-1 2180 (N3), 
1732 (O-C=O), 1396 (-C(CH3»; ~ (400 MHz, CDCh) 1.51 (9H, s, 3 CH3); Oc 
(400 MHz, CDCh) 28.2 (CH3), 85.3 (C), 156.3 (CO); too volatile to get mass data. 
44 
tert-Butyl N-hydroxycarbamate 201a8 
To a cold (0 cC) and vigorously stirred solution of tert-butyl azidoformate 201 
(13.0 g, 0.1 mol) and hydroxylamine hydrochloride (13.0 g, 1.3 equiv.) in water 
(500 mL), a cold solution of sodium hydroxide (22.4 g, 4.0 equiv.) in water (80 
mL) was added dropwise over 1 hour. The reaction was allowed to stir for 1 hour 
at 0 cC. The solid precipitate formed was then dissolved with water (100 mL).The 
solution was extracted with diethyl ether (2 x 50 mL) and the extracts discarded. 
The aqueous solution was allowed to cool in an ice bath and acidified to pH 5 with 
about 75 mL of 6M hydrochloric acid. The resulting mixture was extracted with 
diethyl ether (5 x 50 mL). The combined organic layers were dried and 
concentrated in vacuo. The thick oil was drained to leave a solid giving 201' as a 
white powder (18.5 g, quantitative) (Found: M+, 133.08200. CSHllN03 requires 
133.07389) (Found: C, 45.24; H, 8.37; N, 10.47. requires C, 45.13; H, 8.33; N, 
10.53%); mp 57 cC (lit} 58-59 cC); Vmax (DCM)lcm'l 3300 (OH) and 1715 
(carbamate C=O); OH (400 MHz, CDCh) 1.48 (9H, s, qCH3)3), 7.05 (1H, br, OH); 
3c (400 MHz, CDCh) 28.2 (CH3), 82.1 (OCMe3), 156.7 (CO); mlz (El) 134 (M+, 
12%),115 (77), 77 (33), 57 (100), 43 (34). 
45 
tert-Butyl hydroxy(methyl)carbamate 2029,10 
202 was prepared as it was reported by House and Richey,9 
To a cold (0 QC) stirred mixture of tert-butoxycarbonyl azide 201 (15.6 g, 0.1 mol) 
and N-methylhydroxyl amine hydtochloride (10,0 g, 2.0 equiv.), a solution of 
sodium hydroxide (16.4 g, 4.0 equiv.) in water (145 mL) was added, dropwise 
over I hour. The cooling bath was removed and the reaction was let to stir for 3 
hours and partitioned between ethyl ether (lOO mL) and water. The aqueous phase 
was acidified to pH 5 with 6N hydrochloric acid and extracted with diethyl ether (5 
x 50 mL). The combined organic layers were dried and concentrated in vacuo. 
Distillation of the residual liquid gave the N-hydroxycarbamate 202 as a colourless 
liquid (12.8 g, 79%). 
202 was also prepared by following this procedure: 10 
A solution mixture of tert-butyl hydroxycarbamate 201a (12.0 g, 91,0 mrnol), 
potassium hydroxyde (6.1 g, 1,2 equiv.) and methyl iodide (8.5 mL, 1,5 equiv.) in 
ethanol (750 mL) was heated under reflux for 5 hours. The resulting mixture was 
allowed to cool to 0 QC and filtered. After evaporation of the solvent, the residue 
was extracted with diethyl ether (3 x lOO mL). The combined organic extracts 
were washed with water (3 x 20 mL) and dried with sodium sulfate. The solvent 
was removed. Distillation of the residual liquid gave the N-hydroxycarbamate 202 
as a colourless liquid (12.3 g, 92%) (Found: M+, 147.48831. C6H13N03 requires 
147.08954); vmax (DCM)/cm·1 3176 (OH) and 1720 (carbamate C=O); OH (400 
MHz, CDCh) 1,47 (9H, s, C(CH3h), 3.11 (3H, m, NCH3), 7.34 (lH, br, OH); Cc 
(400 MHz, CDCh) 28.2 (CH3), 38.1 (NCH3), 82.4 (OCMe3), 157,9 (CO); rnlz (El) 
147 (M+, 21 %), 133 (42), 129 (52), 91 (64),57 (lOO), 43 (53). 
46 
tert-Butyl acetyloxy(methyl)carbamate 2039 
To a cold (0 QC) solution of carbamate 202 (12.8 g, 87.0 mmol) and anhydrous 
triethylamine (14.5 mL, 1.2 equiv.) in dichloromethane (420 mL) acetyl chloride 
(8.0 mL, 1.3 equiv.) was added dropwise. The resulting mixture was stirred for 1 
hour at room temperature and then partitioned between a saturated aqueous 
solution of bicarbonate (50 mL) and dichloromethane. The organic layer was dried 
over sodium sulfate and concentrated in vacuo. Distillation of the residual liquid 
gave the N-acetoxycarbamate 203 as a colourless liquid (16.0 g, 97%) (Found: M+, 
189.6773. CSH1SN04 requires 189.10011); Vrnax (neat)/cm-1 1791 (acetate C=O), 
1717 (carbamate C=O); OH (400 MHz, CDCh) 1.47 (9H, s, QCH3h), 2.14 (3H, m, 
CH3CO), 3.22 (3H, br, CH3N); Oc (400 MHz, CDCh) 18.5 (CH3CO), 27.9 (CH3), 
37.8 (NCH3), 82.3 (OCMe3), 157.9 (NC=O), 155.1 (CH3CO); mlz (El) 189 (M+, 
42%),133 (46), 115 (lOO), 99 (45),89 (100), 74 (21), 57 (100), 43 (100). 
47 
N-(Acetyloxy)methanaminium chloride 2049 
A solution of N-acetoxy carbamate 203 (1.6 g, 6.4 mmol) in anhydrous diethyl 
ether (10 mL) was treated with anhydrous hydrochloric acid (0.2 M) in diethyl 
ether (50 mL, 100 mmol).The reaction mixture was allowed to stir for 3 days at 
room temperature under a nitrogen atmosphere. The white precipitate formed was 
filtered and washed with anhydrous diethyl ether, and dried in vacuo. N-
acetoxyamine hydrochloride 204 was obtained as a white powder (0.8 g, 75%) 
(Found: M+, 89.047765. C3H8CIN02 requires 90.055504) (Found: C, 29.14; H, 
6.15; N, 11.18. requires C, 28.82; H, 6.45; N, 11.20%); mp 115 DC (0.70 mm) (lit., 
9 109-111 DC (0.70 mm)); Vmax (DCM)lcm·1 1797 (acetate C=O); 15H (400 MHz, 
CDCh) 2.28 (3H, m, CH3CO), 3.10 (3H, t, J 11, CH3N); lie (400 MHz, CDCh) 
18.4 (CH3CO), 35.8 (NCH3), 154.1 (CO); mlz (El) 89 (M+, 40%), 77 (62), 46 (24), 
43 (lOO). 
48 
tert-Butyl(2-{ 6-[ (2-methoxyethenyl]-3,4-dimethyl-2-cyclohexen-l-
yl}ethoxy)diphenylsilane 213 
b 
r 
a 
/s 
a 
To a solution of aldehyde 112 (0.2 g, 0.5 mmol) and sulfone 107 (0.1 g, 1.2 equiv.) 
in tetrahydrofuran (6 mL) at 0 °C, lithium hexamethyldisilylazide IM (0.2 g, 2.4 
equiv.) was added dropwise. The reaction was stirred overnight at room 
temperature. The reaction mixture was quenched with saturated aqueous 
ammonium chloride (10 mL) and extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were washed with 50 mL of brine, dried over magnesium 
sulfate and concentrated in vacuo. The crude product was purified by 
chromatography on silica gel using light petroleum! ethyl acetate (9: 1) as eluent to 
give the desired product 213 as a colourless oil (0.14 g, 62%) (Found: M+, 
448.27200. C29~o02Si requires 448.27976); Vmax (DCM)/cm'! 2855 (CH30), 1650 
(enol ether), 744 (ArCH); ~ (400 MHz, CDCh) 0.88 (3H, s, 3H.), 0.95 (9H, s, 
9Hn\ 1.01-1.30 OH, m, Hg), 1.30-1.61 (IH, m, Hk), 1.51 (3H, m, 3Hb), 1.69-1.78 
(!H, m, Hg·), 2.04-2.07 (!H, m, He), 2.07-2.10 (OAH, m, Hj cis), 2.10-2.19 (IH, m, 
Hk·), 2.19-2.25 (0.6H, m, Hj ttans), 2.71-2.78 (!H, m, Hr), 3.41 and 3.45 (3H, 2 s, 
3Hs), 3.60-3.68 (2H, m, 2Hh), 4.26 (O.4H, ddd, 3 J 12.7, 3 J 9.3,3 J 6.4, Hr cis), 4.70 
(0.6H, ddd, 3 J 15.6, 3 J 12.7,3 J 7.2, Hr !Tans), 5.82 (O.4H, dd, 3J 6.3, 3 J 1.2, Hi cis), 
6.27 (0.6H, dd, 3 J 12.7,3 J 0.7, Hi trans), 5.25-5.30 (lH, m, He), 7.26-7.33 (6H, m, 
4Hm, 2Hp), 7.57-7.61 (4H, m, 4Ho); Cc (400 MHz, CDCh) 19.3 (C,), 19.9 (Ca), 
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21.4 and 21.5 (Cb), 26.9 and 26.9 (Cn), 32.9 (Cr), 34.1 and 34.5 (Cg), 34.6 and 35.1 
(Cc), 34.9 and 35.0 (Ck), 36.7 (Cj ), 55.9 and 59.5 (Cs), 62.6 and 62.8 (Ch), 106.4 
and 109.8 (Cr), 126.2 and 126.3 (C.), 127.6 and 127.6 (Cm), 129.5 and 129.5 (Cp), 
134.18 and 134.26 (Cq), 135.63 (Co), 137.2 and 137.4 (Cd), 145.3 and 146.4 (Ci); 
mlz (El) 448 (M+, 24%), 417 (20), 390 (33), 224 (38), 239 (11), 209 (100), 193 
(52), 161 (24), 135 (32), 105 (19), 77 (34), 43 (52). 
50 
({ [2-(2-{ [ferf -Butyl( diphenyl)silyljoxy }ethyl)-4,S-dimethyl-3-cycIohexen-l-
ylidenejmethyI}oxy)(triisopropyl)silane 222 
b 
a 
j Iy 
i 0 A-< 
s t 
To a solution of aldehyde 112 (0.9 g, 2.2 mmol) in dry dichloromethane (20 mL) 
at 0 DC successively triisopropyl silyl trifIate (0.7 mL, 1.2 equiv.) and 
triethylamine (0.5 mL, 2.6 equiv.) was added. The solution was allowed to reach 
room temperature and was stirred overnight. The crude reaction mixture was 
washed with a saturated aqueous solution of copper sulfate (3 x 30 mL). The 
combined organic layers were dried over magnesium sulfate and concentrated in 
vacuo. The crude product was purified by chromatography on silica gel using light 
petroleum! diethyl ether (100: 1) as eluent to give the desired product 222 as a 
colourless oil (0.97 g, 34%); one isomer has been isolated: (Found: M+, 
576.38267. C36H5602Siz requires 576.38189); Vrnax (neat)/cm·l 3069 (=CH), 1673 
(enol ether), 738 (=CH aromatic); OH (400 MHz, CDCh) 0.00 (3H, s, 3Hr), 0.95 
(I8H, s, 9Hs, 9Ht), 0.98 (3H, d, J 6.8, 3Ha), 1.07 (9H, s, 9Hn), 1.60 (3H, s, 3Hb), 
1.60-1.80 (3H, m, 2Hg, Hk), 1.85-1.95 (IH, s, Hk-), 1.95-2.05 (lH, rn, He), 3.10-
3.20 (IH, rn, Hr), 3.65-3.72 (2H, m, 2Hh), 5.30 (lH, m, He), 6.07 (lH, m, Hi), 7.33-
7.40 (6H, m, 4Hm, 2Hp), 7.64-7.68 (4H, m, 4Ho); oe (400 MHz, CDCh) 0.0 (Cr), 
11.9 (Cs or Ct), 17.8 (Cs or Ct), 19.2 (Cl), 19.4 (Ca), 21.1 (Cb), 26.9 (Cn), 31.7 (Cr), 
33.8 (Ck), 36.2 (Cc), 38.5 (Cg), 63.1 (Ch), 119.4 (Cj ), 125.5 (Ce), 127.7 (Cm), 129.4 
(Cp), 132.1 (Ci), 134.3 (Cq), 135.6 (Co), 137.3 (Cd); mlz (El) 576 (M+, 1 %), 535 
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(7), 361 (6), 287 (36), 199 (100), 181 (35), 131 (79), 103 (69), 75 (100), 61 (54), 
45 (60). 
ferf-Butyl {2-[ 6-(1,3-dioxolan-2-yl)-3,4-dimethyl-2-cyclohexen-l-
yljethoxy}diphenylsiIane 223 
b 
A mixture of lactone 112 (0.3 g, 0.7 mmol), ethylene glycol (0.4 g, 10.0 equiv.) 
and PPTS (10% mol.) in toluene (10 mL) was heated under reflux with 
azeotropique removal of the water using a Dean-Stark apparatus and was allowed 
to stir for 5 hours. The mixture was cooled down and poured into saturated 
aqueous sodium bicarbonate (50 mL). The organic phase was washed with 
saturated sodium chloride (50 mL), dried over sodium sulfate and concentrated in 
vacuo. The crude product was purified by column chromatography using 
petroleum ether / ethyl acetate (49:1) and afforded the acetal 223 as a colourless 
oil (85.7 rng, 26%) (Found: M+, 465.17583. C29~003Si requires 464.27467); Vrnax 
(neat)lcm'] 2932 (=CH), 2781 (O-CH-O); Ou (400 MHz, CDCb) 1.02 (3H, d, 3 J 
7.0, 3H.), 1.04 (9H, d, 9Hn), 1.30-1.64 (2H, rn, Hg, Hk), 1.62 (3H, s, 3Hb), 1.63-
1.69 (2H, rn, Hg., Hk·), 1.90-2.10 (lH, rn, Hc), 2.27-2.35 (!H, rn, Hr), 2.44-2.56 
(!H, m, Hj ), 3.64-3.69 (!H, m, Hh), 3.70-3.79 (!H, rn, Hh·), 3.84 (2H, rn, 2Hx), 
3.91 (2H, rn, 2Hx), 4.74 (!H, m, HD, 5.53 (!H, d, 3 J 5.2, He) 7.26-7.43 (6H, rn, 
4Hm, 2Hp), 7.66-7.70 (4H, rn, 4Ho); /le (400 MHz, CDCI3) 19.8 (Cl)' 20.0 (Ca), 
21.5 (Cb), 27.4 (Cn), 31.7 (Ck), 32.4 (Cr), 35.0 (Cg), 35.4 (Cc), 41.0 (Cj ), 61.9 (Ch), 
66.7 (Cx), 106.7 (C j ), 126.8 (Ce), 127.4 (Cm), 129.9 (Cp), 134.3 (Cq), 136.1 (Co), 
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137.9 (Cd); mlz (El) 464 (M+, 12%), 337 (15), 239 (14), 225 (56), 165 (25), 127 
(74), 107 (35), 99 (24), 77 (88), 73 (54), 57 (63), 41 (57). 
(2-{ 2-[ (2,2-Dimethylpropanoyl)oxy jethyl }-4,5-dimethyl-3-cydohexen -1-
yl)methyl pivalate 224 
b 
To a solution of diol145 (0.5 g, 2.7 mmol) in dichloromethane (10 mL) pyridine 
(0.3 mL, 1.2 equiv.) and pivaloyl chloride (0.32 g, 1 equiv) was added at 0 QC. The 
reaction mixture was allowed to stir for 5 hours at room temperature. The reaction 
was quenched by addition of saturated ammonium chloride (11 mL). The aqueous 
phase was extracted with ethyl acetate (2 x 50 mL). The combined organic layers 
were finally dried over magnesium sulfate and solvent removed in vacuo. 
Purification of the crude product was done by column chromatography on silica 
gel using a solution of petroleum ether / ethyl acetate (9: I) and afforded the 
diprotected alcohol 224 as a yellow oil (0.95 g, 42%) (Found: M+, 352.63675. 
CZIH3604 requires 352.26136); vmax (neat)/cm,l 1725 (O-C=O); ~ (400 MHz, 
CDCI3) 0.90-1.30 (3H, m, 2Hg, Ht), 0.99 (3H, d, 3 J 6.8, 3Ha), 1.32 (ISH, s, 18Hu), 
1.42-1.47 OH, m, Hk·), 1.58 (3H, s, 3Hb), 1.90-2.00 (lH, m, He), 2.39-2.45(lH, m, 
Hj ), 2.48-2.55 OH, m, Hr), 3.92 and 4.27 (2H, 2 m, 2 Hi), 4.13-4.22 (lH, m, Hh), 
4.23-4.32 OH, m, Hh,), 5.37 (lH, d, 3 J 5.2, He); Bc (400 MHz, CDCh) 20.0 (Ca), 
21.6 (Cb), 25.3 (Cu), 31.9 (Ck), 30.1 (Cg), 32.7(Cr), 34.8 (Cc), 36.6 (Cj), 38.6 (C,), 
63.7 (Ch), 68.7 (Ci), 124.6 (Ce), 137.8 (Cd), 175,0 (C,). 
53 
[(2-{ 3,4-Dimethyl-6-[ (trityloxy )methyI1-2-cyclohexen-l-
yl}ethoxy)(diphenyl)methyll benzene 225 
b 
p m 
To a solution of diol145 (0.5 g, 2.7 nunol) in N,N-dimethylfonnamide (10 mL) a 
catalytic amount of DMAP (10% mol.) and trityl chloride (75.2 mg, 1 equiv.) was 
added at 0 CC. The reaction mixture was stirred overnight at room temperature. 
The solvent was removed in vacuo. The residue was dissolved in dichloromethane 
(20 mL) and washed with saturated aqueous ammonium chloride (10 mL). The 
two phases were separated and the aqueous phase was extracted with diethyl ether 
(2 x 50 mL). The combined organic layers were finally dried over magnesium 
sulfate and solvents removed in vacuo. Purification of the crude product was done 
by column chromatography on silica gel using a solution of petroleum ether / ethyl 
acetate (4:1) and afforded the diprotected alcohol 225 as a yellow oil (0.67 g, 37%) 
(Found: M+, 669.254537. C49lLJ802 requires 668.36543); Vmax (neat)!cm-1 720 (CH 
arom), 698 (CH arom); OH (400 MHz, CDCh) 0.94-1.00 (lH, m, Hk),1.00 (3H, d, 
3 J 6.8, 3H.), 1.26-1.30 (lH, m, Hg), 1.40-1.45 (lH, m, Hk·), 1.62-1.70 OH, m, Hg·), 
1.62 (3H, s, 3Hb), 1.90-2.00 (IH, m, Hc), 2.12-2.24 (lH, m, Hj), 2.41-2.51 (lH, m, 
He), 3.46 and 3.56 (2H, 2 m, 2Hi ), 3.42-3.51 OH, m, Hh), 3.52-3.61 (lH, m, Hh·), 
5.29-5.35 OH, m, He), 7.15-7.26 (30H, m, 12Hm, 6Hp, 12Ho); Oc (400 MHz, 
CDCh) 20.0 (Ca), 21.5 (Cb), 32.0 (Ck), 31.2 (Cg), 32.6(Ce), 35.1 (Cc), 38.6 (Cj), 
64.6 (Ch), 70.6 (C i), 86.0 and 86.4(C1), 123.8 (Cm), 125.6 (Ce), 126.9 (Cp), 129.8 
(Co), 136.6 (Cd), 143.9 (Cq). 
54 
Solution of dimethyldioxirane in acetone 228 11 
0-0 
X 
A 2 L flask was filled with water (127 mL) and acetone (96 mL). Sodium 
hydrogenocarbonate (29.0 g) was added through a solid addition funnel. The 
resulting white suspension was stirred mechanically and vigorously, and the 
reaction was allowed to cool to 0 QC in an ice bath. Oxone (60.0 g) was added to 
the reaction mixture under vigorous stirring. The solid addition funnel was then 
removed and replaced with a thermometer adapter fitted with the thermometer in 
order to keep the temperature of the exothermic reaction mixture between 0 and 5 
QC. After 15 minutes, a conelflexible tubing adapter was connected to a pump and 
a moderate vacuum (100 mmHg) was applied. The reaction mixture was allowed 
to rise 30 QC by means of a warm water bath. The pale yellow effluent of 
dimethyldioxirane-acetone solution was collected in the previously cooled 
receiving flask at -78 QC over 4 hours. When the distillation was over, the pump 
was disconnected and a nitrogen flux was connected to the conelflexible tubing 
adapter. The dimethyldioxirane solution obtained was kept on molecular sieves (4 
A) in a freezer. Iodometric titration allowed us to determine the concentration of 
dimethyldioxirane in the solution (75 mL, 0.05-0.08 M, 5% yield); Vrnax (neat)/cm-I 
2980 (O-C-O), 1210 (C-O); ~ (400 MHz, CDCh) 1.65 (6H, s, 6CH3); Bc (400 
MHz, CDCh) 22.1 (CH3), 214.0 (C(CH3)Z)' 
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Iodometric titration of dimethyldioxirane solution in acetone 
~>( + H + 2H+ o=< + H2O + 12 (1 ) 
228 
2s2ol + 12 21" + S4062. (2) 
Dimethyldioxirane 228 was first reacted with potassium iodide in an acidic 
medium. The oxidation-reduction reaction involved corresponds to the equation 
(1). 
The amount of iodine thereby liberated was subsequently titrated by an aqueous 
sodium thiosulfate solution according to the equation (2). 
The end point is, therefore, indicated by the total disappearence of the 
characteristic yellow colour of iodine. 
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